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ABSTRACT 
 
 The introduction of drinking water disinfection greatly reduced the incidence of 
waterborne diseases. However, the reaction between disinfectants and natural or synthetic 
organic matter in the source water can lead to an unintended consequence which is the 
formation of drinking water disinfection by-products (DBPs). Many DBPs are mutagenic, 
cytotoxic, genotoxic, carcinogenic, or teratogenic. Studies on the molecular mechanisms of 
toxic effects induced by DBPs, and the overall toxicity of DBP complex mixtures are limited. The 
objectives of this dissertation were to i) analyze the occurrence and comparative toxicity of the 
emerging haloacetaldehyde (HAL) DBPs, ii) investigate the molecular mechanism of DBP-
induced toxicity by the haloacetic acids (HAAs), iii) develop a single well microplate-based ATP-
protein assay as a novel toxicity metric for DBPs, iv) investigate the occurrence and in vitro 
mammalian cell toxicity of DBPs in European drinking water samples collected from the site 
where epidemiological studies on reproductive outcomes were being conducted (HIWATE), and 
v) determine the impact of iodinated X-ray contrast media (ICM) in the source water and the 
type of disinfectant on the overall toxicity of DBP mixtures. From this study, iodoacetaldehyde 
was identified as a new DBP and ten HALs induced in vitro cytotoxicity and genotoxicity in 
Chinese hamster ovary (CHO) cells. HALs were the second most cytotoxic DBP class among six 
DBP chemical classes reported in the literature. Three mono-halogenated HAAs (monoHAA) 
including chloroacetic acid, bromoacetic acid, and iodoacetic acid induced ATP depletion in CHO 
cells, and cellular ATP levels was recovered when they were simultaneously treated with 
pyruvate.  The magnitude of monoHAA-mediated ATP depletion highly correlated with the 
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monoHAA-induced inhibition kinetics of GAPDH and with diverse measurements of toxicity 
including cytotoxicity, genotoxicity, mutagenicity and teratogenicity published in the literature.  
A novel single well microplate-based ATP-protein assay was developed and with this assay, 
monoHAAs showed the greatest reduction in ATP levels while diHAAs showed a moderate 
reduction with higher concentration ranges. TriHAAs induced increases in ATP levels. The 
occurrence and in vitro mammalian cell toxicity of DBPs in the HIWATE study was investigated. 
The cytotoxic potency index values significantly correlated with the total number of identified 
DBPs and also with the concentration of 21 target DBPs. The genotoxic potency index values 
were not correlated with either of these metrics or with any DBP chemical class. In the ICM 
study, Iopamidol generated an enhanced level of CHO cell cytotoxicity and genotoxicity after 
disinfection, and the relative Iopamidol-mediated increase in toxicity was greater when 
chloramines was used as the disinfectant compared with chlorine. Four other ICMs (Iopromide, 
Iohexol, Diatrizoate and Iomeprol) expressed some cytotoxicity over the control, and expressed 
higher cytotoxicity when chlorinated. Only Iohexol enhanced genotoxicity compared to the 
chlorinated source water.  
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CHAPTER 1 
INTRODUCTION 
 
1.1. DRINKING WATER DISINFECTION BY-PRODUCTS 
 The introduction of water disinfection greatly reduced the incidence of waterborne 
diseases such as cholera and typhoid and is considered a major public health achievement of 
the 20th century [1]. Chlorine is the most common disinfectant used worldwide, and 
alternatives include ozone, chloramines, chlorine dioxide, and UV radiation [2-4]. However, the 
reaction between disinfectants and natural organic as well as inorganic matter in the water can 
lead to an unintended consequence which is the formation of drinking water disinfection by-
products (DBPs). The spectrum of DBP formation depends on many factors such as the source 
water characteristics, pH, temperature, type of disinfectant, and residence time [5-8].   
 Trihalomethanes (THMs) were the first DBP chemical class discovered in 1974 [9], and to 
date, more than 600 DBPs have been identified in finished drinking waters [6, 10]. Identified 
chemical classes of DBPs include THMs, haloacetic acids (HAAs), haloketones (HKs), 
haloacetaldehydes (HALs) and nitrogen-containing DBPs such as haloacetonitriles (HANs), 
haloacetamides (HAcAms) and hlaonitromethanes (HNMs). However, the chemical 
identification of the majority of DBPs, as the total organic halide in disinfected water, are 
unknown (Figure 1.1) [11]. While most of the DBP occurrence studies were conducted in U.S. 
and Canada, relatively little research has been published in Europe [12]. 
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 In 2006, the U.S. EPA issued the Stage 2 Disinfectants (D)/DBP Rule to control the 
maximum contaminant levels (MCLs) of certain DBPs. Currently, 11 DBPs are regulated in the 
United States (4 THMs; MCL = 80 µg/L, 5 HAAs; MCL = 60 µg/L, Bromate, BrO3
-; MCL = 10 µg/L, 
Chlorite, ClO2
-; MCL = 1.0 mg/L) [13]. Regulations of total THM levels have been established 
with various ranges worldwide (Austria, Belgium, Italy; MCL = 30 µg/L, Germany, Luxembourg, 
Sweden; MCL = 50 µg/L, Taiwan; MCL = 80 µg/L, China, Japan, Norway, Spain, and United 
Kingdom; MCL = 100 µg/L) [14].    
 The high dose in vivo bioassay results from National Institute of Cancer (NCI) indicated 
that THMs are carcinogenic [15] which generated public health concerns. Epidemiological 
studies demonstrated associations between DBPs in chlorinated water and an increased cancer 
risk such as bladder cancer, stomach cancer, and colon cancer [16-20]. Evidence on the 
association between DBPs and adverse pregnancy outcomes including spontaneous abortion, 
low birth weight (LBW), small-for-gestational-age (SGA), still birth, and preterm delivery were 
also found [21-24].  
 During the past decades, Plewa et al. established the first in vitro quantitative, 
systematic comparative studies on chronic cytotoxicity and genotoxicity of DBPs in mammalian 
cells (Figure 1.2 and Figure 1.3) [25, 26]. The cytotoxicity was measured by the reduction in cell 
density as a function of the DBP concentration over a period of 72 h (~3 cell cycles). The single 
cell gel electrophoresis (SCGE, or Comet) assay was used as the genotoxicity metric, which 
quantitatively measures genomic DNA damage in individual nuclei (Figure 1.3). These studies 
provided a direct comparison of the adverse biological impact of DBPs within DBP chemical 
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classes and identified those DBPs that were of highest concern for public health risks. These 
databases also provide guidelines to elucidate the structure-based mechanisms of DBPs toxicity. 
Based on the current results, iodinated and brominated DBPs in general, were shown to be 
more toxic than their chlorinated analogues [27-30]. Similarly, nitrogen-containing DBPs 
showed greater cytotoxicity and genotoxicity than carbon-containing DBPs [31]. These 
comparative databases continued to expand to include emerging DBPs such as haloacetonitriles 
(HANs) [26], haloacetamides (HAcAms) [27], hlaonitromethanes (HNMs) [29] and 
haloacetaldehydes (HALs) which are frequently detected in finished drinking water.   
 Our laboratory is investigating the mode of action of DBP toxicity. We discovered that 
the haloacetic acids (HAAs) inhibit glyceraldehyde 3-phosphate dehydrogenase (GAPDH) which 
is a primary controlling enzyme in glycolysis. When HAAs inhibit GAPDH activity, glycolysis is 
blocked resulting in decrease in pyruvate which is required by the tricarboxylic acid (TCA) cycle 
in the mitochondria. The disruption of the electron transport chain in the TCA cycle induces the 
generation of reactive oxygen species (ROS). Recently, it was found that the mono-halogenated 
HAAs (monoHAAs) inhibit GAPDH activity in a concentration-dependent manner [32] . The 
inhibition rate of GAPDH activity and the toxic potency of the monoHAAs were highly 
correlated.  The inhibition kinetics showed a strong correlation with other toxicological 
endpoints which were previously published [32]. Also, the HAA induced expression of many 
genes involved in ROS response [33]. The quantitative analyses to investigate the roles of 
pyruvate on ATP generation and ROS production is a goal of our laboratory.   
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  While investigating the toxicity of a single chemical is important, the toxicological 
effects of a complex DBP mixture should be considered carefully because the complex mixture 
represents the composition of finished water that people consume in daily life. Most 
correlations in published epidemiology studies are based on the level of total THM, and the 
level of other DBPs are often not considered [23, 24, 34, 35]. These studies may overlook the 
effect of emerging DBPs which may possess higher toxic potencies. In 2009, the European 
Union (EU) started a major research initiative named HIWATE (Health Impacts of long-term 
exposure to disinfection by-products in drinking WATEr) to investigate the occurrence and 
potential human health risks associated with long-term exposure to low levels of DBPs in 
drinking water [36]. During the February 2010 HIWATE Scientific Advisory Committee meeting 
in London, it was proposed to augment the study to include comprehensive analyses of the 
analytical chemistry and the analytical in vitro toxicology of the HIWATE drinking water samples 
collected from different distribution systems, where an epidemiologic study of reproductive 
outcomes was being conducted. This proposal became the foundation of a component of this 
dissertation. 
 Among various factors influencing the spectrum of DBPs in finished water, the source 
water characteristics may play an important role, especially in a local site where large amount 
of industrial or medical contaminants were being discharged. For example, Iodinated X-ray 
contrast media (ICM) are widely used at medical centers for soft tissues medical imaging such 
as organs, veins, and blood vessels. The worldwide consumption of ICM is around 3.5  106 
kg/year, and a single application can be up to 200g/d [37]. Incomplete removal of ICMs in 
wastewater treatment plants could lead to an elevation of ICM concentrations in streams and 
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rivers [38-41]. ICM are primary contributors to the total organic halogen burden in clinical 
wastewater and play a major role as a source of absorbable organic iodine in wastewater [42]. 
ICM may be good sources of iodine to form iodinated DBPs (iodo-DBPs), and the activated 
benzene rings and other functional groups that can react with oxidizing disinfectants may lead 
ICM to be potential DBP precursors. An international collaboration study (U.S. and Germany) is 
ongoing on the impacts of ICM on DBP formation and toxicity. The general hypothesis is that 
oxidizing disinfectants such as chlorine and chloramine react with ICM to form highly toxic iodo-
DBPs and higher molecular weight by-products of unknown toxicity. This study proposed to 
carry out controlled laboratory reactions of 5 ICMs (Iopamidol, Diatrizoate, Iopromide, 
Iomeprol, and Iohexol) with chlorine and chloramine under different condition to simulate 
drinking water treatment. In this dissertation, the mammalian cell cytotoxicity and genotoxicity 
of the reaction product mixtures from two experimental designs were measured to determine 
which ICM and reaction conditions give rise to toxicity, as a part of the overall project. 
 
1.2. RESEARCH OBJECTIVES  
 The overall research objective is to analyze the comparative toxicity of emerging 
haloacetaldehyde DBPs and to investigate the molecular mechanism of DBP induced toxicity 
with HAAs. Development of a single well microplate-based ATP-protein measurement assay 
with HAAs as a novel toxicity metric for DBPs is included as a part of the research. In addition to 
individual DBP studies, two DBP mixture studies are included in the dissertation. First study 
investigated the occurrence and in vitro mammalian cell toxicity of DBPs in European drinking 
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water samples collected from the site where the epidemiology studies on reproductive 
outcomes are being conducted in relation with the HIWATE project.  The other DBP mixture 
study focuses on the impact of ICM in the source water and the type of disinfectant on the 
overall toxicity of DBP mixtures. Specific research objectives are summarized below:  
 
1. The occurrence and comparative toxicity of the haloacetaldehyde disinfection by-products 
in drinking water   
 Develop new analytical chemical methods and identify the occurrence of a new 
haloacetaldehyde DBP in drinking water (In collaboration with Dr. Richardson and Dr. 
Postigo). 
 Analyze the in vitro cytotoxicity and genotoxicity of HALs and related compounds in 
mammalian cells.  
 Determine the cytotoxicity and genotoxicity index values of HALs and develop a 
quantitative, comparative toxicity database.  
 Conduct a mechanism-based structure-activity relationship analysis for the observed 
HAL mediated cytotoxicity and genotoxicity.  
2. Investigate the biological mechanism induced by haloacetic acid disinfection by-products 
and the development of a single well microplate-based ATP-protein measurement assay  
 Measure the impact of the monoHAAs on ATP levels with and without pyruvate 
supplementation. 
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 Develop a new single well microplate-based ATP-protein measurement assay with HAAs 
as a novel molecular toxicity metric for DBPs.  
3. The occurrence and toxicity of disinfection by-products in European drinking waters in 
relation with the HIWATE epidemiology study 
 Obtain disinfected drinking water from HIWATE cities, extract and concentrate the 
organic fractions and chemically analyze for DBPs (in collaboration with Dr. S. 
Richardson).  
 Determine the relative chronic cytotoxicity and acute genotoxicity in mammalian cells 
for each HIWATE sample. 
 Analyze for correlations between the toxicity data and the occurrence and 
concentrations of DBPs. 
4. The impact of X-ray contrast agents on formation and toxicity of disinfection by-products in 
drinking water  
 Generate XAD resin concentrates of source water treated with ICMs and disinfectants 
(in collaboration with Dr. S. Duirk). 
 Measure the mammalian cell cytotoxicity and genotoxicity of the reaction product 
mixtures. 
 Determine which ICM and reaction conditions give rise to toxic by-products.  
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FIGURES 
 
 
 
Figure 1.1. Summary of the distribution of median values of the DBP chemical classes in water analyzed 
in the U.S. EPA Nationwide Occurrence Study as a component of total organic halides [11].  
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Figure 1.2. Comparative CHO cell DBP chronic cytotoxicity database (above) and comparative CHO cell 
DBP acute genotoxicity database (below) conducted by Plewa and Wagner [26]. 
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Figure 1.3. Chinese hamster ovary (CHO) cell line AS 52, clone 11-4-8 (left). Images of single cell gel 
electrophoresis (SCGE) assay illustrating genomic DNA damage in a nucleus (right).  
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1. HALOACETALDEHYDE DISINFECTION BY-PRODUCTS 
2.1.1. Occurrence  
 Aldehyde DBPs are mainly formed through the use of ozone disinfectant where the 
typical levels of the sum of halogenated and non-halogenated aldehyde DBPs are 5 to 20 µg/L 
[1]. In 1996, the U.S. EPA Information Collection Rule (ICR) was announced, which the purpose 
was to collect information on the occurrence and control of microbial pathogens and DBPs in 
drinking water [2]. A large survey was conducted in 296 U.S. water utilities, which operated 
about 500 drinking water plants, including surface water systems and groundwater systems. 
The survey measured 4 THMs, 6 haloacetic acids (HAAs), and 6 other halogenated DBPs in the 
treatment plants and in the distribution systems. In this report, haloacetaldehdyes (HALs) were 
found to be at higher concentrations in water treatment systems using ozone than chlorine 
dioxide (up to 30.6 µg/L) [2].  
 Within the HAL DBP class, chloral hydrate (trichloroacetaldehyde, TCAL) is a major HAL 
identified. TCAL is primarily a chlorine or chloramine generated DBP, and the use of ozone prior 
to chlorination or chloramination is known to increase its formation [3]. According to the ICR, 
TCAL was detected to be at higher levels in the distribution system (median 2.8 µg/L; 90th 
percentile 11.0 µg/L) than in the finished water (median 1.7 µg/L; 90th percentile 7.4 µg/L) [2]. 
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 Chloroacetaldehyde (CAL) and dichloroacetaldehyde (DCAL) are formed in chlorinated 
drinking water. However, information on their occurrence is limited because they can easily be 
transformed into TCAL in water [1]. Previously, the occurrence of brominated HALs was not well 
reported in drinking water analysis because of the lack of commercial standards. Standards of 
bromochloroacetaldehyde (BCAL), dibromoacetaldehyde (DBAL), bromodichloroacetaldehyde 
(BDCAL), dibromochloroacetaldehyde (DBCAL) and tribromoacetaldehyde (TBAL) have been 
made commercially available recently. Brominated HALs are generated when bromide 
containing waters are chlorinated [4]. 
 In 2006, a nationwide occurrence study was published by Krasner et al. [3]. They 
evaluated the effect of source water and treatment conditions on DBP formation and identified 
emerging DBPs. CAL, DCAL, BCAL, and TCAL were included in this study as priority DBPs [3]. In 
this study, HALs were the third largest DBP class by weight of all the DBPs studied and DCAL 
was the most abundant, with a maximum concentration of 16 µg/L in a simulated distribution 
system sample [3]. 
 In early occurrence studies in Canadian drinking water, TCAL was detected in most 
chlorinated water samples [5, 6]. In addition, recent studies have found most target HALs in 
drinking water, while the speciation depends on water parameters such as bromide 
concentration and treatment processes [4, 7]. Koudjonou et al. assessed various Canadian 
drinking water supplies and collected samples at the treatment plant and at the distribution 
system [4, 7]. In their study, TCAL/THMs ratios (w/w) significantly varied with the type of 
disinfectant. TCAL/THMs ratios were the lowest (4-22%) in chloraminated waters, and were the 
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highest (12-52%) when ozone was applied as the pre- or primary disinfectant, prior to post 
chlorination. These results indicated that the ozone followed by post-chlorination enhanced the 
formation of TCAL in waters. Ozone produced increased levels of oxygenated DBPs including 
acetaldehyde, which is a potential precursor of other chlorinated HAL DBPs [8, 9]. It was 
observed that the contribution of TCAL to the total chlorinated DBPs increased in cold water [7]. 
In waters containing bromide, brominated HALs were also detected after chlorination [7]. 
Currently, there is no Canadian guideline for TCAL in drinking water. The guideline for TCAL 
established by the WHO is 10 µg/L and the drinking water guideline in Australia and New 
Zealand is 20 µg/L.    
 In terms of seasonal and spatial variations, LeBel et al. conducted a one-year survey and 
found that the levels of TCAL was higher during the summer than in winter at the treatment 
plant and the early part of the distribution system [5]. In summer, the maximum TCAL levels 
were found within the distribution system and the minimum TCAL levels were found at the end-
system locations, which suggest that TCAL is transformed to THM in warm water through long 
residence time [5]. 
2.1.2. Analytical Methods 
 Currently, two methods, EPA Method 556.1 and Standard Method 6252 are commonly 
used for HAL analysis [10, 11]. Both methods use O-(2,3,4,5,6-pentafluorobenzyl)-
hydroxylamine (PFBHA) to derivatize aldehydes to their pentafluorobenzyl oximes in aqueous 
phase. Their oxime derivatives are then extracted with hexane and analyzed by gas 
chromatography (GC)/electron capture detection (ECD) method.  
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 EPA Method 556.1, a derivative of EPA Method 556, uses a fast gas chromatographic 
technique for oxime detection. Due to its poor extraction efficiency with pentane, for HAL 
analysis, MTBE is used as the extraction solvent, and stock solutions of the brominated 
standards (BCAL, BDCAL, DBAL, CDBAL, TBAL) need to be prepared in MTBE and kept 
refrigerated (4oC)  [4]. Since chloramines are known to cause degradation of TCAL during 
sample storage, ammonium chloride cannot be used for the preservation of TCAL [1]. The 
liquid-liquid extraction (LLE) with GC/ECD method for chlorinated DBPs was validated for the 
determination of other di- and tri-HALs in water, as new standards were made available [4, 11].  
2.1.3. Toxicity of Haloacetaldehydes 
2.1.3.1. Chloroacetaldehyde 
 Chloroacetaldehyde (CAL) is a major reactive metabolite of various industrial chemicals 
such as vinyl chloride, ethylene dichloride and ethylene chlorohydrin. Vinyl chloride is a well 
known carcinogen, which is metabolically activated by cytochrome P450 to chloroethylene 
oxide followed by a rearrangement to CAL [12]. Therefore, many scientists focused on the 
toxicity of CAL as a metabolite of these industrial materials. In 1965, Johnson measured the 
influence of several aliphatic compounds on rat liver glutathione (GSH) levels and found that an 
oral administration of 0.53 mmol/kg of CAL in female rats induced 55% reduction in the GSH 
level [13]. The metabolism of CAL has been studied both in vitro and in vivo by Guengerich et al. 
and it was found that horse liver alcohol dehydrogenase catalyses the NADH-dependent 
reduction of CAL to form 2-chloroethanol, while yeast aldehyde dehydrogenase catalyses the 
NAD+-dependent oxidation CAL to form 2-chloroacetic acid [12]. Ifosfamide, an anticancer drug, 
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undergoes side chain oxidation in humans to form CAL and recent studies focused on the 
toxicity of CAL as side effects of ifosfamide treatment [14]. Lind et al. found that CAL caused 
depletion of GSH in lymphocytes from patients receiving ifosfamide [15]. CAL was used as a 
fluorescent label during the 1970s in biochemical research [16, 17]. Kochetkov et al. 
investigated the interaction of CAL with nucleic acid components and suggested their 
observation as a basis for a method of nucleic acid modification [18]. In that study, CAL reacted 
readily with 9-N-methyladenine and N-methylcytosine in weakly acidic aqueous solutions. 
 The molecular mechanism involved in CAL-induced cytotoxicity was investigated by 
Sood and O’Brien [19, 20]. CAL induced a loss in isolated rat hepatocyte viability in a time- and 
concentration- dependent manner, followed by a steady decrease in protein thiol levels, 
mitochondrial respiration and transmembrane potential which resulted in ATP depletion and 
lipid peroxidation [19]. They suggested that cytotoxic CAL concentrations caused oxidative 
stress and that ATP levels can be restored if cellular redox homeostasis is normalized [20].  The 
effect of chloroacetaldehyde on intracellular Ca2+ homeostasis in human renal proximal tubule 
cells (RPTEC) in primary culture was investigated and CAL induced nephrotoxicity by inhibiting 
the Na+/Ca2+ exchanger which is dependent on protein kinase A (PKA) [21]. CAL induced 
necrotic cell death rather than apoptotic cell death.   
 CAL was mutagenic in various models. CAL reacted with single-stranded DNA to produce 
cyclic etheno adducts (ε-adducts) including 3,N4-ethenocytosine (εC), 1,N6-ethenoadenosine 
(εA), N2,3-ethenoguanine, and 1,N2-ethenoguanine in vitro [22-24]. Biernat et al. observed the 
reaction of CAL with some tRNA constituents and found the –CH2CH/OH/- bridge between the 
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exo and endo nitrogen atoms of the parent compounds [25]. These ε-adducts caused mutations 
both in vitro and in vivo [26-33]. The ε-adducts decreased DNA synthesis [34]. Choi et al. 
observed that CAL preferentially induces C/G to T/A transition and C/G to A/T transversion 
mutations in mammalian cells and concluded that methylated CpG sites were not preferential 
targets for CAL-induced mutagenesis [35]. In a Salmonella typhimurium strain TA1530, CAL was 
a strong alkylating mutagenic agent [36]. In S. typhimurium strain TA100, CAL was hundreds of 
times more mutagenic than other metabolites of vinyl chloride or dichloroethane [37]. 
Guengerich et al. found that CAL irreversibly bound to microsomal protein under in vitro 
conditions when purified dehydrogenases were utilized [12, 38]. In Chinese hamster V79 cells, 
CAL caused a dose-dependent induction of 8-azaguanine and ouabain-resistant mutants in vitro 
[39]. CAL also induced mitotic chromosome malsegregation in Aspergillus nidulans [40].     
  Maciejewska et al. focused on the role of AlkAl, AlkB and Mug proteins, which are 
engaged in repair of CAL-induced ε-adducts [41]. In that study, pIF102 and pIF104 plasmids 
were CAL-damaged in vitro and replicated in E. coli of various genetic backgrounds with 
modified levels of AlkA and AlkB proteins. They showed that all alkA, alkB and mug genes were 
engaged in alleviation of CAL-induced mutagenesis, suggesting that the active site of AlkB 
protein interacts with the CAL induced ε-adducts to affect the repair of εC in vivo.  In addition, 
CAL induced interstrand cross-links in vitro in salmon sperm DNA where the cross-links 
formation depended on the reaction time and CAA concentration [42]. 
 Recently, the carcinogenicity of CAL was investigated. Daniel et al. found that the liver is 
the primary target organ in B6C3F1 mice when they were administered 0.1 g/L of CAL through 
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their drinking water [43]. In that study, hepatocellular necrosis, hepatocellular hyperplasia and 
chronic active inflammation were found in CAL treated mice along with the increased liver 
weight and liver tumor induction.   
2.1.3.2. Trichloroacetaldehyde (Chloral Hydrate) 
 The toxicity of trichloroacetaldehyde (TCAL) is the most widely studied compound 
among HALs. The oral 50% lethal dose (LD50) of TCAL in mice was reported to be 1442 mg/kg 
body weight (bw) in males and 1265 mg/kg bw in females, and the LD50 in rats was 480 mg/kg 
bw [44, 45]. TCAL was mutagenic in S. typhimurium [46-49] and induced chromosomal 
aberrations in mammalian cells [46, 50]. TCAL induced aneuploidy [51, 52] and micronuclei [53-
56] in mammalian cells. Using a micronucleus assay with cultured human lymphocytes, Migliore 
et al. found that TCAL induced aneuploidogenic activity [57]. TCAL induced mitotic aberrations 
[56, 58-60], and DNA strand-breaks [14, 61, 62] in mammalian cells. Administration of TCAL for 
90 days to male rats at a concentration of 2.4 mg/mL increased focal hepatocellular necrosis 
[43]. 
 Several studies focused on the possible adverse reproductive and prenatal effects 
induced by TCAL. TCAL crosses the human placenta at term [63] and low levels of chloral 
hydrate were found in breast milk [63]. Lambert et al. suggested that prolonged administration 
of sedative dose of TCAL to newborns increases the likelihood of hyperbilirubinaemia [64]. TCAL 
induced spindle aberrations and metaphase I arrest in mouse oocytes [65]. TCAL or its 
metabolite in the testis induced spermatid micronuclei in mice where spermatogonial sperm-
cell phase was significantly affected [53]. Male rats administered with 2 g/L TCAL in drinking 
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water for 52 weeks showed significantly decreased percentages of motile and progressively 
motile sperm [66].  A shift from a straight-line velocity distribution of sperm to a lower modal 
velocity range was observed as well.   
2.1.3.3. Other Haloacetaldehydes 
 Crebelli et al. found that dichloroacetaldehyde (DCAL) induced mitotic aneuploidy in 
lower eukaryotes [40].  They examined several halogenated aliphatic hydrocarbons to test their 
ability to induce somatic segregation in Aspergillus nidulans and found that DCAL significantly 
increased the frequency of haploid sectors and diploid non-disjunctional sectors. Because 
commercial standards for most brominated HALs were not available until recently, limited 
studies were performed on brominated HALs. Bromoacetaldehyde (BAL) irreversibly bound to 
DNA and protein in rat liver microsomes [38]. Tribromoacetaldehyde (TBAL) induced single- and 
double-strand DNA breaks [14].  
 Most of these toxicological studies were conducted for one or two compounds and 
considered the HAL as a metabolite of a parent chemical of interest. Therefore, to gain better 
understanding on HAL toxicity and their relative health risks compared with other DBPs, a 
systematic, quantitative, comparative study on the toxicity of individual HALs was needed. 
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2.2. MOLECULAR MECHANIMS OF HALOACETIC ACID DISINFECTION BY-PRODUCTS INDUCED 
TOXICITY 
2.2.1. Haloacetic Acid Disinfection By-products 
 Haloacetic acids (HAAs) DBPs are found in most disinfected drinking waters. Currently, 
five HAAs, chloroacetic acid (CAA), dichloroacetic acid (DCAA), trichloroacetic acid (TCAA), 
bromoacetic acid (BAA), and dibromoacetic acid (DBAA) are regulated by the U.S. EPA at a 
maximum contaminant level of 60 µg/L for the sum of them (Figure 2.1) [67]. Other 
unregulated HAAs include bromochloroacetic acid (BCAA), iodoacetic acid (IAA), tribromoacetic 
acid (TBAA), bromodichloroacetic acid (BDCAA), and chlorodibromoacetic acid (CDBAA). Based 
on the U.S. EPA’s information collection rule record, the mean and 90th percentile 
concentration for the regulated five HAAs from all water sites measured were 23 µg/L and 47.5 
µg/L [2]. DCAA and TCAA were the dominant HAAs found in drinking water. Levels of 
brominated species (BCAA and DBAA) increased when high bromide levels (>50 µg/L) were 
present in the source waters [3, 68]. 
 2.2.2. Toxicological Studies on Haloacetic Acids 
 HAAs are mutagenic in S. typhimurium and genotoxic in Chinese hamster ovary (CHO) 
cells and non-transformed human cells [69-73]. IAA induced chromosome aberration in CHO 
cells [74]. DCAA induced a weak chromosome breaks in mice and induced mutation and 
chromosome aberrations in mouse lymphoma cells [75, 76]. Monohalogenated HAAs 
(MonoHAAs) were teratogenic in mouse embryos [77, 78]. Hunter et al. found that monoHAAs 
induce dysmorphogenesis and affected neural tube development, eye development, and heart 
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development under ex-vivo conditions [77]. IAA induced malignant transformation in NIH/3T3 
mouse embryonic fibroblast cells that progressed to aggressive fibrosarcomas when implanted 
in Balb/c nude mice [79]. Gestational exposure of mixtures of regulated five HAAs resulted in 
pregnancy loss and eye malformation in rats [80]. Dichloroacetic acid (DCAA), 
bromochloroacetic acid (BCAA), and dibromoacetic acid (DBAA) altered intestinal microflora 
and metabolism in rats which could further affect the bioactivation of promutagens or 
procarcinogens [81].    
 Since the HAAs are the most regulated chemical class of DBPs, many studies focused on 
the molecular basis of HAA toxicity as well. Toxicogenomic analyses using non-transformed 
human cells found that monoHAAs modulated the gene expressions involved in stress response 
to DNA damage, DNA repair, especially, the repair of double-strand breaks, and in cell cycle 
regulation [82, 83]. IAA induced toxicity in hippocampal neuronal cells by inhibiting the 
glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH), which led to the 
generation of reactive oxygen species (ROS) and hypoglycemia [84]. Similar effects were found 
in hippocampal astrocytes [85]. 
 Glycolysis is the major metabolic pathway that converts glucose into pyruvate, which 
consists of a series of enzyme-catalyzed steps. The free energy released during this process is 
used to form ATP and NADH. GAPDH is an enzyme involved in the sixth step of glycolysis, which 
catalyses the conversion of glyceraldehyde 3-phosphate to D-glycerate 1,3-bisphosphate. When 
the activity of GAPDH is inhibited, glycolysis is blocked resulting in a reduction of pyruvate 
which is required by the tricarboxylic acid (TCA) cycle in the mitochondria. A disruption of the 
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electron transport chain in the TCA cycle induces the generation of ROS. Pals et al. found that 
the monoHAAs inhibit GAPDH activity in a concentration-dependent manner [86]. The 
inhibition of GAPDH activity and the toxic potency of the monoHAAs were highly correlated and 
the inhibition kinetics showed a strong correlation with other toxicological endpoints which 
were previously published [86]. However, quantitative analyses to investigate the detailed 
mechanisms connecting pyruvate level, ATP generation and ROS production were needed.   
  
2.3. EPIDEMIOLOGICAL STUDIES ON ADVERSE EFFECTS OF DISINFECTION BY-PRODUCT 
EXPOSURE  
2.3.1. Cancer Risks 
 Overall, evidence for the induction of urinary bladder cancer has been the most 
consistent, indicating the association with chlorinated DBPs [87] (Table 2.1). Most of the studies 
used the total THM (TTHM) levels as an indicator of DBP exposure and showed an association of 
DBP exposure with bladder cancer, with few exceptions [88-90]. It is also notable that recent 
study results which involved better estimation of DBP exposure showed higher, and statistically 
significant odd ratios (ORs) compared to old studies. These continuing results are strongly 
supporting the public concerns on DBPs as a possible cancer risk factor.  
 On the other hand, the epidemiologic evidence on chlorination DBPs to an association 
with increased colon and rectal cancer risk is still inconclusive. King et al. conducted a 
population-based case-control study in Canada to access the relationship between chlorination 
by-products in public water supplies and colon and rectum cancers [91]. In that study, males 
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exposed to chlorinated surface water for 35-40 years had an increased risk of colon cancer 
compared to those exposed for < 10 years (OR=1.53, 95% confidence interval (CI) = 1.13-2.09). 
No relationship was observed for females and no relationship was observed between rectal 
cancer risk and exposure to chlorination by-products for both males and females. In a 
prospective cohort study conducted with postmenopausal women, it was found that women 
who were consistently in the high exposure categories had the highest risk of colon cancer 
(Relative ratio (RR) = 1.86, 95% Cl = 1.29-2.69) [89]. Rahman et al. conducted a meta-analysis 
with a total of 13 studies (3 cohort and 10 case-control) and the pooled RR estimates of colon 
cancer were 1.11 (95% CI = 0.73-1.70) for cohort studies, 1.33 (95% CI = 1.12-1.57) for case-
control studies and 1.27 (95% CI = 1.08-1.50) for all studies. For rectal cancer, the 
corresponding RR estimates were 0.88 (95% CI = 0.57-1.35), 1.40 (95% CI = 1.15-1.70) and 1.30 
(95% CI = 1.06-1.59) [92].  
2.3.2. Adverse Pregnancy Outcomes 
 The summary of epidemiological studies on adverse pregnancy outcomes associated 
with DBP exposure is presented in Table 2.2. Compared to the studies on cancer risk, studies on 
adverse pregnancy outcomes have broader endpoints and tend to have lower ORs. Hwang et al. 
conducted a cross-sectional study to evaluate the risks of birth defects according to four 
chlorination by-product exposure categories on the basis of chlorination (yes/no) and level of 
water color, which represents the amount of natural organic matter.  The risks of any birth 
defect (OR = 1.13, 95% CI = 1.01-1.25), cardiac defect (OR = 1.37, 95% CI = 1.00-1.89), 
respiratory system defect (OR = 1.89, 95% CI = 1.00-3.58), and urinary tract defect (OR = 1.46, 
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95% CI = 1.00-2.13) were significantly associated with medium and high combined exposure 
[93]. The OR of the risk of any birth defect in the chlorination and high-color was 1.18 (95% CI = 
1.02-1.36). There was no consistent association of chlorination and color with the risk of neural 
tube defects (OR = 1.05, 95% CI = 0.54-2.03) for combined medium and high exposure. However, 
the risk of neural defects for no chlorination and high-color showed a high OR of 2.60 (95% CI = 
1.30-5.26). Chisholm et al. conducted a study to examine birth defect rates at Australia 
metropolitan locations with high levels of brominated DBPs [94]. Women living in high-TTHM 
areas (≥ 130 µg/L) showed an increased risk of any birth defect (OR = 1.22, 95% CI = 1.01-1.48) 
and of any cardiovascular birth defect (OR = 1.62, 95% CI = 1.04-2.51), compared with women 
living in low-TTHM areas (<60 µg/L). In a recent study conducted in Taiwan, the risk of 
ventricular septal defects (OR = 1.81, 95% CI = 0.98-3.35) and cleft palate (OR = 1.56, 95%CI = 
1.00-2.41) were increased in the high TTHM (>20 µg/L) exposure group [95]. 
 Based on the studies, it should be noted that it is still unknown whether there is a strong 
correlation between DBP exposure and adverse pregnancy outcomes. Several points need to be 
considered in advance to support a reasonable conclusion. First, the exposure assessment is a 
big challenge. The DBP exposure route is possible not only through ingestion, but also through 
showering and bathing. Therefore, a detailed questionnaire or interview is needed for better 
estimation of exposure, and blood sampling may improve the accuracy of actual exposure level.  
As shown in Table 2.2., people have tested various birth defect endpoints and different results 
may reflect different DBP biological impacts on specific birth defects. It is notable that the 
standard to categorize high- vs. low- THMs levels also varied by individual studies, and setting 
the level for high- and low- exposure could alter the study results. Using THM only as an 
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indicator of DBP levels should be reconsidered. Even though THMs are the most abundant DBP 
class found in drinking water, currently more than 600 DBPs have been identified and evidence 
demonstrated that other identified DBPs are more cytotoxic and genotoxic than THMs [96, 97]. 
Therefore, efforts to expand DBP chemical classes to the analysis may improve the resolving 
power of epidemiological studies.   
 
2.4. TOXICITY OF COMPLEX DISINFECTION BY-PRODUCTS MIXTURES 
2.4.1. Evaluation of Disinfection By-products Complex Mixtures 
 While investigating the toxicity of a single chemical is important, the toxicological effects 
of a complex DBP mixture should be considered carefully because the complex mixture 
represents the composition of finished water that people consume in daily life. Therefore, there 
is a need for toxicology research with whole DBP mixtures with extensive quantitative chemical 
analyses. Well-designed complex DBP mixture experiments will provide information that fills 
the gap between single DBP studies in vitro and with animal experiments to provide guidelines 
to estimate the health risks. 
 To address this issue, scientists from the U.S. EPA Office of Research and Development 
initiated the research project, “Integrated Disinfection Byproducts Mixtures Research: 
Toxicological and Chemical Evaluation of Alternative Disinfection Treatment Scenarios”, also 
called as the “Four Lab Study” [98]. The main objective of the Four Lab Study was to assess the 
reproductive/developmental effects of DBP mixtures through a “whole mixture” approach, 
along with chemical analyses. However, preparing complex DBP concentrate from the finished 
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water for toxicological researches was challenging. XAD resin extraction and elution with 
organic solvent is the typical method used for DBP concentrate preparation [99]. Using XAD 
resin extraction has limitations in the toxicological studies because the concentrate is produced 
in an organic solvent, which is difficult to redissolve in a water matrix for in vivo toxicology 
studies. For multigenerational rodent bioassays, large amounts of concentrates are needed, but 
such amounts exceed the capacity of XAD resins. Also, some volatile DBPs are often lost during 
the XAD resin extraction process.  To resolve this issue, reverse osmosis (RO) membranes was 
suggested as an alternative method to concentrate large amounts of water in a short time 
compared to XAD, while maintaining the DBP concentrate suitable for animal studies [100]. 
However, the four lab study employed RO concentrate waters that contained a salt residual 
equivalent to about 2 g/L Na+. These high salt levels are intrinsically toxic and may cause 
difficulties in the interpretation of the results. Efforts on developing new methods to 
concentrate DBPs in finished water are ongoing [101]. While the development of methods for 
complex DBP mixture preparation is actively ongoing, there are only few bioassays to 
investigate the in vitro toxicity of DBP mixtures [102]. Therefore, a good molecular metric which 
measures a comparative toxicity of complex mixture needs to be established.  
    In 2009, the European Union (EU) started a major research initiative named HIWATE 
(Health Impacts of long-term exposure to disinfection by-products in drinking WATEr) to 
address the shortcomings of previous DBP studies. The overall objective was to investigate 
potential human health risks including cancer and adverse reproductive outcomes associated 
with long-term exposure to low levels of DBPs in drinking water (www.hiwate.org) [103]. This 
project involved 16 teams in eight European countries and was divided into different topics 
30 
 
such as exposure assessment, epidemiology, risk assessment and management. For exposure 
assessment, DBP composition and levels in drinking water in various regions in Europe were 
collected where epidemiological studies are conducted. Samples were analyzed for various 
types of DBPs (i.e. THMs, haloacetonitirles (HANs), HAAs, haloketones (HAKs), chloral hydrate 
(CH), chloropicrin (CP), etc.) [104]. Therefore, the results from the HIWATE project will allow us 
to assess the correlation between complex DBP mixtures and human health risks.   
2.4.2. Impacts of Contaminants in Source Water on Disinfection By-products Formation  
 Among various factors influencing the spectrum of DBPs in finished water, the 
composition of the source water may play an important role, especially in a local site where 
large amount of industrial contaminants are being discharged. Iodinated X-ray contrast media 
(ICM) are widely used at medical centers for soft tissues medical imaging such as organs, veins, 
and blood vessels.  ICM are 2,4,6-triiodinated benzoic derivatives where their molecular 
weights varies (600 – 850 Da) by the type of side chains (Figure 2.2). The iodine atoms are 
responsible for the absorption of X-rays, and the compounds are designed to be persistent and 
polar so that the compounds can be excreted within few hours after application. After 
consumption, 95% of unmetabolized ICM are eliminated through urine and feces within 24 
hours [105]. Incomplete removal of ICM in wastewater treatment plants could lead to an 
elevation of ICM concentrations in source waters such as rivers, streams, and groundwater for 
further disinfection by water utilities [106-108]. In a previous occurrence study involving 23 
cities, four ICM including Iopamidol, Iopromide, Iohexol, and Diatrizoate were found in source 
waters [97]. A risk assessment on Iopromide found no toxic effects in bacteria, crustaceans, and 
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fish for 10 g/L Iopromide [109]. No toxic effect was found in a chronic test with D. magna for 
concentrations up to 1 g/L Iopromide as well [109].    
 ICM may be good sources of iodine to form iodinated DBPs, and the activated benzene 
rings and other functional groups that can react with oxidizing disinfectants may lead ICM to be 
potential DBP precursors [102]. An international collaboration study (U.S. and Germany) is 
being conducted to study the impacts of ICM on DBP formation and toxicity, where the overall 
hypothesis is that oxidizing disinfectants such as chlorine and chloramine react with ICM to 
form highly toxic iodo-DBPs and higher molecular weight by-products of unknown toxicity.  
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TABLES AND FIGURES 
Table 2.1. Summary of epidemiology studies on urinary bladder cancer associated with chlorinated DBPs 
exposure.  
Exposure Comparison  Adjusted OR  
(95% CI) 
Study Design 
(Country) 
Reference 
(year) 
Male: Municipal (disinfected) watera 
Female: Municipal (disinfected) watera 
1.80 (0.80-4.75) 
1.60 (0.54-6.32) 
Nonconcurrent 
prospective 
(MD, U.S.) 
Wilkins & 
Comstock 
(1981) [110]  
Male: 40-59 yrs, chlorinated surface waterb 
Male: ≥60 yrs, chlorinated surface waterb 
Female: ≥ 60 yrs, chlorinated surface waterb 
1.2 (0.8-1.7) 
1.2 (0.7-2.1) 
3.2 (1.2-8.7)* 
Case-control 
(IA, U.S.) 
Cantor et al. 
 (1987) [111]  
Male: ≥40 yrs, 1 µg/L THM vs. ≤ 1 µg/L THMc 
Female: ≥40 yrs, 1 µg/L THM vs. ≤ 1 µg/L 
THMc 
Both: ≥40 yrs, 1 µg/L THM vs. ≤ 1 µg/L THMc 
1.37 (0.95-1.98) 
1.97 (0.92-4.21) 
1.52 (1.10-2.10) 
Case-control 
(IA, U.S.) 
Lynch et al. 
(1989) [112] 
Male: ≥40 yrs, 1 µg/L THM vs. ≤ 1 µg/L THMc 
Female: ≥40 yrs, 1 µg/L THM vs. ≤ 1 µg/L 
THMc 
Both: ≥40 yrs, 1 µg/L THM vs. ≤ 1 µg/L THMc 
1.20 (0.74-1.94) 
0.46 (0.14-1.55) 
1.02 (0.66-1.57) 
Case-control 
(France) 
Cordier et al. 
(1993) [113] 
Both: 21-30 yrs, any chlorinated waterd 
Both: >30 yrs, any chlorinated waterd 
1.5 (0.8-2.9) 
1.8 (1.1-2.9)* 
Case-control 
(CO, U.S.) 
McGeehin et al. 
(1993) [114] 
Both: >35 yrs, chlorinated surface waterd 
Both: >35 yrs,  ≥25 µg/L TTHM surface waterd 
1.41 (1.09-1.81)* 
1.58 (1.17-2.14)* 
Case-control 
(Canada) 
King & Marrett 
(1996) [115] 
Male: >40 yrs, Municipal (disinfected) watere 
Female: >40 yrs, Municipal (disinfected) 
watere 
2.2 (0.8-5.1) 
0.6 (0.2-2.2) 
Case-control 
(MD, U.S.) 
Freedman et al. 
(1997) [90] 
Female: 25 µg/L TTHM vs. < limit of detection 0.62 (0.25-1.59) 
Cohort 
(IA, U.S.) 
Doyle et al. 
(1997) [89] 
Male: 40-59 yrs, chlorinated surface waterb 
Male: ≥60 yrs, chlorinated surface waterb 
Female: ≥ 60 yrs, chlorinated surface waterb 
1.5 (0.95-2.3) 
1.9 (1.1-3.6)* 
0.7 (0.2-2.4) 
Case-control 
(IA, U.S.) 
Cantor et al. 
(1998) [88] 
Both: >30 yrs, mutagenic chlorinated waterf 1.22 (0.92-1.62) 
Case-control 
(Finland) 
Koivusalo et al. 
(1998) [116]  
Both: >50 µg/L TTHM vs. <1 µg/L TTHM 2.99 (1.1-8.5)* 
Case-control 
(France) 
Chevrier et al. 
(2004) [117] 
Male: >25-30 yrs, chlorinated surface waterd 
Male: >30 yrs, chlorinated surface waterd 
Female: >30 yrs, chlorinated surface waterd 
2.58 (1.33-5.01)* 
2.21 (1.17-4.20)* 
2.33 (0.51-10.55) 
Case-control 
(Spain) 
Villanueva et al. 
(2007) [118] 
Both: 74-352 µg/L TTHM vs. 0-38 µg/L TTHM 2.34 (1.01-3.66)* 
Case-control 
(NY, U.S.) 
Bove et al.  
(2007) [119] 
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Table 2.1. (Continued) 
Exposure Comparison  Adjusted OR  
(95% CI) 
Study Design 
(Country) 
Reference 
(year) 
Both: 26-49 µg/L TTHM vs. ≤ 8 µg/L TTHM 
Both: >49 µg/L TTHM vs. ≤ 8 µg/L TTHM 
2.34 (1.16-4.71)* 
2.06 (0.83-5.08) 
Case-control 
(Spain) 
Michaud et al. 
(2007) [120] 
 
Abbreviations; TTHM = total THM. * Statistically significant. a Compared with deep well water users. b 
Compared with unchlorinated water or chlorinated groundwater. c Data represented by Villanueva et al. 
[19]. d Compared with unchlorinated water. e Compared with non-municipal water. f Compared with 
non-mutagenic water. 
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Table 2.2. Summary of epidemiology studies on adverse pregnancy outcomes associated with 
chlorinated DBPs exposure.  
Endpoint and  
Exposure Comparison  
Adjusted OR  
(95% CI) 
Study Design 
(Country) 
Reference 
(year) 
Stillbirth: 
public water supplies from the communities  
(chlorinated surface water) 
2.6 (0.9-7.5) 
Case-control 
(MA, U.S.) 
Aschengrau  
et al. (1993) 
[121] 
Low birth weight:  
TTHM >100 ppb vs. <20 ppb 
Small for gestational age: 
TTHM >100 ppb vs. <20 ppb  
All surveillance birth defects: 
TTHM >100 ppb vs. <20 ppb 
All surveillance birth defects: 
TTHM >80 ppb vs. <20 ppb  
 
1.42 (1.22-1.65)a 
 
1.50 (1.36-1.65)a 
 
1.04 (0.58-1.76)b 
 
1.57 (1.23-1.99)b 
Cross-sectional 
(NJ, U.S.) 
Bove et al.   
(1995) [122] 
Any malformation: 
Colored chlorinated water vs. no chlorination  
Neural tube defects:  
Colored chlorinated water vs. no chlorination  
Urinary tract defects: 
Colored chlorinated water vs. no chlorination  
 
1.14 (0.99-1.31) 
 
1.26 (0.61-2.62) 
 
1.99 (1.10-33.57) 
Retrospective 
(Norway) 
Magnus et al. 
(1999) [123] 
Any birth defect: 
Chlorination and high-color 
Neural tube defects:  
No chlorination and high-color 
1.18 (1.02-1.36) 
1.05 ( 0.54-2.03) 
Cross-sectional 
(Norway) 
Hwang et al. 
(2002) [93] 
Small for gestational age(pregnancy average): 
TTHM levels >80 μg/L vs. ≤ 60 μg/L 
Small for gestational age(second trimester): 
TTHM levels >80 μg/L vs. ≤ 60 μg/L 
1.14 (1.02-1.26) 
1.13 (1.03-1.24) 
Cross-sectional 
(MA, U.S.) 
Wright et al. 
(2003) [124] 
Term low birth weight: 
HAA5 <15 μg/L vs. HAA5 15-19 μg/L 
 
HAA5 <15 μg/L vs. HAA5 ≥19 μg/L 
 
1.26 (0.96-1.65) 
1.25 (0.96-1.64) 
Retrospective 
(AZ, U.S.) 
Hinckley et al. 
(2005) [125] 
Preterm delivery: 
TTHM <4.93 μg/L vs. TTHM 4.93–13.11 μg/L 
 
TTHM <4.93 μg/L vs. TTHM >13.11 μg/L 
 
1.03 (0.94–1.13)  
1.08 (0.98–1.18) 
Retrospective 
(Taiwan) 
Yang et al. 
(2007) [126] 
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Table 2.2. (Continued) 
Endpoint and  
Exposure Comparison  
Adjusted OR  
(95% CI) 
Study Design 
(Country) 
Reference 
(year) 
Any birth defect: 
High-TTHM (≥ 130 µg/L) vs. low (<60 µg/L) 
Any cardiovascular birth defect:  
High-TTHM (≥ 130 µg/L) vs. low (<60 µg/L) 
1.22 (1.01-1.48) 
1.62 ( 1.04-2.51) 
Prevalence 
design  
(Australia) 
Chisholm et al. 
(2008) [94] 
Ventricular septal defects: 
High-TTHM (>20 µg/L) vs. reference (0-4 µg/L) 
Cleft palate: 
High-TTHM (>20 µg/L) vs. reference (0-4 µg/L) 
1.81 (0.98-3.35) 
1.56 ( 1.00-2.41) 
Cross-sectional 
(Taiwan) 
Hwang et al. 
(2008) [95] 
 
Abbreviations; TTHM = total THM. * Statistically significant. a 50% confidence interval. . b 90% confidence 
interval.   
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Figure 2.1. Chemical structures of regulated five haloacetic acid DBPs 
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Figure 2.2. Chemical structures of iodinated X-ray contrast agents. 
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CHAPTER 3 
OCCURRENCE AND COMPARATIVE TOXICITY OF THE HALOACETALDEHYDE 
DISINFECTION BY-PRODUCTS IN DRINKING WATER 
 
PREFACE  
 This work was a collaboration study involving research on analytical biology and 
analytical chemistry. Dr. C. Postigo (IDAEA-CSIC, Barcelona, Spain) conducted the analytical 
chemistry component under the direction of Dr. S. Richardson (University of South Carolina, SC). 
 
3.1. INTRODUCTION  
 The disinfection of drinking water was an outstanding contribution for the protection of 
the public health [1]. An unintended consequence of water disinfection is the generation of 
disinfection by-products (DBPs). Since the trihalomethanes (THMs) were discovered as the first 
chemical class of DBPs [2], research lead to the identification of emerging DBPs [3-6], formation 
kinetics [7-9], exposure assessment [10-13], risk assessment [12, 14], and toxicology [15-17]. 
Epidemiological studies demonstrated associations between DBPs with increased risk for 
bladder, stomach, and colon cancers [18-22]. Evidence was found associating DBPs and adverse 
pregnancy outcomes, including spontaneous abortion, low birth weight, small-for-gestational-
age (SGA), still birth, and preterm delivery [11, 23-29]. Many DBPs are cytotoxic, genotoxic, 
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teratogenic and carcinogenic [15, 17, 30-33]. To date, more than 600 DBPs have been identified 
with the haloacetaldehydes (HALs) as one of the emerging DBP chemical classes [34].  
 Aldehyde DBPs are preferentially formed with ozone disinfection; levels of halogenated 
and non-halogenated aldehydes range from 5 to 20 µg/L [35]. In the U.S. EPA Information 
Collection Rule (ICR), HALs were found at higher concentrations in water treatment systems 
using ozone than with chlorine dioxide (up to 30.6 µg/L) [36]. Chloral hydrate 
(trichloroacetaldehyde, TCAL) was the major HAL; chloroacetaldehyde (CAL) and 
dichloroacetaldehyde (DCAL) were also formed in disinfected water. However, the evaluation of 
the occurrence of individual HALs is limited because some can be transformed into TCAL in 
water [35]. Brominated HALs such as bromochloroacetaldehyde (BCAL), dibromoacetaldehyde 
(DBAL), bromodichloroacetaldehyde (BDCAL), dibromochloroacetaldehyde (DBCAL) and 
tribromoacetaldehyde (TBAL) were detected when bromide-containing waters were 
chlorinated [37]. In a nationwide occurrence study, 4 HALs (CAL, DCAL, BCAL, and TCAL) were 
included as priority DBPs. HALs were the third largest DBP class by weight, with DCAL as the 
most abundant HAL detected (maximum concentration; 16 µg/L) [38]. 
 Previous studies focused on the toxicology of several HALs [17]. TCAL was mutagenic in 
Salmonella typhimurium [39-42] and induced chromosomal aberrations [39, 43] and aneuploidy 
[44, 45] in mammalian cells. TCAL induced micronuclei [46-50], mitotic aberrations [50-53], and 
DNA strand-breaks [54-56] in mammalian cells. The toxicity of CAL was studied as a metabolite 
of industrial chemicals such as vinyl chloride [57]. CAL was cytotoxic in rat hepatocytes [58] and 
induced nephrotoxicity in human renal proximal tubule cells [59]. CAL formed DNA adducts and 
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caused mutations [60-66]. CAL generated mitotic chromosome malsegregation [67] and 
interstrand cross-links [68], and DCAL induced mitotic aneuploidy [69]. BAL irreversibly bound 
to DNA and protein in rat liver microsomes [70]. TBAL induced single- and double-strand DNA 
breaks [54]. However, systematic toxicological effects of other emerging HAL DBPs were not 
investigated and there is no quantitative, comparative database on the toxicity of individual 
HALs. 
 The objective of our research was to: (i) develop new analytical chemical methods and 
identify the occurrence of a new HAL DBP in drinking water, (ii) analyze the in vitro cytotoxicity 
and genotoxicity of HALs and related compounds in mammalian cells, (iii) determine the 
cytotoxicity and genotoxicity index values of HALs and develop a quantitative, comparative 
toxicity database, and (iv) conduct a mechanism-based structure-activity relationship analysis 
for the observed HAL mediated cytotoxicity and genotoxicity. In 1974, trihalomethanes (THMs) 
were discovered as the first chemical class of disinfection by-products (DBPs) in drinking water 
[2]. Since then, numerous efforts were put onto the DBP research including identification of 
emerging DBPs, formation kinetics, exposure assessment, risk assessment, toxicology and 
molecular mechanisms, epidemiological evidence, and evaluation of mixtures. To date, more 
than 600 DBPs have been identified, and haloacetaldehydes (HALs) are in a class of unregulated 
emerging DBPs. 
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3.2. MATERIALS AND METHODS  
3.2.1. General Reagents 
 General reagents were purchased from Sigma-Aldrich Co. (St. Louis, MO) and Fisher 
Scientific Co. (Itasca, IL). Media and fetal bovine serum (FBS) were purchased from Fisher 
Scientific Co. (Itasca, IL). Chemical standards were purchased from Sigma-Aldrich, ChemService 
(West Chester, PA), Orchid Cellmark (Westminster, BC, Canada), and TCI America (Waltham, 
MA) at the highest level of purity.  
3.2.2. Preparation of Haloacetaldehydes 
 Ten HALs were analyzed and their sources and purities are presented in Table 3.1. The 
chemical structure of each HAL is presented in Figure 3.1. A 2M stock solution of each HAL was 
prepared in dimethylsulfoxide (DMSO) prior to the toxicological experiments. Stock solutions 
were immediately stored in sterile glass vials under dark conditions at −20°C.  
3.2.3. Chinese Hamster Ovary Cells  
 Chinese hamster ovary (CHO) cell line AS52, clone 11-4-8 was used for the toxicity 
studies [71-73]. The CHO cells were maintained in Ham’s F12 medium containing 5% FBS, 1% 
antibiotics (100 U/mL sodium penicillin G, 100 µg/mL streptomycin sulfate, 0.25 µg/mL 
amphotericin B in 0.85% saline), and 1% glutamine at 37°C in a humidified atmosphere of 5% 
CO2.  
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3.2.4. CHO Cell Chronic Cytotoxicity Assay  
 This 96-well microplate assay measures the reduction in cell density as a function of the 
HAL concentration over a period of 72 h (~3 cell cycles) [15, 32]. Chronic cytotoxicity to CHO 
cells was measured using an assay we previously developed for the analysis of DBPs [32]. In 
general, 8 replicates were prepared for each concentration of HAL. Eight wells were reserved 
for the blank control consisting of 200 µL of F12 medium + 5% FBS. The negative control 
consisted of 8 wells containing 100 µL of a tittered CHO cell suspension (3×104 cells/mL) plus 
100 µL F12 + FBS. The wells for the remaining columns contained 3,000 CHO cells, F12 + FBS 
and a known concentration of HAL for a total volume of 200 μL. To prevent cross-over 
contamination between wells due to volatilization of the organic extract, a sheet of sterile 
AlumnaSeal™ (RPI Corporation, Mt. Prospect, IL) was pressed over the wells before the 
microplate was covered. The microplate was placed on a rocking platform for 10 min to 
uniformly distribute the cells, and then placed in a tissue culture incubator for 72 h. After 
incubation, each well was gently aspirated, fixed in 100% methanol for 10 min, and stained for 
10 min with a 1% crystal violet solution in 50% methanol. The plate was gently washed in tap 
water, inverted and tapped dry upon paper towels, and 50 μL of DMSO/methanol (3:1 v/v) was 
added to each well for 10 min. The plate was analyzed in a BioRad microplate reader at 595 nm. 
The data were automatically recorded and transferred to an Excel spreadsheet on a 
microcomputer connected to the microplate reader. The blank-corrected absorbance of the 
negative control (cells with medium only) was set at 100%. The absorbance for each treatment 
group well was converted into a percentage of the negative control. The experiments were 
repeated 2-4 times. A concentration-response curve was generated for each HAL and a 
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regression analysis was conducted for each curve. The LC50 values were calculated, where the 
LC50 represents the HAL concentration that induced a 50% reduction in cell density as compared 
to the concurrent negative controls. 
3.2.5. CHO Cell Single Cell Gel Electrophoresis Assay 
 Single cell gel electrophoresis (SCGE, or Comet) assay quantitatively measures genomic 
DNA damage in individual nuclei [74-76]. We employed the microplate SCGE method [77]. The 
SCGE metric for genomic DNA damage induced by the HALs was the %tail DNA value (%TDNA), 
which is the amount of DNA that migrated from the nucleus into the microgel [78]. The day 
before treatment, 4×104 CHO cells were added to each microplate well in 200 µL of F12 + 5% 
FBS and incubated. The next day, the cells were washed with HBSS and treated with a series of 
concentrations of HALs in F12 medium without FBS in a total volume of 25 μL for 4 h at 37°C, 5% 
CO2. The wells were covered with sterile AlumnaSeal™. After incubation, the cells were washed 
2× with HBSS and harvested with 50 μL of 0.01% trypsin + 53 μM EDTA. The trypsin was 
inactivated with 70 µL of F12 + FBS. Acute cytotoxicity was measured from a 10 μL aliquot of 
cell suspension mixed with 10 µL of 0.05% trypan blue vital dye in phosphate-buffered saline 
(PBS) [79]. SCGE data were not used if the acute cytotoxicity exceeded 30%. The remaining cell 
suspension from each well was embedded in a layer of low melting point agarose prepared with 
PBS upon clear microscope slides that were previously coated with a layer of 1% normal melting 
point agarose prepared with deionized water and dried overnight. The cellular membranes 
were removed by an overnight immersion in lysing solution (2.5 M NaCl, 100 mM Na2EDTA, 10 
mM Tris, 1% sodium sarcosinate, 1% Triton X-100, and 10% DMSO)  at 4°C. The microgels were 
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placed in an alkaline buffer (1 mM Na2EDTA, 300 mM  NaOH,  pH 13.5) in an electrophoresis 
tank, and the DNA was denatured for 20 min. The microgels were electrophoresed at 25 V, 300 
mA (0.72 V/cm) for 40 min at 4°C. The microgels were neutralized with tris buffer (pH 7.5), 
rinsed in cold water, dehydrated in cold methanol, dried at 50°C, and stored at room 
temperature in a covered slide box. For analysis, the microgels were hydrated in cold water for 
30 min and stained with 65 μL of ethidium bromide (20 μg/mL) for 3 min. The microgels were 
rinsed in cold water and analyzed with a Zeiss fluorescence microscope with an excitation filter 
of BP 546/10 nm and a barrier filter of 590 nm. For each experiment, 2 microgels were 
prepared per treatment group. Randomly chosen nuclei (25 per microgel) were analyzed using 
a charged coupled device camera. A computerized image analysis system (Comet IV, 
Perspective Instruments, Ltd, Suffolk, UK) was employed to determine the SCGE %Tail DNA 
value of the nuclei as indices of DNA damage. The digitalized data were automatically 
transferred to a computer based spreadsheet for subsequent statistical analysis. Within each 
experiment, a negative control, a positive control (3.8 mM ethylmethanesulfonate), and 9 
concentrations of HALs were analyzed concurrently. The experiments were repeated 2-3 times. 
For each HAL concentration range, a concentration-response curve was generated. A regression 
analysis was used to fit the curve, and the concentration inducing a 50%Tail DNA value was 
calculated.  
3.2.6. Statistical Analyses 
 For the cytotoxicity assay, a one-way analysis of variance (ANOVA) test was conducted 
to determine if the HAL induced a statistically significant level of cell death at a specific 
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concentration. If a significant F value (P ≤ 0.05) was obtained, a Holm-Sidak multiple 
comparison versus the control group analysis was performed to identify the lowest cytotoxic 
concentration. The power of the test statistic (1−β) was maintained as ≥ 0.8 at α = 0.05. For the 
SCGE assay, the %Tail DNA values are not normally distributed, which limits the use of 
parametric statistics [80]. The mean %Tail DNA value for each microgel was calculated and 
these values were averaged among all of the microgels for each HAL concentration. A one-way 
ANOVA test was conducted on these averaged %Tail DNA values [81]. If a significant F value of P 
≤ 0.05 was obtained, a Holm-Sidak multiple comparison versus the control group analysis was 
conducted with the power ≥ 0.8 at α = 0.05. A bootstrap statistical approach was used to 
generate a series of multiple LC50 values and %Tail DNA per each HAL [82, 83]. For each LC50 
value a cytotoxicity index (CTI) value was calculated as (LC50)
-1(103). For each %Tail DNA value a 
genotoxicity index (GTI) value was calculated as (50%Tail DNA)-1(103). These dimensionless 
values were then analyzed using an ANOVA test to determine significant differences among the 
HALs. A Pearson’s Product Moment correlation test was conducted to test for correlations 
among cytotoxicity and genotoxicity data and HAL chemical characteristics.  
3.2.7. Haloacetaldehyde Analytical Methods (By Dr. C. Postigo and Dr. S. Richardson) 
 Two analytical methodologies based on gas chromatography coupled to mass 
spectrometry were validated to investigate the occurrence of HALs in source and disinfected 
waters. Mono-halogenated HALs (monoHALs) and di-halogenated HALs (diHALs) were 
derivatized with pentafluorobenzylhydroxylamine (PFBHA), and subsequently liquid-liquid 
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extracted. Tri-halogenated HALs (triHALs) was pre-concentrated by means of solid-phase 
extraction.  
 
3.3. RESULTS  
3.3.1. Haloacetaldehyde DBP Analytical Methods and Results (By Dr. C. Postigo and Dr. S. 
Richardson) 
 The work on the chemical analysis section was conducted by Dr. Cristina Postigo under 
the direction of Dr. S. Richardson. The chemical analysis of the source and disinfected water 
revealed the absence of target HALs in the source waters and the presence of all target HALs in 
drinking waters. However, trace levels of DBAL, TBAL, DBCAL and IAL were detected in one 
sample of source waters. The level of IAL in drinking water ranged between 0.6 ppb and 4.6 ppb. 
Overall, IAL concentrations were similar to those observed for triHALs and DBAL, and slightly 
higher than those measured for CAL, DCAL and BAL. An example of the identification of IAL is 
presented in Figure 3.2. 
3.3.2. CHO Cell Chronic Cytotoxicity 
 CHO cell chronic cytotoxicity analyses of each HAL are summarized in Table 3.2. Figure 
3.3 illustrates the concentration-response curves for the HALs. The individual concentration-
response curves of each HAL are presented in the Figures 3.4 - 3.13). An all pairwise ANOVA 
test of the CTI values generated a descending rank order of chronic cytotoxicity of the ten HALs 
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as TBAL ≈ CAL > DBAL ≈ BCAL ≈ DBCAL > IAL > BAL ≈ BDCAL ≈ DCAL > TCAL. The mean bootstrap 
CTI (±SE) values are presented in Table 3.4 and Figure 3.14. 
3.3.3. CHO Cell Acute Genotoxicity 
 CHO cell acute genotoxicity analyses of each HAL are summarized in Table 3.3. Figure 
3.15 illustrates the concentration-response curves for the HALs. The individual concentration-
response curves of each HAL with the cell viability data are presented in Figures 3.16-3.25. An 
all pairwise ANOVA test of the GTI values generated a descending rank order of genotoxicity of 
the ten HALs as DBAL > CAL ≈ DBCAL > TBAL ≈ BAL ≈ BDCAL ≈ BCAL ≈ DCAL ≈ IAL. TCAL was not 
genotoxic. The mean bootstrap GTI (±SE) values are presented in Table 3.4 and Figure 3.26. 
 
3.4. DISCUSSION 
3.4.1. Structure-Activity Relationships of Haloacetaldehyde Toxicity 
 The most cytotoxic HALs were TBAL and CAL, followed by DBAL and BCAL. The most 
genotoxic HAL was DBAL, followed by CAL and DBCAL (Table 3.4 and Figure 3.14). The 
cytotoxicity and genotoxicity of these 10 HALs were not significantly correlated (r = 0.36; P = 
0.308). This response is in contrast to other chemical DBP classes such as haloacetic acids (HAAs) 
[84], THMs [32], or haloacetamides (HAcAms) [16] where the halogen affected toxicity 
(iodinated- > brominated- > chlorinated-DBPs).  
 The toxicity of HALs is complex in that these compounds possess two potential reactive 
sites to react with nucleophiles in cells. One is the α-carbon (αC)-halogen (X) bond which is 
57 
 
associated with SN2 type reactions. With the monohalogenated HAAs (monoHAAs) and 
monoHAcAms, the rank order of toxicity followed I > Br >> Cl, which corresponds to the leaving 
tendency of the halogens of alkyl halide [16, 84, 85]. We found that the monoHAAs irreversibly 
inhibit glyceraldehyde-3-phosphate dehydrogenase (GAPDH) activity and that there was a high 
correlation with the dissociation energy of the αC-X bond and the alkylation potential of the 
HAA [84, 85]. The rate of inhibition of GAPDH and the toxic potency of the monoHAAs showed a 
concentration-dependent manner with the same rank order as above. A pattern for the 
cytotoxicity of the HALs was a rank order for the triHALs was TBAL > DBCAL > BDCAL > TCAL and 
for the diHALs was DBAL > BCAL > DCAL. With the combined data of triHALs and diHALs, a 
strong significant correlation was found between the number of Br atoms and the CTI (r = 0.90; 
P ≤ 0.006), while a good but not significant correlation was found with the GTI values (r = 0.63; 
P = 0.13).  However, the impact of the halogen was not observed in the monoHALs.  
 The other reactive site of HALs is the carbonyl C=O bond of the aldehyde group. 
Aliphatic aldehydes are able to undergo Schiff base formation (Figure 3.27). The Schiff base 
formation is a mechanism used by enzymes to catalyze reactions between an amine group with 
either an aldehyde or ketone. It proceeds through the carbinolamine intermediate with an 
imine as a final product. HALs may induce genotoxic effects such as DNA adducts, DNA-DNA 
cross-links, or DNA-protein cross-links by reacting with DNA chains through Schiff base 
formation [60, 65, 66]. Therefore, the overall toxic potency may differ by individual compounds 
depending on the combinative reactivity of SN2 type reaction and Schiff base formation in a 
biological system.  
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 In an aqueous phase, HALs exist in equilibrium between an aldehyde and a hydrate form 
(Figure 3.28). This hydration equilibrium constant is defined as Khydration, with Khydration= [hydrate] 
/ [aldehyde]. As Khydration increases, the hydrate species is dominant in the aqueous system. 
Based on the theoretical Khydration values obtained from a predictive modeling system, SPARC 
(SPARC Performs Automated Reasoning in Chemistry), which was developed by the U.S. EPA [86, 
87], Khydration values increased as the number of halogens increased (Table 3.4). Table 3.4 
presents the predicted Khydration values for each HAL analyzed for toxicity. The monoHALs 
expressed a Khydration that were 2-4 orders of magnitude smaller than the diHALs and triHALs. 
The halogen-induced toxicity pattern seen with other DBP classes was not expressed in the 
monoHALs. MonoHALs have distinct Khydration values where the distribution of reactive aldehyde 
species will differ by halogen type. Therefore, monoHALs may induce overall toxicity outcomes 
through more than one mode of action. For the di- and triHALs the halogen-mediated SN2 
reaction may perform the predominant role in the induction of toxicity.     
3.4.2. Comparison of the Toxicity of Haloacetaldehydes to Other DBP Classes 
 We compared the cytotoxic and genotoxic potencies among HALs and other DBP 
chemical classes with their calculated cytotoxicity and genotoxicity indices (Figure 3.29). The 
cytotoxicity index was determined by calculating the mean (LC50)
−1(103) value of all of the 
individual compounds of a single class of DBPs. The genotoxicity index was determined by 
calculating the mean SCGE genotoxic potency value which is defined by the reciprocal of 
midpoint value of the SCGE tail moment ×103 from the individual compounds within a single 
class of DBPs (SCGE tail moment; the integrated value of DNA density multiplied by the 
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migration distance) [32]. Total of six DBP chemical classes (THMs, HAAs, HALs, 
halonitromethanes, haloacetonitriles, and haloacetamides) were compared. The HALs were the 
second most cytotoxic DBP class, while their genotoxicity ranked the second lowest. However, 
using SCGE tail moment as the metric for genotoxicity has a possibility to underestimate the 
genotoxicity by their role as DNA cross-linkers. Formaldehyde and acetaldehyde are well-known 
DNA cross-linkers. With a similar structure, HALs may form DNA cross-links and such formations 
will reduce the migration of DNA fragments from the nuclei and result in lower genotoxicity 
measurements.  
 
3.5. CONCLUSION  
 The HALs are the third largest group by weight of identified DBPs formed in drinking 
water. This study identified a new HAL DBP, IAL, and showed that HALs are cytotoxic and 
genotoxic to mammalian cells. This study provided the first systematic, quantitative comparison 
of HAL toxicity. The most cytotoxic HALs were TBAL and CAL, followed by DBAL and BCAL. The 
most genotoxic HAL was DBAL, followed by CAL and DBCAL. HALs were highly cytotoxic among 
other DBP chemical classes. Therefore, HALs may adversely affect the public health and the 
environment and further research are needed to investigate the mode of action of its toxicity.  
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TABLES AND FIGURES 
Table 3.1. Name, sources and purities of haloacetaldehydes analyzed in this study.  
Haloactaldehyde Abbreviation CASN 
Molecular 
Weight 
Source 
Purity 
(%) 
Chloroacetaldehyde CAL 107-20-0 78.50 CanSyn Chem. Co >95 
Bromoacetaldehyde BAL 17157-48-1 122.95 AldLab Chem. 95 
Iodoacetaldehyde IAL 57782-51-62 169.95 AldLab Chem. 95 
Dichloroacetaldehyde DCAL 79-02-7 112.94 CanSyn Chem. Co >95 
Dibromoacetaldehyde DBAL 3039-13-2 201.85 CanSyn Chem. Co >95 
Bromochloroacetaldehyde BCAL 98136-99-3 157.39 CanSyn Chem. Co 85 
Trichloroacetaldehyde TCAL 75-87-06 147.39 CanSyn Chem. Co >95 
Tribromoacetaldehyde TBAL 115-17-3 280.74 CanSyn Chem. Co 97 
Bromodichloroacetaldehyde BDCAL 34619-29-9 191.84 CanSyn Chem. Co 93 
Dibromochloroacetaldehyde DBCAL 64316-11-6 236.29 CanSyn Chem. Co 87 
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Table 3.2. Summary of the CHO cell chronic cytotoxicity of the haloacetaldehydes.  
Name (Abbrev.) 
Conc.  
Range 
(µM) 
Lowest 
Cytotoxic 
Conc.(µM) a 
LC50  
(µM) b 
r2 c ANOVA Test Statistic d 
Chloroacetaldehyde 
(CAL) 
0 – 7 0.5 3.51 0.99 F11, 176 = 241;  P ≤ 0.001 
Dichloroacetaldehyde 
(DCAL) 
0 – 15 8 29.25 0.91 F 20, 335 = 37.5;  P ≤ 0.001 
Trichloroacetaldehyde 
(TCAL) 
0 – 1600 375 1163 0.94 F 24, 333 = 34.0;  P ≤ 0.001 
Bromoacetaldehyde 
(BAL) 
0 – 42 8 17.28 0.98 F 23, 248 = 76.1;  P ≤ 0.001 
Dibromoacetaldehyde 
(DBAL) 
0 – 6 2 4.7 0.99 F 10, 177 = 165;  P ≤ 0.001 
Tribromoacetaldehyde 
(TBAL) 
0 – 10 2 3.58 0.99 F 15, 316 = 256;  P ≤ 0.001 
Iodoacetaldehyde 
(IAL) 
0 – 10 5 6.00 0.96 F 12, 163 = 79.6;  P ≤ 0.001 
Bromochloroacetaldehyde 
(BCAL) 
0 – 10 2.5 5.34 0.97 F 14, 169 = 31.5;  P ≤ 0.001 
Bromodichloroacetaldehyde 
(BDCAL) 
0 – 50 10 20.35 0.89 F 14, 209 = 23.4;  P ≤ 0.001 
Dibromochloroacetaldehyde 
(DBCAL) 
0 – 10 4 5.15 0.95 F 16, 167 = 36.1;  P ≤ 0.001 
 
a Lowest cytotoxic concentration was the lowest concentration of the haloacetaldehyde in the 
concentration-response curve that induced a statistically significant reduction in cell density as 
compared to the concurrent negative controls. b The LC50 value is the concentration of the 
haloacetaldehyde, determined from a regression analysis of the data, that induced a cell density of 50% 
as compared to the concurrent negative controls. c r2 is the coefficient of determination for the 
regression analysis upon which the LC50 value was calculated. 
d The degrees of freedom for the between-
groups and residual associated with the calculated F-test result and the resulting probability value. 
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Table 3.3. Summary of the CHO cell acute genotoxicity of the haloacetaldehydes.  
Name (Abbrev.) 
Conc.  
Range 
(µM) 
Lowest  
%TDNA 
Genotoxic 
Conc. a 
(µM)  
50% 
TDNA b 
(µM)  
r2 c  ANOVA Test Statistic d 
Chloroacetaldehyde 
(CAL) 
0 – 500 100 142.8 0.99 F10, 59 = 62.6;  P ≤ 0.001 
Dichloroacetaldehyde 
(DCAL) 
0 – 2000 800 795 0.98 F 19, 60 = 64.0;  P ≤ 0.001 
Trichloroacetaldehyde 
(TCAL) 
0 – 5000 NS NS NS F 20, 37 = 0.556;  P = 0.918 
Bromoacetaldehyde 
(BAL) 
0 – 550 200 381.2 0.98 F 10, 68 = 57.2;  P ≤ 0.001 
Dibromoacetaldehyde 
(DBAL) 
0 – 300 50 111.3 0.98 F 9, 44 = 41.5;  P ≤ 0.001 
Tribromoacetaldehyde 
(TBAL) 
0 – 500 100 340.3 0.99 F 11, 64 = 168;  P ≤ 0.001 
Iodoacetaldehyde 
(IAL) 
0 – 1000 900 1009 0.98 F 13, 103 = 22.5;  P ≤ 0.001 
Bromochloroacetaldehyde 
(BCAL) 
0 – 700 500 621.4 0.92 F 10, 51 = 22.0;  P ≤ 0.001 
Bromodichloroacetaldehyde 
(BDCAL) 
0 – 600 300 470.4 0.91 F 17, 106 = 16.4;  P ≤ 0.001 
Dibromochloroacetaldehyde 
(DBCAL) 
0 – 220 100 143.7 0.99 F 5, 29 = 34.4;  P ≤ 0.001 
 
a The lowest genotoxic concentration was the lowest concentration of the haloacetaldehyde in the 
concentration-response curve that induced a statistically significant amount of genomic DNA damage as 
compared to the negative control. b The SCGE 50% Tail DNA value is the haloacetaldehyde concentration 
determined from a regression analyses of the data that was calculated to induce a 50% SCGE Tail DNA 
value. c r2 is the coefficient of determination for the regression analysis upon which the SCGE % Tail DNA 
value was calculated. d The degrees of freedom for the between-groups and residual associated with the 
calculated F-test result and the resulting probability value. 
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Table 3.4. Comparison of calculated Khydration values, cytotoxicity index (CTI) values, and genotoxicity 
index (GTI) values of haloacetaldehydes.  
Name (Abbrev.) 
SPARC a 
Khydration 
CTI (±SE) b GTI (±SE) c 
Chloroacetaldehyde 
(CAL) 
17.8 279.0±7.0 7.20±0.42 
Bromoacetaldehyde 
(BAL) 
11.0 64.6±3.5 2.68±0.11 
Iodoacetaldehyde 
(IAL) 
4.37 170.4±7.3 0.96±0.03 
Dichloroacetaldehyde 
(DCAL) 
1.95103 35.7±0.8 1.26±0.03 
Dibromoacetaldehyde 
(DBAL) 
1.58103 207.5±2.1 9.11±0.60 
Bromochloroacetaldehyde 
(BCAL) 
1.70103 207.4±11.0 1.61±0.21 
Trichloroacetaldehyde 
(TCAL) 
3.24104 0.94±0.03 NS 
Tribromoacetaldehyde 
(TBAL) 
1.15104 279.8±4.8 3.00±0.03 
Bromodichloroacetaldehyde 
(BDCAL) 
4.37104 51.1±4.3 2.24±0.05 
Dibromochloroacetaldehyde 
(DBCAL) 
2.00104 200.2±1.4 6.99±0.28 
 
a SPARC (SPARC Performs Automated Reasoning in Chemistry) models are mechanistic perturbation 
models developed by the U.S. EPA to calculate chemical reactivity and physical processes for compounds 
from molecular structure [85, 86]. b The Cytotoxicity index (CTI) value was calculated from the individual 
LC50 values generated from the bootstrap analyses. The mean CTI was calculated as the (LC50)
-1(103). c 
The Genotoxicity index (GTI) value was calculated from the individual 50%TDNA values generated from 
the bootstrap analyses. The mean GTI was calculated as the (LC50)
-1(103). A Pearson correlation analysis 
demonstrated that no significant correlation exists among the hydration constants and the CTI or the 
GTI.  
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Figure 3.1.  Chemical structures of the haloacetaldehydes analyzed in this study.  
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Figure 3.2. . Analyte signal after derivatization-LLE extraction-GC-MS analysis of MiliQ water spiked at a 
level of 0.5 ppb at a level of 1 ppb for all compounds but for IAL (spiked at 4 ppb). 
 
Cl-CHO 2Cl-CHO Br-CHO BrCl-CHO 2Br-CHOI-CHO S.S.
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Figure 3.3. Comparison of the CHO cell chronic cytotoxicity concentration-response curves of ten 
haloacetaldehydes. 
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Figure 3.4. Chloroacetaldehyde CHO cell chronic cytotoxicity.  
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Figure 3.5. Dichloroacetaldehyde CHO cell chronic cytotoxicity.  
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Figure 3.6. Trichloroacetaldehyde CHO cell chronic cytotoxicity.  
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Figure 3.7. Bromoacetaldehyde CHO cell chronic cytotoxicity.  
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Figure 3.8. Dibromoacetaldehyde CHO cell chronic cytotoxicity.  
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Figure 3.9. Tribromoacetaldehyde CHO cell chronic cytotoxicity.  
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Figure 3.10. Iodoacetaldehyde CHO cell chronic cytotoxicity.  
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Figure 3.11. Bromochloroacetaldehyde CHO cell chronic cytotoxicity.  
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Figure 3.12. Bromodichloroacetaldehyde CHO cell chronic cytotoxicity.  
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Figure 3.13. Dibromochloroacetaldehyde CHO cell chronic cytotoxicity.  
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Figure 3.14. The mean bootstrap CHO Cell Cytotoxic Index (CTI) values of ten haloacetaldehydes.  
 
 
  
84 
 
   
 
Figure 3.15. Comparison of the CHO cell acute genotoxicity concentration-response curves of ten 
haloacetaldehydes.  
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Figure 3.16. Chloroacetaldehyde CHO cell genotoxicity.  
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Figure 3.17. Dichloroacetaldehyde CHO cell genotoxicity. 
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Figure 3.18. Trichloroacetaldehyde CHO cell genotoxicity. 
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Figure 3.19. Bromoacetaldehyde CHO cell genotoxicity. 
 
  
89 
 
Dibromoacetaldehyde (µM)
0 100 200 300
C
H
O
 C
e
ll 
G
e
n
o
m
ic
 D
N
A
 D
a
m
a
g
e
 a
s
 t
h
e
 A
v
e
ra
g
e
M
e
a
n
 S
C
G
E
 %
T
a
il 
D
N
A
 V
a
lu
e
 (
±
S
E
)
0
20
40
60
80
%
 V
ia
b
le
C
e
lls
60
80
100
 
 
Figure 3.20. Dibromoacetaldehyde CHO cell genotoxicity. 
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Figure 3.21. Tribromoacetaldehyde CHO cell genotoxicity. 
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Figure 3.22. Iodoacetaldehyde CHO cell genotoxicity. 
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Figure 3.23. Bromochloroacetaldehyde CHO cell genotoxicity. 
 
  
93 
 
Bromdichloroacetaldehyde (µM)
0 100 200 300 400 500 600
C
H
O
 C
e
ll 
G
e
n
o
m
ic
 D
N
A
 D
a
m
a
g
e
 a
s
 t
h
e
 A
v
e
ra
g
e
M
e
a
n
 S
C
G
E
 %
T
a
il 
D
N
A
 V
a
lu
e
 (
±
S
E
)
0
20
40
60
80
%
 V
ia
b
le
C
e
lls
60
80
100
 
 
Figure 3.24. Bromodichloroacetaldehyde CHO cell genotoxicity. 
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Figure 3.25. Dibromochloroacetaldehyde CHO cell genotoxicity. 
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Figure 3.26. The mean bootstrap CHO Cell Genotoxic Index (GTI) values of ten haloacetaldehydes. 
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Figure 3.27. Schiff base formation by aliphatic aldehydes.  
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Figure 3.28. Equilibrium between aldehydes and hydrates. 
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Figure 3.29. Comparisons of the CHO cell chronic cytotoxicity index values and acute genotoxicity index 
values of DBP chemical classes. The genotoxicity index was determined by calculating the mean SCGE 
genotoxic potency value which is defined by the SCGE tail moment from the individual compounds 
within a single class of DBP. (The SCGE tail moment is the integrated value of DNA density multiplied by 
the migration distance.) 
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CHAPTER 4 
INVESTIGATE THE BIOLOGICAL MECHANISM INDUCED BY HALOACETIC ACID 
DISINFECTION BY-PRODUCTS AND THE DEVELOPMENT OF A SINGLE WELL 
MICROPLATE-BASED ATP-PROTEIN MEASUREMENT ASSAY 
 
PREFACE 
 Part of this research was published:  Dad, A.; Jeong, C. H.; Pals, J. A.; Wagner, E. D.; 
Plewa, M. J., Pyruvate remediation of cell stress and genotoxicity induced by haloacetic acid 
drinking water disinfection by-products. Environ. Mol. Mutagen. 2013, 54, (8), 629-637. With 
permission from Wiley and Sons.  A. Dad and C.H. Jeong were co-first authors of the paper. 
 
 
4.1. INTRODUCTION 
 A preeminent public health accomplishment achieved during the last century was the 
disinfection of drinking water. Water treatment and distribution of disinfected water was an 
effective strategy in controlling waterborne diseases such as cholera, typhoid and dysentery [1]. 
However, disinfection by-products (DBPs) are inadvertently generated when chlorine or other 
disinfectants react with organic matter present in source water [1, 2]. Many DBPs are cytotoxic, 
genotoxic, mutagenic, carcinogenic and teratogenic [3]. Epidemiological studies demonstrated 
an association between lifetime exposures to DBPs and increased risk of bladder cancer [4-7], 
100 
 
colorectal cancer [8, 9] and skin cancer [10]. The U.S. Environmental Protection Agency (U.S. 
EPA) estimated that between 2 and 17% of bladder cancer cases in the U.S. may be induced by 
DBPs [11]. Epidemiological studies also demonstrated an association between disinfected 
drinking water and adverse pregnancy outcomes [12-14]. 
 Currently, over 600 DBPs have been identified and the spectrum of DBP chemical classes 
are influenced by the source water, water contaminants and the disinfectant used [2, 15, 16]. In 
chlorinated water the second largest occurring DBP chemical class is the haloacetic acids (HAAs) 
[17]. The HAAs are the most highly regulated DBPs. The U.S. EPA regulates chloroacetic acid 
(CAA), dichloroacetic acid (DCAA), trichloroacetic acid (TCAA), bromoacetic acid (BAA), and 
dibromoacetic acid (DBAA) to a total maximum contaminant level of 60 µg/L [18]. At all water 
sites measured, the U.S. EPA Information Collection Rule recorded the mean and 90th 
percentile concentration for the 5 regulated HAAs (HAA5) as 23 µg/L and 47.5 µg/L, respectively 
[19]. 
 HAAs are alkylating agents and follow SN2 reactivity, which is primarily dependent on 
the α-carbon-halide (αC-X) bond length and the bond dissociation energy. The αC-X bond length 
follows the pattern of C-I > C-Br > C-Cl, which implies that the greater the bond length, the 
lower the dissociation energy required to react with the target molecule [20]. Cytotoxic and 
genotoxic potencies induced by the monohaloacetic acids (monoHAAs) expressed the pattern 
of iodoacetic acid (IAA) > BAA >> CAA, which highly correlated to the SN2 reactivity, αC-X bond 
length and αC-X dissociation energy [20]. 
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 HAAs are cytotoxic and genotoxic in Chinese hamster ovary (CHO) cells [21] and non-
transformed human cells [22]. They are mutagenic in Salmonella typhimurium and CHO cells [20, 
23, 24] and toxic in a variety of other bioassays [3]. The monoHAAs modulated the gene 
expression pathways of ATM, MAPK, p53, BRCA1, BRCA2, and ATR, in non-transformed human 
FHs 74-Int cells originated from a female fetus 3-4 months into gestation [25].  These pathways 
are involved in stress response to DNA damage and regulate different stages in cell cycle 
progression or apoptosis [22, 26]. IAA induced malignant transformation in NIH/3T3 mouse 
embryonic fibroblast cells that progressed to highly aggressive fibrosarcomas when implanted 
in Balb/c nude mice [27]. Under ex-vivo conditions, monoHAAs were teratogenic and induced 
dysmorphogenesis in CD-1 mouse embryos and affected neural tube development, eye 
development and produced anomalies in heart development [28]. Gestational exposure of 
mixtures of HAA5 resulted in pregnancy loss and eye malformation in rats [29]. DCAA, DBAA, 
and bromochloroacetic acid (BCAA) altered intestinal microflora and metabolism in rats which 
could further affect bioactivations of promutagens or procarcinogens [30].    
  IAA induced toxicity in hippocampal neuronal cells by inhibiting the glycolytic enzyme 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), which led to hypoglycemia and the 
generation of reactive oxygen species (ROS) [31]. Similar effects were induced by IAA in 
hippocampal astrocytes [32]. The direct role of monoHAA-mediated inhibition kinetics of 
GAPDH, their high correlation with many toxicity measurements and their impact on gene 
expression of human ROS regulation was recently published by our laboratory [33].  
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 Our hypothesis is that GAPDH is inhibited by monoHAAs, which reduces the generation 
of pyruvate that is required for the tricarboxylic acid (TCA) cycle for the further production of 
ATP. We postulate that the unavailability of pyruvate causes mitochondrial stress leading to the 
generation of ROS and a reduction in cellular ATP levels, which may further induce cytotoxicity 
in HAA-treated cells. If this hypothesis is correct, then exogenous pyruvate supplementation in 
monoHAA-treated cells should restore cellular ATP levels. Along with the mechanistic study, we 
suggest that ATP measurement assay could be a novel bioassay which quantitatively measures 
the inhibition potency of a common cellular mechanism related to toxicity. However, to avoid 
the artifact such as different ATP levels caused by different cell viability of the cell suspensions, 
the experimental designs should be refined to include total protein analyses from the same 
suspension which the ATP levels are measured.  
  The objectives of this research were to: i) measure the impact of the monoHAAs on ATP 
levels with and without pyruvate supplementation, ii) develop a quantitative bioassay that will 
measure the reduction of ATP generation and the protein amount at non-cytotoxic levels of 
DBPs (pmol ATP/mg protein) from a same suspension, and analyze ten known HAAs with this 
new assay to test the sensitivity of this assay as a novel metric to compare ATP reduction 
potency of individual DBPs, and iii) analyze for correlation between the previously published 
toxicity data and the ATP reduction potency and determine the utility of the assay as an 
indicator of toxicological effects. 
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4.2. MATERIALS AND METHODS  
4.2.1. Reagents  
 General reagents were purchased from Fisher Scientific Co. (Itasca, IL) and Sigma 
Chemical Co. (St. Louis, MO). The sources and purities of the monoHAAs used in this research 
are listed in Table 4.1. The sources and purities of di- and triHAAs are listed in Table 4.2. Cell 
culture F12 medium and fetal bovine serum (FBS) were purchased from Fisher Scientific Co. 
Pyruvic acid was purchased from Acros Organics (Fair Lawn, NJ). Cell Titer-Glo reagent was 
purchased from Promega (Madison, WI). The monoHAAs were dissolved in dimethylsulfoxide 
(DMSO) and stored at −20 °C in sealed sterile glass vials (Sulpelco, Bellefonte PA).  Pyruvate was 
dissolved directly either in F12 medium or Hank’s balanced salt solution (HBSS) according to the 
experimental design. Individual HAA stock solutions in DMSO (1M) were diluted in F12 medium 
or HBSS depending upon the experimental design on the day of experiment.  
4.2.2. Chinese Hamster Ovary Cells  
 CHO cell clone 11-4-8 was used [34]. Cells were grown in 100 mm glass petri plates with 
F12 medium containing 5% FBS, 1% glutamine and 1% antibiotic-antimycotic solution at 37 °C in 
a humidified atmosphere of 5% CO2. 
4.2.3. Pyruvate Supplementation: ATP Analysis  
 Cellular ATP levels were determined after exposure to monoHAAs alone, pyruvic acid 
alone or monoHAAs plus pyruvic acid with a TUNE-SpectraMax Paradigm® Multi-Mode 
Microplate Detection Platform (Sunnydale, CA) using Promega Cell Titer–Glo ATP reagents. The 
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day before ATP analysis, 3×104 CHO cells/well were cultured in a 96 well opaque microplate in 
200 µL of F12 containing 5% FBS. The next day, the cells were washed with 100 µL of HBSS and 
treated with concentrations of the monoHAAs with and without pyruvic acid in 50 µL HBSS 
(with 1.3 mM CaCl2 and 1.1 mM MgSO4). The microplate was covered with AlumnaSeal and 
incubated for 4 h at 37°C, 5% CO2. Each experiment contained a concurrent negative control, a 
bioluminescence background control, pyruvic acid (10 mM), the monoHAAs, monoHAAs plus 
pyruvic acid and an ATP standard curve. After incubation, the cells were washed with 100 µL of 
HBSS and supplemented with 10 mM pyruvate (for the pyruvate containing treatment groups), 
covered with AlumnaSeal and incubated for 30 min at 37°C, 5% CO2 and then equilibrated to 
room temperature for 30 min. The ATP contents of the cells were measured according to the 
manufacturer’s protocol using 50 µL of Cell Titer-Glo ATP reagents. Data were collected in an 
Excel spreadsheet and the pmol of ATP was calculated for each well.  
4.2.4. Pyruvate Supplementation: Protein Determination  
 Parallel ATP and protein analyses were performed. The day before the experiment, 
3×104 CHO cells/well were cultured in a 96 well flat bottom clear microplate in 200 µL of F12 
containing 5% FBS. The next day, cells were treated with the HAAs with and without pyruvate 
as discussed above for the ATP analysis. After treatment, the cells were lysed by adding 25 µL of 
Solulyse® cell homogenizing solution (Genlantis, San Diego, CA). The microplate was covered 
with sterile AlumnaSeal and put on a rocker platform (at 37°C) shaken for 5 min after which the 
plate was rotated 90° and shaken for an additional 5 min. After cell lyses, 10 µL of the lysate 
from each well was transferred into a new microplate; 10 µL of an anti-foaming agent (Sigma 
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240, 0.01% v/v), 40 µL of Bradford solution (BioRad), and 140 µL of dH2O for a final volume of 
200 µL were added into each well. A BioRad protein (BSA) standard was prepared on the same 
microplate, using 0.68 µg/µL of a BSA standard solution. The contents of each well were 
carefully mixed and incubated at room temperature for 20 min. The absorbance was read at 
595 nm using a SpectraMax Molecular Device plate reader. The data were collected in an Excel 
spreadsheet and the mg of protein was calculated for each well.  
4.2.5. Single Well Approach: Cell Treatment  
 The day before the treatment, 3×104 CHO cells/well were cultured in a 96 well opaque 
microplate in 200 µL of F12 plus 5% FBS. The next day, the cells were washed with 100 µL of 
HBSS and treated with concentrations of the HAAs in 50 µL HBSS containing 1.3 mM CaCl2 and 
1.1 mM MgSO4. Each experiment contained a concurrent negative control, a blank control, and 
two different concentrations of each HAA. The microplate was covered with AlumnaSeal and 
incubated for 3 h 30 min at 37°C, 5% CO2, followed by additional 30 min incubation at room 
temperature (total 4 h treatment). After 4 h of treatment, the cells were washed with 100 µL of 
HBSS and were lysed by adding 25 µL of Solulyse® cell homogenizing solution (Genlantis, San 
Diego, CA). 10 µL of the lysate from each well were immediately transferred to a new 96 well 
clear microplate for protein measurement. 
4.2.6. Single Well Approach: ATP Analysis  
 In the 96 well opaque microplate with the remaining 15 µL lysate, 10 µL of HBSS were 
added to each well. An ATP standard curve was set-up in the same plate. Cell Titer-Glo ATP 
reagents (25 µL) were added into each well, and the plate was incubated in the orbital shaker 
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for 2 min at 37°C, followed by an additional incubation at room temperature for 10 min. The 
ATP levels were measured using a bioluminescent agent with a TUNE-SpectraMax Paradigm® 
Multi-Mode Microplate Detection Platform. Data were collected in an Excel spreadsheet and 
the pmol of ATP per 25 µL lysate was calculated for each well.  
4.2.7. Single Well Approach: Protein Determination  
 In the 96 well clear microplate containing 10 µL of lysate, 10 µL of an anti-foaming agent, 
Antifoam 204 (0.01% v/v, Sigma-Aldrich Co.) were added. A protein standard curve was 
conducted in the same microplate with a BSA standard solution. 40 µL of Bradford solution 
(BioRad) and 140 µL of dH2O were added and each well was mixed gently by using a multi-pipet. 
The plate was incubated for 20 min at room temperature before measurement. The absorbance 
was read at 595 nm using a SpectraMax Molecular Device plate reader. Data were collected in 
an Excel spreadsheet and mg of protein per 25 µL lysate was calculated for each well. 
4.2.8. Statistical Analysis   
  A Pearson’s Product Moment correlation test was conducted to investigate the 
correlations of ATP alteration potency with HAA physiochemical parameters and various 
toxicological parameters including cytotoxicity, genotoxicity, mutagenicity, and teratogenicity 
as well as the GAPDH inhibition kinetics in CHO cells. The number of groups analyzed per 
experiment was two (HAA-treated and its independent concurrent control). A t-test was 
performed to examine the statistical significance of the generation of the bioluminescence 
units in the HAA-treated cells compared to its concurrent negative control.  
107 
 
4.3. RESULTS  
4.3.1. Depletion of ATP by MonoHAAs 
 CHO cells were treated with 25 and 40 µM IAA, 60 µM BAA and 6 mM CAA for 4 h in 
HBSS. The concentrations of each monoHAA were previously determined to be genotoxic in 
CHO cells without acute cytotoxicity [35]. The cellular ATP levels (as the average 
bioluminescence unit) for monoHAA-treated cells were significantly reduced as compared to 
the negative control. The ATP levels with CAA-treated cells were approximately the same as the 
blank (Figure 4.1). By observation, we did not detect CHO cell cytotoxicity after 4 h.  
4.3.2. Pyruvate Supplementation and ATP Levels in MonoHAA-treated Cells 
 We determined the minimum concentration of each monoHAA in HBSS (with 1.3 mM 
CaCl2 and 1.1 mM MgSO4) that induced a significant reduction in cellular ATP levels. The lowest 
non-cytotoxic concentrations of IAA, BAA and CAA that induced a significant reduction in ATP 
levels as compared to each concurrent negative control were 3 µM, 6 µM, and 1 mM (Figure 
4.2).  Using these concentrations of IAA, BAA and CAA, we conducted parallel experiments to 
determine the absolute amount of ATP and the total protein content of each cell suspension 
within each treatment group. This experimental design allowed us to determine concentrations 
of ATP and protein for each CHO cell suspension for a precise measurement of ATP depletion 
and restoration. The concentration of ATP as pmol/mg protein for each monoHAA treatment 
group is presented in Table 4.3. Figure 4.3 illustrates cellular ATP levels (pmol ATP/mg protein) 
normalized as 100% for each concurrent negative control for each monoHAA treatment group. 
A reduction in ATP levels was observed with exposures to 3 µM IAA, 6 µM BAA and 1 mM CAA 
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with ATP levels of 18.7%, 48.2% and 50.8% of the concurrent negative controls, respectively. 
When monoHAA-treated cells were simultaneously treated with 10 mM pyruvate, a significant 
recovery of cellular ATP levels was measured. For IAA, ATP levels increased from 18.7% to 45.0% 
of the concurrent negative control. Similar responses were observed for BAA (48.2% to 122.1%) 
and CAA (50.8% to 80.2%) (Figure 4.3). The CHO cells treated with IAA had the greatest 
reduction in cellular ATP levels (0.54%) per pmol IAA. For the BAA and CAA treatment groups, 
the reduction in cellular ATP levels per pmol monoHAA was 0.15% for BAA and 0.001% for CAA 
(Table 4.3).  
4.3.3. Single Well Approach: Alteration of ATP Levels in HAA-treated Cells 
 CHO cells were treated with HAA for 4 h in HBSS (with 1.3 mM CaCl2 and 1.1 mM MgSO4) 
with two concentrations of each HAA. Treated concentrations were previously determined to 
be genotoxic in CHO cells without acute cytotoxicity [35]. The minimum concentration of each 
HAA that induced a significant reduction in cellular ATP levels as compared to each concurrent 
negative control was used for further analysis (Table 4.6 and Figure 4.5). Effects of the HAAs on 
ATP levels compared to its concurrent negative control in CHO cells with t-test analysis are 
presented in Table 4.6. The cellular ATP levels for monoHAA-treated cells were significantly 
reduced, but were not concentration-dependent (Figure 4.4). Figure 4.5 illustrates cellular ATP 
levels (pmol ATP/mg protein) normalized as 100% for each concurrent negative control for HAA 
treatment group. All ATP levels except TCAA showed a statistically significant alteration of 
celluler ATP levels. Interestingly, while all mono- and diHAAs showed a reduction in ATP levels, 
three triHAAs showed an increase of ATP levels. The % alteration of cellular ATP per pmol HAA 
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in CHO cells and other toxicological parameters of HAAs are presented in Table 4.7. We 
calculated the CHO cell ATP alteration potency index value (|%Alteration per pmol HAA|  103) 
for each HAA (Table 4.7). 
 To investigate correlations between CHO cell ATP alteration potency and other HAA 
toxicological parameters, we applied a Pearson’s Product Moment statistical test (Table 4.8) 
[36]. The cytotoxic potency significantly correlated with monoHAA %ATP alteration potency (r = 
0.997; P ≤ 0.05) and all HAA %ATP alteration potency (r = 0.997; P ≤ 0.001). The genotoxic 
potency significantly correlated with all HAA %ATP alteration potency (r = 0.961; P ≤ 0.001). The 
cytotoxic potency with diHAA %ATP alteration potency, and the genotoxic potency with 
monoHAA %ATP alteration potency  showed good, but not statistically significant correlations (r 
= 0.992; P = 0.081 and r = 0.950; P = 0.202).    
 
4.4. DISCUSSION 
4.4.1. Depletion of ATP Levels and the Effect of Pyruvate Supplementation in MonoHAA-
Treated Cells 
 All three monoHAAs induced ATP depletion in CHO cells, and when they were 
simultaneously treated with 10 mM pyruvate, a significant recovery of cellular ATP levels was 
measured. The monoHAA-mediated ATP depletion followed a rank order of IAA > BAA >> CAA. 
This pattern and magnitude of ATP depletion directly correlated with the αC-X bond length and 
relative alkylation potential of each monoHAA and was inversely correlated with the αC-X bond 
dissociation energy (Table 4.4). ATP depletion was highly correlated with the inhibition kinetics 
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of GAPDH [33] (Table 4.6). A conserved cysteine residue in the active site of GAPDH is central to 
its glycolytic function [37-39]. This cysteine serves as a nucleophile in the first catalytic step in 
the conversion of glyceraldehyde-3-phosphate to 1,3-bis-phosphoglycerate [40].  The αC of 
each monoHAA is a primary alkyl halide and an electrophile due to electron withdrawal from 
the carbon by the halogen substituent. IAA, BAA and CAA inhibit GAPDH when the α-carbon 
undergoes an SN2 reaction with the nucleophilic thiol group on the catalytic cysteine residue. 
This results in a carboxymethylated cysteine which irreversibly inhibits the catalytic function of 
the enzyme.  
 Our results suggest that a major pathway in the toxic mode of action by the monoHAAs 
is the irreversible inhibition of GAPDH and the subsequent reduction of cellular ATP levels 
induced by a blockage in the generation of pyruvate from glucose. Previous studies 
demonstrated that IAA blocked glycolysis by inhibiting GAPDH that led to neurotoxicity [31, 32, 
41], ROS generation [31, 41], ATP depletion  [31, 32] and disruption of intracellular Ca2+ 
homeostasis [32, 42]. Of importance is that ATP depletion by the monoHAAs is highly correlated 
with diverse measurements of toxicity including cytotoxicity, genotoxicity, mutagenicity and 
teratogenicity published in the literature over the past 17 years (Table 4.5).     
 Overall, our suggested molecular mechanism is that the monoHAAs inhibit GAPDH by 
alkylating the thiol group at the GAPDH active site which leads to glycolytic ATP depletion and 
blocks the production of pyruvate that is a mitochondrial substrate for the TCA cycle [39]. 
Pyruvate starvation enhances mitochondrial stress, disrupts the TCA cycle and affects the 
generation of reducing power (NADH and FADH2) within mitochondria during the TCA cycle. 
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This deficiency in reducing power disturbs normal oxidative phosphorylation, which eventually 
generates ROS, depletes mitochondrial ATP and increases cytosolic Ca2+ concentration [31, 40, 
43, 44]. This proposed mechanism is supported in the pattern of toxicological response of IAA > 
BAA > CAA and that IAA-induced mutagenicity in Salmonella typhimurium and genotoxicity in 
CHO cells was repressed by the antioxidants catalase and butylated hydroxyanisole [45]. We 
believe that ATP depletion and ROS generation are the principal forcing mechanisms for 
monoHAA-mediated toxicity [33, 46, 47]. 
4.4.2. Alteration of ATP Levels in HAA-treated Cells Determined by a Novel Microplate-based 
Single Well ATP-protein Measurement Assay 
  The cellular ATP levels for monoHAA-treated cells were significantly reduced, but were 
not concentration-dependent (Figure 4.4). This result suggests that the new single well assay is 
less sensitive than the parallel assay used of the pyruvate supplementation experiment which 
showed a concentration-dependent manner (Figure 4.2). The blank bioluminescence signal of 
the single well experiment was an order of magnitude lower than the blank signal of the 
parallel experiment. Therefore, the low sensitivity of the single well assay may be due to the 
smaller amount of Cell Titer-Glo ATP reagents used of the measurement compared to the 
parallel assay which leads to a lower resolving power. However, it should be emphasized that 
the new assay was able to obtain statistically significant changes in bioluminescence signals. 
The fact that the measurement of protein was performed within the same cell suspension used 
for the ATP level measurement strengthens the accuracy of the calculated ATP alteration 
potency index value. Since the single well assay only needs half amount of the testing 
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compound compared to the parallel assay, once the single well assay is refined and further 
optimized, it may be useful for testing the toxicity of limited amount of samples such as 
complex DBP mixtures.   
 An interesting trend was found in the ATP levels in terms of the number of halogens 
attached (Table 4.6 and Figures 4.5-4.6). MonoHAAs showed the greatest reduction in ATP 
levels, whereas diHAAs showed a moderate reduction with higher concentration ranges. 
TriHAAs induced significant increase in ATP levels except for TCAA. The average ATP levels as 
the % of negative control was 40.9% for monoHAAs, 72.9% for diHAAs, and 120% for triHAAs 
(Figure 4.6). These results were unexpected because from a previous experiment in our 
laboratory, all ten HAAs induced an inhibition of GAPDH activity. The increased ATP level for 
triHAAs indicates that HAAs may be involved in other ATP regulation pathways in addition to 
GAPDH activity.  
 Whitehouse et al. reported that TCAA inhibits pyruvate dehydrogenase kinase (PDK) and 
increased the proportion of active pyruvate dehydrogenase (PDH) in the pig heart [48]. PDH is 
an enzyme in the pyruvate dehydrogenase complex (PDC) which converts pyruvate into acetyl-
CoA. This decarboxylation step is known to be the rate-limiting step for the pyruvate PDC 
machinery. Since acetyl-CoA is an essential substrate for TCA cycle, PDH activity is important in 
linking the glycolysis pathway to the TCA cycle, and ATP production. Therefore, it is possible 
that the increase of ATP levels were induced by triHAAs because the dominant molecular 
pathway was the activation of PDH instead of GAPDH inhibition. DCAA also inhibited the PDK at 
approximately the same concentrations as for TCAA in the same study. Later, Kline et al. found 
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that DCAA activates myocardial PDH and increase myocardial tissue content of ATP [49]. This 
indicates that diHAAs can also activate PDH and increase ATP production. Since DCAA showed 
the lowest ATP alteration potency index value (index value = 0.087, Table 4.7), it is possible that 
diHAAs have similar extent of activities in both GAPDH inhibition and PDH activation to 
compensate the overall ATP level as a result. However, further investigation is needed to 
confirm this hypothesis.     
 One other possible mechanism related to ATP production is the pyruvate transport 
pathway into mitochondria. In eukaryotic cells, the glycolysis occurs in the cytosol, and the TCA 
cycle occurs in the mitochondria matrix. Thus, pyruvate generated through glycolysis needs to 
get transported into the mitochondria matrix for ATP production. In a study investigating the 
kinetics of pyruvate transport into mitochondria, CAA and DCAA appeared to be a substrate for 
the mitochondrial pyruvate carrier, while TCAA did not, which indicates that mono- and diHAAs 
may interfere with pyruvate carrier to alter the ATP production [50]. However, whether these 
results are due to different mechanisms that involving cellular energy homeostasis are unclear. 
 
4.5. CONCLUSION 
 This study extended our research on the molecular mechanism(s) of toxicity of these 
important DBPs by investigating the impact of monoHAAs on cellular ATP levels and the 
attenuation by pyruvate supplementation. This study also provided a platform for the 
development of a novel bioassay, which quantitatively measures the toxicity of DBPs at 
molecular cellular levels. An alteration in cellular ATP homeostasis at non-cytotoxic 
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concentration may be an important measure of toxic action. Additional studies are needed to 
validate the utility of the assay, and we will further determine if PDH is stimulated by the di- 
and triHAAs.     
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TABLES AND FIGURES 
Table 4.1. Monohaloacetic acid characteristics, sources and purities. 
HAA a CASN MW 
(g/mol) 
 
C−X b Bond 
Length 
(Å) c 
Dissociation 
Energy 
(kcal/mol) d 
Source Purity 
(%) 
IAA 64-69-7 185.95 C−I 2.14 57.4 Sigma-Aldrich >99 
BAA 79-08-3 138.95 C−Br 1.93 65.9 Fluka >99 
CAA 79-11-8 94.50 C−Cl 1.77 78.5 Fluka >99 
 
a Abbreviations: HAA, haloacetic acids; IAA, iodoacetic acid; BAA, bromoacetic acid; CAA, chloroacetic 
acid. b α-Carbon-halogen bond. c C−X  bond length summarized from [51].d C−X  bond dissociation energy 
summarized from [51].  
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Table 4.2. Di- and trihaloacetic acids characteristics, sources and purities. 
HAA a CASN 
MW 
(g/mol) 
Source 
Purity 
(%) 
DCAA 79-43-6 128.94 Fluka >99 
DBAA 631-64-1 217.86 Fluka >97 
BCAA 5589-96-8 173.39 U.S. EPA >98 
TCAA 76-03-9 163.39 Fluka >99 
TBAA 75-96-7 296.76 Fluka >98 
DBCAA 5278-95-5 252.30 Cerilliant >98 
BDCAA 71133-14-7 207.84 Radian International >98 
 
a Abbreviations: HAA, haloacetic acids; DCAA, dichloroacetic acid; DBAA, dibromoacetic acid; BCAA, 
bromochloroacetic acid; TCAA, trichloroacetic acid; TBAA, tribromoacetic acid; DBCAA, 
dibromochloroacetic acid; BDCAA, bromodichloroacetic acid.   
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Table .4.3. Effects of the monoHAAs on ATP levels in CHO cells with and without pyruvate 
supplementation.  
HAA Group Treatment Conditions pmol ATP/mg Protein 
Mean Value ± SE 
% Reduction per 
pmol HAA 
IAA 
Negative Control  (IAA) 29788 ± 3197 NA 
10 mM Pyruvate 29476 ± 3575 NA 
3 µM IAA 5557 ± 274 0.54229 
3 µM IAA + Pyruvate 13411 ± 1105 NA 
BAA 
Negative Control (BAA) 18225 ± 1503 NA 
10 mM Pyruvate 29297 ± 2782 NA 
6 µM BAA 8786 ± 897 0.15136 
6 µM BAA + Pyruvate 24338 ± 2487 NA 
CAA 
Negative Control (CAA) 6814 ± 755 NA 
10 mM Pyruvate 23464 ± 2278 NA 
1 mM CAA 3463 ± 419 0.00098 
1 mM CAA + Pyruvate 5465 ± 589 NA 
 
NA, not applicable. 
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Table 4.4. Pearson Product Moment Correlation analyses of HAA physiochemical parameters and the 
percent reduction of cellular ATP per pmol HAA in CHO cells. 
Physicochemical 
Parameters 
ELUMO 
(r) a 
C─X 
Bond Length 
(r) b 
C─X 
Dissociation 
Energy (r) b 
Relative 
Alkylation 
Potential 
(SN2) (r) 
b 
ATP % Reduction per pmol 
HAA c 
−0.986 0.985 −0.935 0.999 
ELUMO  −1.000 0.981 −0.980 
C─X Bond Length   −0.982 0.979 
C─X Dissociation Energy    −0.922 
 
a Calculated ELUMO (energy of the lowest unoccupied molecular orbital) summarized from [52]. b 
Summarized from [51]. c Calculated from data presented in this paper. 
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Table 4.5. Pearson Product Moment Correlation analyses of HAA toxicological parameters and the 
percent reduction of cellular ATP per pmol HAA in CHO cells. 
HAA Toxico-
logical  
Parameters  
CHO cell 
cyto-
toxic 
index (r) 
CHO cell 
geno-
toxic 
index (r) 
FHs cell 
geno-
toxic 
index (r) 
Salmonella 
cytotoxic 
index (r) 
Salmonella 
mutagenic 
potency (r) 
CHO cell 
muta-
genicity 
index (r) 
Mouse 
terato-
genicity 
(r) 
GAPDH 
inhibi-
tion (r) 
ATP % 
reduction 
per pmol 
HAA a 
1.00 0.968 0.992 0.991 0.993 0.965 0.999 −0.986 
CHO cell 
cytotoxic 
index b 
 0.976 0.996 0.995 0.996 0.956 0.998 −0.990 
CHO cell 
genotoxic 
index c 
  0.992 0.993 0.991 0.868 0.959 −0.997 
FHs cell 
genotoxic 
index c 
   1.00 1.00 0.925 0.987 −0.999 
Salmonella 
cytotoxic 
index d 
    1.00 0.921 0.986 −0.999 
Salmonella 
mutagenic 
potency d 
     0.926 0.988 −0.999 
CHO cell 
mutagenici
ty index e 
      0.974 −0.906 
Mouse 
terato-
genicity f 
       −0.979 
GAPDH 
inhibition 
kinetics g 
       1.00 
 
a Calculated from data presented in this paper. b Derived as the reciprocal of the LC50 concentration (× 
constant to generate whole numbers), data from [21].  c Derived as the reciprocal of the SCGE genotoxic 
potency value (× constant to generate whole numbers), data from [21, 33].  d Data from [20, 23]. e Data 
from [24]. f Data from [28]. g The average rate of GAPDH inhibition per μM monoHAA concentration 
derived from the slope of the inhibition curves for each monoHAA [33]. 
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Table 4.6. Effects of the HAAs on ATP levels compared to its concurrent negative control in CHO cells 
and t-test statistical analysis calculated with the LUM as the % of negative control. 
HAA Group 
Number of 
Replicates 
(N) 
Average LUM  
(RLU ± SE) 
Average LUM 
as the % of 
control (± SE) 
t df P 
CAA control 32 4142.4 ± 185.6   100.00 ± 4.48 
10.820 62 <0.001 
CAA 700 µM  32 1386.9 ± 174.4  33.48 ± 4.21  
BAA control 23 5195.4 ± 222.9 100.00 ± 4.29 
10.943 45 <0.001 
BAA 15 µM 24 2585.0 ± 94.5 49.76 ± 1.82 
IAA control 32 4856.3 ± 309.2 100.00 ± 6.37 
8.529 62 <0.001 
IAA 4 µM 32 1917.0 ± 152.2  39.47 ± 3.13 
DCAA control 24 4708.8 ± 90.4 100.00 ± 1.92 
3.133 44 0.003 
DCAA 2000 µM 22 4296.0 ± 96.0 103.71 ± 2.04 
DBAA control 24 5270.1 ± 93.7 100.00 ± 1.78 
14.270 46 <0.001 
DBAA 700 µM 24 3707.1 ± 56.6 70.34 ± 1.07 
BCAA control 34 6309.8 ± 177.4 100.00 ± 2.81 
9.545 66 <0.001 
BCAA 700 µM 34 4147.8 ± 136.2 66.16 ± 2.16 
TCAA control 31 4760.9 ± 226.3 100.00 ± 4.75 
-0.749 61 0.456 
TCAA 2000 µM 32 4969.6 ± 164.5 104.38 ± 3.46 
TBAA control 24 4220.3 ± 208.5 100.00 ± 4.94 
-3.830 46 <0.001 
TBAA 1000 µM 24 5168.1 ± 133.3 122.46 ± 3.16 
BDCAA control 30 4852.3 ± 82.8 100.00 ± 1.71 
-5.453 60 <0.001 
BDCAA 2000 µM 32 5883.6 ± 165.8 121.25 ± 3.42 
DBCAA control 32 4771.7 ± 191.4 100.00 ± 4.01 
-4.473 62 <0.001 
DBCAA 1000 µM 32 6044.0 ± 210.4 126.66 ± 4.41 
 
Abbreviations: HAA, haloacetic acid; CAA, chloroacetic acid; BAA, bromoacetic acid; IAA, iodoacetic acid; 
DCAA, dichloroacetic acid; DBAA, dibromoacetic acid; BCAA, bromochloroacetic acid; TCAA, 
trichloroacetic acid; TBAA, tribromoacetic acid; BDCAA, bromodichloroacetic acid; DBCAA, 
dibormochloroacetic acid; LUM, luminescence; RLU, relative light unit; SE, standard error; df, degrees of 
freedom. 
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Table 4.7. Toxicological parameters of HAAs and the percent alteration of cellular ATP per pmol HAA in 
CHO cells. 
HAA Group 
Treated 
Concentration 
(µM) 
% Alteration 
per pmol HAA 
CHO Cell 
Cytotoxic 
Potency 
Index
 a,d
 
CHO Cell 
Genotoxic 
Potency 
Index
 b,d
 
CHO Cell 
ATP 
Alteration 
Potency 
Index
 c
 
CAA 700 1.9010-3 12.3 24.4 1.90 
BAA 15 6.710-2 1000 588 67.0 
IAA 4 3.0310-1 3450 1150 303 
DCAA 2000 8.6610-5 1.27 NA 0.087 
DBAA 700 1.1110-3 16.9 5.56 1.11 
BCAA 700 9.6710-4 12.8 3.33 0.97 
TCAA 2000 -9.2010-5 4.17 NA 0.092 
TBAA 1000 -4.4910-4 118 4.00 0.45 
BDCAA 2000 -2.1310-4 14.5 NA 0.21 
DBCAA 1000 -5.8610-4 50.0 0.714 0.59 
 
Abbreviations: HAA, haloacetic acid; CAA, chloroacetic acid; BAA, bromoacetic acid; IAA, iodoacetic acid; 
DCAA, dichloroacetic acid; DBAA, dibromoacetic acid; BCAA, bromochloroacetic acid; TCAA, 
trichloroacetic acid; TBAA, tribromoacetic acid; BDCAA, bromodichloroacetic acid; DBCAA, 
dibormochloroacetic acid.  
a The CHO cell cytotoxic potency index value corresponds to (LC50
-1 102) for each HAA. b The CHO cell 
genotoxic potency index value corresponds to (SCGE GP-110-2), where SCGE GP value is the HAA 
concentration that was calculated, using regression analysis, at the midpoint of the curve within the 
concentration range that expressed above 70% cell viability. c The CHO cell ATP alteration potency index 
value corresponds to (|%Alteration per pmol HAA| 103) for each HAA.  d Data from [21]. 
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Table 4.8. Pearson Product Moment Correlation analyses of HAA toxicological parameters and the % 
ATP alteration potency of HAA groups categorized by the number of halogens in the α-carbon.  
HAA Group 
CHO Cell Cytotoxic 
Potency Index
 a,d 
(LC50
-1102) 
CHO Cell Genotoxic 
Potency Index
 b,d 
(SCGE GP-110-2) 
CHO Cell Cytotoxic Potency 
vs 
CHO Cell Genotoxic Potency 
MonoHAA CHO Cell  
ATP Alteration Potency Index c  
r = 0.997 
P ≤ 0.05 
r = 0.950  
P = 0.202 
r = 0.971 
P = 0.154 
DiHAA CHO Cell  
ATP Alteration Potency Index c 
r = 0.992 
P = 0.0813 
NA NA 
TriHAA CHO Cell  
ATP Alteration Potency Index c 
r = 0.676  
P =0.324 
NA NA 
All HAA CHO Cell  
ATP Alteration Potency Index c 
r = 0.997  
P ≤ 0.001 
r = 0.961 
P ≤ 0.001 
r = 0.976 
P ≤ 0.001 
 
Abbreviations: HAA, haloacetic acid.  
a The CHO cell cytotoxic potency index value corresponds to (LC50
-1 102) for each HAA. b The CHO cell 
genotoxic potency index value corresponds to (SCGE GP-110-2), where SCGE GP value is the HAA 
concentration that was calculated, using regression analysis, at the midpoint of the curve within the 
concentration range that expressed above 70% cell viability. c The CHO cell ATP alteration potency index 
value corresponds to (|%Alteration per pmol HAA| 103) for each HAA. d Data from [21]. 
 
 
127 
 
 
Figure 4.1. Impact of monoHAA exposure on the cellular ATP levels as measured using relative 
bioluminescence units. The * indicates a significant difference from the negative control. The insert is a 
ATP standard curve.  
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Figure 4.2. Reduction of ATP levels measured as bioluminescence units in CHO cells after exposure to 
monoHAAs. All monoHAA treatments induced a significant reduction in ATP levels as compared to the 
concurrent negative controls. 
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Figure 4.3. Recovery of ATP levels in monoHAA-treated cells after pyruvate supplementation. 
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Figure 4.4. Reduction of ATP levels measured as bioluminescence units in CHO cells after exposure to 
monoHAAs using a single well approach bioassay. All monoHAA treatments induced a significant 
reduction in ATP levels as compared to the concurrent negative controls. 
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Figure 4.5. Impacts of HAA exposure on the cellular ATP levels (pmol ATP/mg protein). ATP levels are 
normalized as 100% for each concurrent negative control for each HAA treatment group. Standard error 
(SE) used for the negative control is the average of all individual negative control SEs. The * indicates a 
statistically significant difference from their concurrent negative control (t-test, See Table 4.6).   
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Figure 4.6.  Impacts of numbers of halogens attached to HAA on the cellular ATP levels (pmol ATP/mg 
protein). ATP levels were normalized as 100% for each concurrent negative control for each HAA 
treatment group. Individual ATP % alteration values were grouped by the number of halogen attached 
and averaged.  
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CHAPTER 5 
THE OCCURRENCE AND TOXICITY OF DISINFECTION BY-PRODUCTS IN EUROPEAN 
DRINKING WATERS IN RELATION WITH THE HIWATE EPIDEMIOLOGY STUDY 
 
PREFACE 
 This research was published in: Jeong, C. H.; Wagner, E. D.; Siebert, V. R.; Anduri, S.; 
Richardson, S. D.; Daiber, E. J.; McKague, A. B.; Kogevinas, M.; Villanueva, C. M.; Goslan, E. H.; 
Luo, W.; Isabelle, L. M.; Pankow, J. F.; Grazuleviciene, R.; Cordier, S.; Edwards, S. C.; Righi, E.; 
Nieuwenhuijsen, M. J.; Plewa, M. J., The occurrence and toxicity of disinfection byproducts in 
European drinking waters in relation with the HIWATE epidemiology study. Envion. Sci. Technol. 
2012, 46, (21), 12120-12128. With permission from American Chemical Society. The analytical 
chemistry work was conducted by Dr. S. Richardson (University of South Carolina). 
 
5.1. INTRODUCTION 
 The introduction of water disinfection greatly reduced the incidence of waterborne 
infectious diseases [1]. Although chlorine is the most common disinfectant, alternatives include 
ozone, chloramines, chlorine dioxide, and UV radiation [2-4]. An unintended consequence of 
disinfection is the formation of drinking water disinfection by-products (DBPs) from the 
reaction between organic and inorganic materials in the water and disinfectants. Chemical 
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classes of DBPs include halomethanes, haloacetic acids (HAAs), and nitrogen-containing DBPs 
(N-DBPs); to date, more than 600 DBPs have been identified in drinking water [5, 6]. The 
spectrum of DBP generation depends on the source water, pH, temperature, disinfection type 
and processes [6-9]. Less than 20 DBPs are currently regulated in the United States and in other 
countries [5, 10]. 
 Previous epidemiological studies reported associations between DBPs in chlorinated 
water and increased cancer risk [11-15] as well as DBPs and adverse pregnancy outcomes 
including spontaneous abortion, low birth weight (LBW), small-for-gestational-age (SGA), still 
birth, and preterm delivery [16-19]. HAAs were teratogenic in mice embryos [20]; mixtures of 
trihalomethanes (THMs) and HAAs were teratogenic in rats [21]. 
 In 2006, the European Union (EU) established the project HIWATE (Health Impacts of 
long-term exposure to disinfection byproducts in drinking WATEr) to investigate potential 
human health risks associated with long-term exposure to DBPs [22]. Pregnancy cohorts (N 
≈23,000) were included from France, Lithuania, Spain, Italy, and the United Kingdom (Figure 
5.1). These locations encompassed a variety of disinfectants and treatments including chlorine, 
ozone, chlorine dioxide, and desalination with reverse osmosis (Table 5.1). Metrics for adverse 
pregnancy outcomes were LBW, SGA, preterm delivery, fetal growth restriction (FGR), and 
parameters derived from ultrasound medical diagnosis. 
 This project represents the first systematic analysis combining DBP analytical chemistry 
and in vitro mammalian cell toxicology with adverse pregnancy outcomes. Our objectives were 
to (i) obtain disinfected drinking water from HIWATE cities, extract and concentrate the organic 
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fraction and chemically analyze for DBPs, (ii) determine the relative chronic cytotoxicity and 
acute genotoxicity in mammalian cells for each HIWATE sample, and (iii) analyze for 
correlations between the toxicity data and the occurrence and concentrations of DBPs.  
 
5.2. MATERIALS AND METHODS 
5.2.1. Chemicals and Reagents 
 General reagents were purchased from Sigma-Aldrich Co. (St. Louis, MO) and Fisher 
Scientific Co. (Itasca, IL). Media and fetal bovine serum (FBS) were purchased from Fisher 
Scientific Co. (Itasca, IL). Chemical standards were purchased from Sigma-Aldrich, ChemService 
(West Chester, PA), Orchid Cellmark (Westminster, BC, Canada), and TCI America (Waltham, 
MA) at the highest level of purity.   
5.2.2. Sample Preparation 
 Drinking water samples (20 L) were collected from 11 different distribution systems 
from 7 cities within 5 European countries, where an epidemiologic study of reproductive 
outcomes was being conducted. Samples were collected from March-June 2010 using 2L Teflon 
bottles (headspace-free) and were commercially shipped in coolers with icepacks to the U.S. 
Environmental Protection Agency (U.S. EPA) laboratory in Athens, GA. Water samples were 
extracted immediately upon arrival using XAD resins [23]. The final extract (2 mL in ethyl 
acetate) was equally divided for GC/MS analysis and genotoxicity/cytotoxicity analysis. For 
toxicity analyses the solvent ethyl acetate was evaporated with a stream of dry N2 and 
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exchanged to dimethylsulfoxide (DMSO) resulting in a 105× concentration. These samples were 
stored in glass Supelco 1-mL Micro Reaction Vessels (No. 27036) at −20 °C.  
5.2.3. Broad-Screen GC/MS Analyses   
 Half of the extract was derivatized with diazomethane [24] to identify halo-acids 
(through their corresponding methyl esters), while the other half was analyzed directly for 
other DBPs. Comprehensive gas chromatography/mass spectrometer  (GC/MS) analyses were 
performed on a high-resolution magnetic sector mass spectrometer (Autospec, Waters, Inc.) in 
electron ionization mode, equipped with an Agilent model 6890 gas chromatograph and 
operated at an accelerating voltage of 8 kV and source temperature of 200 °C, in both low-
resolution (1000) and high-resolution (10,000) modes. Injections of 1 µL of the extracts were 
introduced via a split/splitless injector (in splitless mode) onto a GC column (ZB-5, 30 m X 0.25 
mm ID, 0.25 µm film thickness, Phenomenex (Torrance, CA). The GC temperature program 
consisted of an initial temperature of 35 °C (4 min) followed by an increase at 9 °C/min to 
285 °C (held for 30 min). Transfer lines were held at 280 °C and the injection port at 250 °C. To 
prevent decomposition of THMs, separate analyses were made with an injection port 
temperature of 180 °C [25]. For analysis of data by the Massworks expert system [26], extracts 
were analyzed in the continuum mode at 1000 resolution.  
 Mass spectra of unknown compounds in the drinking water extracts were subjected to 
library database searching (National Institute of Standards and Technology and Wiley 
databases). For DBPs not present in either database, high-resolution-MS and Massworks 
software (Cerno Bioscience, Norwalk, CT) were used to provide empirical formulas for 
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molecular ions and fragments. Mass spectra were also interpreted extensively to provide 
tentative structural identifications. When possible, pure standards were obtained to confirm 
identifications through a match of GC retention times and mass spectra. 
5.2.4. GC X GC-TOF-MS Measurements  
 GC X GC-time-of-flight (TOF)-MS measurements were conducted using a Leco Pegasus 
4D GC X GC-TOF mass spectrometer (Leco Corp., St. Joseph, Michigan). The extracts (1 µL) were 
introduced via a split/splitless injector (in splitless mode). A DB-VRX (45 m, 0.25 mm i.d., 1.4 µm 
film thickness, Agilent, Santa Clara CA) served as the primary column and a Stabilwax (1.5 m, 
0.25 mm i.d., 0.25 µm film thickness, Restek, Bellefonte, PA) as the secondary column. The 
primary GC oven program consisted of an initial temperature of 45 °C (3 min), an increase at 
10 °C/min to 145 °C (3 min), an increase at 5oC/min to 240 °C, and final hold of 20 min. The 
secondary GC oven was 13 °C above the primary GC oven. The modulator offset was 20 °C 
above to the primary GC oven. The modulation period was 7 s with 1.5 s hot pulse. The transfer 
line and source temperature were maintained at 248 °C and 200 °C, respectively. The MS data 
were acquired from m/z 35 to 500 at rate of 150 spectra/s in electron ionization mode. 
5.2.5. Quantitative Chemical Analyses 
  THMs (chloroform, bromodichloromethane, dibromochloromethane, and bromoform), 
haloacetonitriles (dichloroacetonitrile, bromochloroacetonitrile, dibromoacetonitrile, and 
trichloroacetonitrile), haloketones (1,1-dichloro- and 1,1,1-trichloropropanone), 
trichloroacetaldehyde (chloral hydrate), and trichloronitromethane (chloropicrin) were 
extracted using a modified form of U.S. EPA Method 551.1 [27]. HAAs (chloro-, bromo-, 
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dichloro-, trichloro-, bromochloro-, dibromo-, bromodichloro-, dibromochloro-, and 
tribromoacetic acid) were analyzed using a modified form of U.S. EPA Method 552.3 [28]. The 
limit of detection for each DBP was 1 µg/L, with the exception of chloroacetic acid (detection 
limit was 2 µg/L).  
5.2.6. Chinese Hamster Ovary Cells 
 Chinese hamster ovary (CHO) cell line AS52, clone 11-4-8 was used for the biological 
assays [29-31]. CHO cells were maintained on glass culture plates in Ham’s F12 medium 
containing 5% fetal bovine serum (FBS), 1% antibiotics (100 U/mL sodium penicillin G, 100 
µg/mL streptomycin sulfate, 0.25 µg/mL amphotericin B in 0.85% saline), and 1% glutamine at 
37°C in a humidified atmosphere of 5% CO2.  
5.2.7. CHO Cell Chronic Cytotoxicity Assay 
 This assay measures the reduction in cell density as a function of the organic extract 
concentration over a period of approximately 3 cell divisions (72 h). Chronic cytotoxicity to CHO 
cells was measured using an assay we previously developed for the analysis of DBPs [32]. Flat-
bottom, tissue culture 96-well microplates were employed; 4 replicate wells were prepared for 
each concentration of a specific organic extract for each HIWATE water sample. Eight wells 
were reserved for the blank control consisting of 200 µL of F12 medium + 5% fetal bovine 
serum (FBS). The negative control consisted of 8 wells containing 100 µL of a titered CHO cell 
suspension (3×104 cells/mL) plus 100 µL F12 + FBS. The wells for the remaining columns 
contained 3,000 CHO cells, F12 + FBS and a known concentration of an HIWATE water sample 
organic extract for a total of 200 μL. To prevent cross-over contamination between wells due to 
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volatilization of the organic extract, a sheet of sterile AlumnaSeal™ (RPI Corporation, Mt. 
Prospect, IL) was pressed over the wells before the microplate was covered. The microplate 
was placed on a rocking platform for 10 min to uniformly distribute the cells, and then placed in 
a tissue culture incubator for 72 h. After incubation, each well was gently aspirated, fixed in 100% 
methanol for 10 min, and stained for 10 min with a 1% crystal violet solution in 50% methanol. 
The plate was gently washed in tap water, inverted and tapped dry upon paper towels, and 50 
μL of dimethyl sulfoxide/methanol (3:1 v/v) was added to each well for 10 min. The plate was 
analyzed in a BioRad microplate reader at 595 nm. The data were automatically recorded and 
transferred to an Excel spreadsheet on a microcomputer connected to the microplate reader. 
The blank-corrected absorbance value of the negative control (cells with medium only) was set 
at 100%. The absorbance for each treatment group well was converted into a percentage of the 
negative control. For each organic extract concentration, 4-8 replicate wells were analyzed per 
experiment, and the experiments were repeated 2-3 times. 
5.2.8. Single Cell Gel Electrophoresis Assay  
 Single cell gel electrophoresis (SCGE) is a molecular genetic assay that quantitatively 
measures the level of genomic DNA damage induced in individual nuclei of treated cells [33-35]. 
We employed the microplate SCGE method [36]. The day before treatment, 4×104 CHO cells 
were added to each microplate well in 200 µL of F12 + 5% FBS and incubated. The next day, the 
cells were washed with Hank’s balanced salt solution (HBSS) and treated with a series of 
concentrations of an organic extract from the HIWATE water samples in F12 medium without 
FBS in a total volume of 25 μL for 4 h at 37°C, 5% CO2. The wells were covered with sterile 
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AlumnaSeal™. After incubation, the cells were washed 2× with HBSS and harvested with 50 μL 
of 0.01% trypsin + 53 μM EDTA. The trypsin was inactivated with 70 µL of F12 + FBS. Acute cyto-
toxicity was measured from a 10 μL aliquot of cell suspension mixed with 10 µL of 0.05% trypan 
blue vital dye in phosphate-buffered saline (PBS) [37]. SCGE data were not used if the acute 
cytotoxicity exceeded 30%. The remaining cell suspension from each well was embedded in a 
layer of low melting point agarose prepared with PBS upon clear microscope slides that were 
previously coated with a layer of 1% normal melting point agarose prepared with deionized 
water and dried overnight. The cellular membranes were removed by an overnight immersion 
in lysing solution (2.5 M NaCl, 100 mM Na2EDTA, 10 mM Tris, 1% sodium sarcosinate, 1% Triton 
X-100, and 10% DMSO)  at 4°C. The microgels were placed in an alkaline buffer (1 mM Na2EDTA, 
300 mM  NaOH,  pH 13.5) in an electrophoresis tank, and the DNA was denatured for 20 min. 
The microgels were electrophoresed at 25 V, 300 mA (0.72 V/cm) for 40 min at 4°C. The 
microgels were neutralized with Tris buffer (pH 7.5), rinsed in cold water, dehydrated in cold 
methanol, dried at 50°C, and stored at room temperature in a covered slide box. For analysis of 
the HIWATE samples, the microgels were hydrated in cold water for 30 min and stained with 65 
μL of ethidium bromide (20 μg/mL) for 3 min. The microgels were rinsed in cold water and 
analyzed with a Zeiss fluorescence microscope with an excitation filter of BP 546/10 nm and a 
barrier filter of 590 nm. For each experiment, 2 microgels were prepared per treatment group. 
Randomly chosen nuclei (25 per microgel) were analyzed using a charged coupled device 
camera. A computerized image analysis system (Comet IV, Perspective Instruments, Ltd, Suffolk, 
UK) was employed to determine the SCGE %Tail DNA value of the nuclei as indices of DNA 
damage. The digitalized data were automatically transferred to a computer based spreadsheet 
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for subsequent statistical analysis. Within each experiment, a negative control, a positive 
control (3.8 mM ethylmethanesulfonate), and 9 concentrations of an organic extract from 
HIWATE water samples were analyzed concurrently. The experiments were repeated 2-3 times 
for each HIWATE organic extract.  
5.2.9. Statistical Analyses 
 For the cytotoxicity assay, a one-way analysis of variance (ANOVA) test was conducted 
to determine if the HIWATE sample induced a statistically significant level of cell death at a 
specific concentration factor. If a significant F value (P ≤ 0.05) was obtained, a Holm-Sidak 
multiple comparison versus the control group analysis was performed to identify the lowest 
cytotoxic concentration factor. The power of the test statistic (1−β) was maintained as ≥ 0.8 at 
α = 0.05.  
 For the SCGE assay, the %Tail DNA values are not normally distributed, which limits the 
use of parametric statistics [38]. The mean %Tail DNA value for each microgel was calculated 
and these values were averaged among all of the microgels for each HIWATE sample 
concentration factor. Averaged mean values express a normal distribution according to the 
central limit theorem [38]. A one-way ANOVA test was conducted on these averaged %Tail DNA 
values  [39]. If a significant F value of P ≤ 0.05 was obtained, a Holm-Sidak multiple comparison 
versus the control group analysis was conducted with the power ≥ 0.8 at α = 0.05.  
 The mammalian cell cytotoxicity and genotoxicity analyses were compared with the 
following analytical chemical metrics: (i) the numbers of DBPs identified in each HIWATE sample, 
(ii) the chromatographic peak area for the entire sample, (iii) peak areas for specific classes of 
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DBPs, (iv) the total concentration of 21 selected DBPs and, (v) concentrations of specific DBP 
classes within the group of 21 DBPs. A Pearson’s Product Moment correlation test was 
conducted. 
 
5.3. RESULTS AND DISCUSSION 
5.3.1. Chemical Analyses  
 Over 90 DBPs were identified in the samples, including several haloacids (including 3- 
and 4-carbon acids and di-acids), halophenols, haloamides, halonitromethanes, haloketones, 
haloaldehydes, and haloalkenes (Table 5.2). Approximately 300 chromatographic peaks were 
observed in the original GC/MS chromatograms including DBPs and other compounds present 
in the raw waters prior to disinfection (Figure 5.2). With GC X GC-TOF-MS analyses, these peaks 
were resolved into >1000 peaks (Figure 5.3). Several DBPs identified were not in mass spectral 
library databases and these identifications were made through the methods outlined previously 
utilizing Massworks software. Several new DBPs were presumptively identified, including cis- 
and trans-2,3-dibromo-3-chloropropenoic acid, 3,3-dibromo-2-chloropropenoic acid, and 
several halophenols and haloalkenes. A total of 21 target DBPs, including 4 U.S-regulated THMs, 
9 HAAs, 4 haloacetonitriles (HANs), 2 haloketones (HKs), trichloroacetaldehyde (chloral hydrate), 
and trichloronitromethane (chloropicrin) were quantified (Table 5.3).  
 Substantial differences were observed in the DBPs from the different locations. As 
expected, drinking waters from coastal Spain (Barcelona and Valencia) had relatively high DBP 
levels with many brominated (and some iodinated) species due to higher levels of total organic 
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carbon (TOC), bromide and iodide in their source waters (surface water), as well as the use of 
chlorine as a disinfectant. Drinking waters from coastal Spain averaged 90 and 33 µg/L for 
THM4 and HAA9, respectively (Table 5.3). In contrast, drinking water from Modena, Italy had 
fewer DBPs and those present were at much lower levels; these were primarily chlorine-
containing species. The source water for Modena is a low-TOC groundwater that is treated with 
low chlorine dioxide doses (0.1 mg/L), which forms fewer DBPs as compared to other 
disinfectants [4, 40-42]. None of the 21 target DBPs were detected in the drinking water from 
Modena, but a few were detected in the broad screen analyses due to lower detection limits. 
Drinking water from other locations (samples 4, 6, 8-11, Table 5.1) expressed intermediate DBP 
levels with a mix of chloro-bromo species probably due to lower levels of bromide and TOC in 
their source waters as compared to waters from costal Spain (Table 5.2 and Table 5.3).  
 Of the N-DBPs [43], haloacetonitriles and haloamides were prevalent in drinking waters 
from coastal cities in Spain (samples 1-3, 7), which involved treatment with chlorine, alone or in 
combination with ozone or chlorine dioxide. Previous research demonstrated that ozonation 
increased the formation of halonitromethanes when used prior to chlorination or 
chloramination [44-46]. While chloramination increases the formation of some N-DBPs [6], 
none of the cities in this study employed chloramines. 
5.3.2. CHO Cell Chronic Cytotoxicity 
 CHO cell chronic cytotoxicity analyses of each HIWATE sample are summarized in Table 
5.4. The concentration factor is the fold concentration of the isolated organic material as 
compared to the original water. The lowest concentration factor of each sample which induced 
144 
 
a statistically significant reduction in cell density as compared to its concurrent negative control 
was determined by an ANOVA test statistic. The data from replicated experiments were 
averaged and plotted (Figure 5.4, Figures 5.5-5.15); regression analyses were used to calculate 
the LC50 (%C½ ) value for each sample. Based on the LC50 values, the descending rank order of 
chronic cytotoxicity was, sample 3 > sample 1 > sample 2 ≈ sample 4 > sample 7 > sample 10 > 
sample 9 > sample 8 ≈ sample 11 > sample 6 > sample 5. Samples from Barcelona, Spain were 
ranked as the 3 most cytotoxic. We calculated the cytotoxicity index value (LC50
-1  1000) for 
each HIWATE sample (Figure 5.16, Table 5.5). 
5.3.3. CHO Cell Acute Genotoxicity 
 CHO cell acute genotoxicity analyses of each HIWATE sample are summarized in Table 
4.6. The lowest genotoxic concentration factor was that which induced a statistically significant 
amount of genomic DNA damage as compared to the concurrent negative control. Figure 5.17 
(individual plots are shown in Figures 5.18-5.28) illustrates the concentration-response curves 
for the HIWATE samples. Based on 50% Tail DNA values, the descending rank order of 
genotoxicity was, sample 10 > sample 4 > sample 7 > sample 1 ≈ sample 2 > sample 3 > sample 
9 > sample 11 > sample 6 > sample 8 >> sample 5. We calculated the genotoxic index value as 
50% Tail DNA-1  104 for each sample (Figure 5.29, Table 5.5).  
5.3.4. Correlation of Toxicology, Chemistry and Epidemiology 
 To investigate correlations between DBP occurrence and DBP classes with mammalian 
cell toxicity, we applied a Pearson’s Product Moment statistical test [38]. The cytotoxic potency 
index values statistically significantly correlated with the number of identified DBPs (r = 0.78; P 
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≤ 0.005, Table 5.7) and the level of 21 target DBPs (r = 0.77; P ≤ 0.006, Table 4.3). The genotoxic 
potency index values were not correlated with either of these metrics or with any DBP chemical 
class (Table 5.3 and Table 5.7). Interestingly, the cytotoxicity and genotoxicity indices indicated 
a good correlation (r = 0.74; P ≤ 0.009). The cytotoxic potency index showed a good correlation 
with the U.S-regulated DBPs (r = 0.78; P ≤ 0.006) and unregulated DBPs (r = 0.60; P ≤ 0.05; Table 
4.3). 
 Cytotoxicity was significantly correlated with the relative concentrations of the following 
DBP classes: THMs (r = 0.74; P ≤ 0.01), haloacids (r = 0.75; P ≤ 0.008), other monoacids (r = 0.68; 
P ≤ 0.021), halodiacids (r = 0.80; P ≤ 0.003), haloamides (r = 0.68; P ≤ 0.021), haloaromatics (r = 
0.64; P ≤ 0.035), brominated (r = 0.68; P ≤ 0.022), chlorinated (r = 0.78; P ≤ 0.005) , and 
iodinated (r = 0.82; P ≤ 0.002) DBPs (Table 5.8). There were no statistically significant 
correlations with genotoxicity and the above DBP classes, although there were associations or 
trends in relationships between genotoxicity and the relative concentrations of haloacids (r = 
0.54; P ≤ 0.088), haloaromatics (r = 0.52; P ≤ 0.103), chlorinated (r = 0.56; P ≤ 0.073) and 
iodinated (r = 0.53; P ≤ 0.093) DBPs (Table 5.8). It should be noted that some highly polar 
components might have been missed by GC/MS and this may explain, in part, the reduced 
correlation seen with the genotoxicity data and analytical chemistry of the water samples. 
Recently several papers have been published on novel methods to detect polar 
iodinated/brominated DBPs [47-49]. 
 Epidemiology results from Lithuania were recently published [50] and a dose-response 
relationship for the THM internal dose and risk for LBW was reported. The authors also found 
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slight an increase in the risk of SGA related to elevated internal doses of THMs during 
pregnancy. We expanded comparisons to include the number of identified DBPs and the toxic 
potency indices from the current study with these epidemiologic measurements. We compared 
prevalence of LBW and SGA for the high THM exposure group which corresponded to HIWATE 
sample 4 (this study) and a low THM exposure group which corresponded to sample 6 (this 
study). We found that the prevalence of LBW, SGA, the number of identified DBPs the level of 
DBPs, the cytotoxic potency, and the genotoxic potency were all higher for sample 4 versus 
sample 6 (Figure 5.16 and Figure 5.29, Table 5.4, Tables 5.6-5.7, and Table 5.9). This relationship 
suggests a coherence association between the analytical chemistry, the in vitro toxicology, and 
the epidemiologic results and support epidemiologic findings for an association between 
adverse reproductive effects and exposure to DBPs.  
 Epidemiology results in Spain were recently published that included 3 sites of the 
HIWATE project corresponding to samples 3, 7 and 9 of this study [51]. The authors focused on 
maternal exposure to THMs and its association with birth weight, SGA, LBW, and preterm 
delivery. Although the authors found that residential THM exposure during pregnancy driven by 
inhalation and dermal contact routes was not associated with birth weight, SGA, LBW, or 
preterm delivery in Spain, we expanded comparisons to include the number of identified DBPs 
and the toxic potency indices from the current study with these epidemiologic measurements. 
There was a trend with higher SGA levels and higher numbers of identified DBPs, and higher 
genotoxicity and cytotoxicity index values (Table 5.9). An epidemiological study from Rennes, 
France (HIWATE) concluded that THM and haloacetic acid biomarkers of disinfection by-product 
exposure suggested prenatal exposure affects fetal growth, but the causal agent or agents 
147 
 
remain to be identified [52]. From these studies it appears that expanding the chemical and 
toxicological characterization of water samples may enhance the resolving power of 
epidemiological investigations. It should be noted that the drinking water samples for the 
epidemiologic analyses and the current chemical/toxicological evaluations were not collected at 
the same time.  
 
5.4. CONCLUSION  
 This was the first study that integrated quantitative in vitro toxicological data with 
analytical chemistry and human epidemiologic data for drinking water DBPs. This project 
focused on the relationship of the occurrence and concentration of DBPs with mammalian cell 
toxicity. The range of the number of DBPs identified and their levels reflect the diverse 
collection sites, different disinfection processes, and the different characteristics of the source 
waters. CHO cytotoxicity was well correlated with the numbers of DBPs identified and the levels 
of DBP chemical classes. Although there was a clear difference in genotoxic responses, these 
data did not correlate well with chemical analyses of the HIWATE samples. Thus, the agents 
responsible for the genomic DNA damage observed in the HIWATE samples may be due to 
unresolved associations of combinations of identified DBPs, unknown emerging DBPs that were 
not identified, or other toxic water contaminants.  
 We are continuing to compare the epidemiology with the in vitro toxicity and analytical 
chemistry analyses. Future study will investigate the possible association between chronic 
cytotoxicity, acute genotoxicity, multivariate comparisons of identified DBPs and epidemiology 
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across the entire HIWATE program. We plan to compare other in vitro and molecular toxicity 
metrics and rates of adverse pregnancy measurements. Finally, we propose to determine the 
contribution of source water, and disinfection chemistry to the observed toxicity and 
epidemiology results and develop solutions to protect the public health and the environment. 
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TABLES AND FIGURES 
Table 5.1. HIWATE water sampling locations and applied disinfection methods. 
Sample 
Number 
Sampling Location (Site) Disinfection Method 
HIWATE 1 Barcelona, Spain (Badalona) Cl2-Cl2 
HIWATE 2 Barcelona, Spain (Hospitalet del 
Llobregat) 
Blend of Cl2-Cl2 , Cl2-O3-Cl2, Desal-RO-ClO2   
HIWATE 3 Barcelona, Spain (Sabadell) Blend of (ClO2/Cl2)-Cl2, Cl2-Cl2   
HIWATE 4 Kaunas, Lithuania (Petruniusai) Cl2  
HIWATE 5 Modena, Italy ClO2   
HIWATE 6 Kaunas, Lithuania (Viciunai) Cl2 
HIWATE 7 Valencia, Spain Cl2-Cl2   
HIWATE 8 Rennes, France O3-Cl2   
HIWATE 9 Asturias, Spain Cl2 
HIWATE 10 Bradford, U.K. (Shipley) Cl2 
HIWATE 11 Bradford, U.K. (Airedale) Cl2 
 
Cl2 = chlorination, O3 = ozonation, ClO2 = chlorine dioxide, Desal-RO = desalination with reverse osmosis. 
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Table 5.2. DBPs identified from the broadscreen anlaysisa. 
 
HIWATE Sample Number and Relative Concentrations of DBPs 
Regulated THMsb 1 2 3 4 5 6 7 8 9 10 11 
Bromodichloromethane  71957 43619 42668 17579 ND ND 50493 36343 48465 35449 26330 
Dibromochloromethane  99952 103640 118499 7429 1154 1568 123682 71944 43365 14724 22480 
Bromoform 134734 150331 158731 200 1000 500 107089 61451 17688 500 2371 
 
           Unregulated halomethanes 
           Dichloroiodomethane 3885 1768 662 8578 ND 780 3176 3133 ND ND 2917 
Bromochloroiodomethane  2990 5774 3651 2220 ND ND 5654 2927 5568 ND 484 
Dibromoiodomethane   7548 7829 12034 172 ND ND 4421 2348 1440 ND ND 
 
           Haloalkenes 
           Hexachlorocyclopentadiene 100 ND 100 4236 ND ND 100 ND 6921 3777 1363 
Bromopentachlorocyclopentadiene ND ND 50 400 ND ND 50 50 500 200 100 
Dibromotetrachlorocyclopentadiene ND ND ND 1308 ND ND 200 ND 200 300 300 
 
             
155 
 
Table 5.2. (Continued)            
Haloacetic acids 
           Bromoacetic acid   2834 3405 4402 ND ND ND 3097 1321 ND ND ND 
Dichloroacetic acid   27347 8358 19066 24875 437 471 32384 22568 40491 61010 5000 
Bromochloroacetic acid 23808 12111 24172 3840 ND 385 44492 27264 ND 3299 ND 
Dibromoacetic acid   106492 99125 109402 ND ND ND 128964 73451 ND ND ND 
Trichloroacetic acid   46087 21075 44130 25729 436 788 25146 13146 110081 72121 38623 
Bromodichloroacetic acid  24640 16993 27003 2885 ND ND 45921 18504 21768 4521 6681 
Dibromochloroacetic acid  74411 106576 110691 ND ND ND 100516 32733 ND ND ND 
 
           Other Mono-haloacids 
           2-Bromopropanoic acid 2440 1658 4969 ND ND ND 3428 1359 ND ND ND 
2,2-Dichloropropanoic acid 6229 1733 6785 1975 ND ND 5213 2066 5760 13578 5641 
2,3-Dibromopropanoic acid 26425 17717 21135 ND ND ND 9638 2511 ND ND ND 
3,3-Dichloropropenoic acid 756 2066 2033 ND ND ND 1582 746 100 570 1401 
3,3-Bromochloropropenoic acid ND 2368 1744 ND ND ND 1717 610 ND ND 279 
            
  
156 
 
Table 5.2. (Continued)            
Other Mono-haloacids (continued)            
trans-2,3-Bromochloropropenoic acid ND 3152 1582 ND ND ND 2661 1124 ND ND 100 
cis-2,3-Dibromopropenoic acid 100 63129 62735 ND ND ND 25869 4691 ND ND ND 
trans-2,3-Dibromopropenoic acid 100 6484 3875 ND ND ND 650 ND ND ND ND 
2-Bromo-3,3-dichloropropenoic acid 100 3780 3367 ND ND ND 3220 2517 2093 2884 2684 
(E)-3-Bromo-2,3-dichloropropenoic acid 100 5238 2640 ND ND ND 1869 1466 1497 2041 1804 
(Z)-3-Bromo-2,3-dichloropropenoic acid 100 3353 1694 ND ND ND 1678 771 1500 5723 2999 
3,3-Dibromo-2-chloropropenoic acid 200 8750 7783 ND ND ND 6058 4197 ND ND ND 
(E)-2,3-Dibromo-3-chloropropenoic acid 200 8750 7783 ND ND ND 7000 1631 ND ND ND 
(Z)-2,3-Dibromo-3-chloropropenoic acid 200 8750 7783 ND ND ND 11257 6061 ND ND 100 
Tribromopropenoic acid 100 ND ND ND ND ND ND ND ND ND ND 
cis-2-Bromobutenoic acid 4763 2948 6296 ND ND ND 6499 ND ND ND ND 
trans-2-Bromobutenoic acid 3621 16340 15316 ND ND ND 1044 ND ND ND ND 
trans-2,3-Dibromobutenoic acid 200 14950 2711 ND ND ND 1805 278 ND ND ND 
Dibromohexanoic acid 1000 1500 1300 ND ND ND 200 100 ND ND ND 
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Table 5.2. (Continued)            
Other Mono-haloacids (continued)            
Bromoheptanoic acid, isomer #1 7817 3227 8193 ND ND ND 11428 2247 ND 749 ND 
Bromoheptanoic acid, isomer #2 2000 1500 3569 ND ND ND 6386 1511 ND ND ND 
Bromooctanoic acid 3070 3316 9408 ND ND ND 12749 2037 ND 781 50 
            
Halo-di-acids 
           cis-2,3-Dichlorobutenedioic acid 100 100 4361 2283 ND ND 3213 1806 1740 572 236 
trans-2,3-Dichlorobutenedioic acid 100 ND 6005 3500 ND ND 7228 3031 5404 4773 4109 
trans-2,3-Dibromobutenedioic acid 24438 21022 38116 ND ND ND 17935 3902 5531 ND ND 
 
           Halonitriles 
           Dichloroacetonitrile   22941 8062 5885 15406 ND ND 9632 5199 38435 24513 4016 
Bromochloroacetonitrile  19192 18931 19149 2969 ND ND 30593 19087 10733 4023 769 
Dibromoacetonitrile   84107 48881 51157 ND ND ND 156558 28079 4045 ND ND 
Dibromochloroacetonitrile  9092 3409 3196 ND ND ND 3816 3046 731 ND ND 
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Table 5.2. (Continued)            
Halonitriles (continued)            
Tribromoacetonitrile   10005 8517 7848 ND ND ND 10169 3566 ND ND ND 
2,2-Dibromopropanenitrile 1941 1983 1995 ND ND ND 2474 400 ND ND ND 
 
           Haloketones 
           1,1-Dichloropropanone  ND ND ND 3098 ND ND ND ND ND ND ND 
1-Bromo-1-chloropropanone 1439 2331 854 965 ND ND 1702 4180 ND ND ND 
1,1-Dibromopropanone  16332 18195 ND ND ND ND 2170 6951 ND ND ND 
1,1,1-Trichloropropanone  11,589 4046 5068 8908 394 ND 11370 10932 24592 13469 683 
1-Bromo-1,1-dichloropropanone  7886 3054 967 1262 ND ND 5595 7068 ND ND ND 
1,1,1-Tribromopropanone  7500 ND ND ND ND ND ND ND ND ND ND 
1,1,3-Tribromopropanone 1546 ND ND ND ND ND ND ND ND ND ND 
1,1,1,3-Tetrachloropropanone  2688 ND 1655 1095 ND ND ND ND 16254 1864 1354 
1,1,3,3-Tetrachloropropanone  ND ND ND 2000 ND ND ND ND 24351 3356 200 
1,1,3,3-Tetrabromopropanone  5317 914 1877 ND ND ND 200 ND ND ND ND 
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Table 5.2. (Continued)            
Haloketones (continued)            
Pentachloropropanone 9277 ND 3125 3338 ND ND 2000 ND 46254 8919 961 
3-Bromo-2-butanone 16880 960 388 ND ND ND 200 946 ND ND ND 
 
           Haloaldehydes 
           Bromodichloroacetaldehyde  3240 7354 526 ND ND ND 3365 2102 1215 500 ND
Dibromochloroacetaldehyde  16301 21083 11149 ND ND ND 3438 3545 593 ND ND 
Tribromoacetaldehyde   28471 22575 11791 ND ND ND 3318 1867 ND ND ND 
 
           Halonitromethanes 
           Dichloronitromethane  ND ND ND ND ND ND ND ND ND 8390 ND 
Bromochloronitromethane  ND 3602 1092 ND ND ND ND 2049 ND ND ND 
Dibromonitromethane   11004 18400 6702 ND ND ND 3780 5832 ND ND ND 
Trichloronitromethane (Chloropicrin) ND ND ND ND ND ND ND ND ND ND 1000 
Bromodichloronitromethane  ND ND ND ND ND ND ND 1693 1169 983 ND 
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Table 5.2. (Continued)            
Halonitromethanes (continued)            
Dibromochloronitromethane  ND ND ND ND ND ND ND 9999 400 ND ND 
Tribromonitromethane   12857 683 4422 ND ND ND 18563 13283 ND ND ND 
 
           Haloamides 
           Dichloroacetamide   17151 ND 12794 3000 ND ND 200 7147 ND ND ND
Bromochloroacetamide 16218 10291 10254 416 ND ND ND 3592 ND ND ND 
Dibromoacetamide   109188 94776 105496 ND ND ND 106659 61437 ND ND ND 
Trichloroacetamide   11204 2162 7720 1150 ND ND 9459 4165 5909 4259 ND 
Bromodichloroacetamide 62406 144668 124452 ND ND ND 83074 5000 ND ND ND 
Dibromochloroacetamide 7317 13211 11800 ND ND ND 27653 8228 ND ND ND 
Tribromoacetamide 13435 7442 12383 ND ND ND 19549 3811 ND ND ND 
            Haloaromatics 
           Dichlorobenzene 2000 4944 5223 1633 2563 1325 3370 2038 2220 200 382
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Table 5.2. (Continued)            
Haloaromatics (continued)            
Dibromophenol, isomer #1 4680 3427 2550 ND ND ND 5934 3548 2500 500 500 
Dibromophenol, isomer #2 2368 277 4714 2707 ND 1224 4820 1346 ND ND ND 
Trichlorophenol, isomer #1 1958 2591 2720 1173 879 ND 6819 2000 500 200 4498 
Trichlorophenol, isomer #2 4263 3558 3055 3350 1039 782 8811 4300 ND ND ND 
Trichlorophenol, isomer #3 3767 ND ND ND ND ND ND ND ND ND ND 
Bromochlorophenol, isomer #1 40405 91241 40609 17142 10239 9279 51408 7003 19147 ND ND 
Bromochlorophenol, isomer #2 66243 67840 68444 42865 ND 42595 57520 8109 41944 500 300 
Bromochlorophenol, isomer #3 ND 6432 2843 2000 ND 2000 8948 1500 ND ND ND 
Bromodichlorophenol, isomer #1 100 ND ND ND 100 100 1146 100 500 200 6393 
Bromodichlorophenol, isomer #2 100 100 100 1575 492 680 8306 100 300 100 ND 
Bromodichlorophenol, isomer #3 100 ND 100 1025 ND 100 2076 ND ND ND 2448 
Dibromochlorophenol, isomer #1 1980 775 2477 ND ND ND 1958 2694 2541 200 ND 
Dibromochlorophenol, isomer #2 1573 1581 2155 4921 ND 200 8786 5445 10651 200 910 
Dibromochlorophenol, isomer #3 1361 ND 1324 2776 ND 200 1516 5450 3343 200 1105 
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Table 5.2. (Continued)            
Haloaromatics (continued)            
Tribromophenol, isomer #1 933 500 1291 ND 100 ND 500 500 ND ND ND 
Tribromophenol, isomer #2 7179 4287 5852 500 200 100 4787 3201 3873 500 2580 
Tribromophenol, isomer #3 100 100 100 ND ND ND ND ND ND ND ND 
Dibromoimidazole 642 ND 921 ND ND ND ND ND ND ND ND 
 
a Numbers represent measured GC/MS peak areas; ND = not detected; compound names in italics were confirmed through the analysis of 
authentic standards; all other identifications should be considered tentative. b Note:  Chloroform was detected in corresponding quantitative 
analyses of volatile analytes, but was not detected in broadscreen analyses, which are designed for semivolatile analytes. 
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Table 5.3. Levels of DBPs by chemical classes and correlation with CHO cell cytotoxic potency index and genotoxic potency index. 
HIWATE 
Sample 
Number 
21 DBPsc 
(µg/L) 
4 THMs 
(µg/L) 
9 HAAs 
(µg/L) 
4 HANs 
(µg/L) 
2 HKs 
(µg/L) 
CH 
(µg/L) 
CP 
(µg/L) 
U.S.-
Regulated 
DBPs 
(µg/L) 
Unregulated 
DBPs 
(µg/L) 
1 115 70.9 36.0 6.47 0.21 1.27 <LOD d 94.7 20.1 
2 91.1 66.8 19.5 4.70 <LOD <LOD <LOD 77.1 13.9 
3 202 139 51.5 8.88 1.11 1.80 <LOD 168 33.8 
4 3.24 3.24 <LOD <LOD <LOD <LOD <LOD 3.24 <LOD 
5 <LOD <LOD <LOD <LOD <LOD <LOD <LOD <LOD <LOD 
6 1.11 1.11 <LOD <LOD <LOD <LOD <LOD 1.11 <LOD 
7 118 83.9 26.7 4.80 <LOD 2.46 <LOD 103 14.6 
8 27.8 14.7 13.3 <LOD <LOD <LOD <LOD 26.5 1.25 
9 92.9 55.0 <LOD 4.02 6.86 23.2 3.78 55.0 37.9 
10 40.6 22.6 13.3 <LOD 3.28 1.43 <LOD 29.0 11.6 
11 45.2 29.3 11.6 <LOD 3.08 1.23 <LOD 36.8 8.37 
Cytotoxic 
Potency 
Index
a
 
r = 0.77  
P ≤ 0.006 
r = 0.77  
P ≤ 0.006 
r = 0.75  
P ≤ 0.009 
r = 0.73  
P = 0.011 
r = 0.04 
P = 0.913 
r = 0.04  
P = 0.905 
r = -0.02  
P = 0.947 
r = 0.76  
P ≤ 0.006 
r = 0.60 
P = 0.051 
Genotoxic 
Potency 
Index
b
 
r = 0.36  
P = 0.273  
r = 0.37  
P = 0.260 
r = 0.40  
P = 0.221 
r = 0.36  
P = 0.281 
r = -0.08  
P = 0.827 
r = -0.12  
P = 0.720 
r = -0.18  
P = 0.600 
r = 0.38  
P = 0.248 
r = 0.22 
P = 0.521 
 
a The CHO cell cytotoxic potency index value corresponds to (LC50
-1  103) for each HIWATE sample. b The CHO cell genotoxic potency index 
value is the reciprocal HIWATE sample concentration factor that was calculated to induce a 50% SCGE tail DNA value 104. c These 21 
quantitatively measured DBPs are listed in the text. d LOD = limit of detection. 
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Table 5.4. CHO cell chronic cytotoxicity analyses of the HIWATE samples. 
Sample 
Number 
Concentration  
Factor Range 
Lowest 
Cytotoxic 
Concentration 
Factor a 
LC50 Value 
b 
(Conc. Factor ± SE) 
 
r2 c 
 
ANOVA Test Statistic d 
HIWATE 1 0 – 150 60 102.7 ± 4.2 0.95 F10, 37 = 58.4;  P ≤ 0.001 
HIWATE 2 0 – 150 
 
 
70 107.8 ± 3.8 0.97 F 10, 37 = 59.2;  P ≤ 0.001 
HIWATE 3 0 – 300 
 
50 79.1 ± 4.1 0.96 F 19, 76 = 130;  P ≤ 0.001 
HIWATE 4 0 – 300 
 
22.5 107.5 ± 3.7 0.97 F 19, 76 = 134;  P ≤ 0.001 
HIWATE 5 0 – 1000 
 
300 605.8 ± 4.3 0.98 F 9, 33 = 69.2;  P ≤ 0.001 
HIWATE 6 0 – 800 
 
300 366.9 ± 4.1 0.99 F 10, 37 = 113;  P ≤ 0.001 
HIWATE 7 0 – 350 
 
50 122.1 ± 3.4 0.99 F 11, 44 = 212;  P ≤ 0.001 
HIWATE 8 0 – 300 
 
70 162.5 ± 4.8 0.98 F 10, 37 = 71.7;  P ≤ 0.001 
HIWATE 9 0 – 300 
 
 
 
 
80 140.0 ± 4.9 0.98 F 10, 37 = 90.8;  P ≤ 0.001 
HIWATE 10 0 – 300 
 
 
80 128.9 ± 4.6 0.97 F 11, 40 = 77.9;  P ≤ 0.001 
HIWATE 11 0 – 600 
 
 
100 164.4 ± 5.2 0.98 F 10, 37 = 78.0;  P ≤ 0.001 
 
a Lowest cytotoxic concentration was the lowest concentration factor of the HIWATE sample in the 
concentration-response curve that induced a statistically significant reduction in cell density as 
compared to the concurrent negative controls. b The LC50 value is the fold concentration factor of the 
HIWATE sample, determined from a regression analysis of the data, that induced a cell density of 50% as 
compared to the concurrent negative controls. The LC50 error term was calculated as Σ ̅SE. 
c r2 is the 
coefficient of determination for the regression analysis upon which the LC50 value was calculated. 
d The 
degrees of freedom for the between-groups and residual associated with the calculated F-test result and 
the resulting probability value. 
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Table 5.5. Cytotoxicity and genotoxicity index values. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
HIWATE Sample Number Cytotoxicity Index Values 
(LC50)
-1(103)  
Genotoxicity Index Values 
(50% Tail DNA)-1(104) 
HIWATE 1 9.7 8.73 
HIWATE 2 9.3 8.71 
HIWATE 3 12.6 6.99 
HIWATE 4 9.3 9.27 
HIWATE 5 1.6 1.77 
HIWATE 6 2.7 5.19 
HIWATE 7 8.2 8.94 
HIWATE 8 6.1 4.53 
HIWATE 9 7.1 5.41 
HIWATE 10 7.8 9.50 
HIWATE 11 6.1 5.26 
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Table 5.6. CHO cell SCGE genotoxicity analyses of the HIWATE samples. 
 
 
a The lowest genotoxic concentration was the lowest concentration of the HIWATE sample in the 
concentration-response curve that induced a statistically significant amount of genomic DNA damage as 
compared to the negative control. b The SCGE 50% Tail DNA value is the HIWATE sample concentration 
factor determined from a regression analyses of the data that was calculated to induce a 50% SCGE Tail 
DNA value. The 50% SCGE Tail DNA value error term was calculated as as Σ ̅SE. 
c r2 is the coefficient of 
determination for the regression analysis upon which the SCGE % Tail DNA value was calculated. d The 
degrees of freedom for the between-groups and residual associated with the calculated F-test result and 
the resulting probability value. 
  
Sample 
Number 
Concentration  
Factor Range 
Lowest Genotoxic 
Concentration 
Factor a 
50% tail DNA 
Value b 
(Conc. Factor 
±SE) 
r2 c 
ANOVA  
Test Statistic d 
HIWATE 1 0 – 1700 
 
1000 1146 ± 9.1 0.99 F9, 33 = 10.5; P ≤ 0.001 
HIWATE 2 0 – 2000 
 
 
1000 1148 ± 3.8 0.99 F 10, 37 = 43.6; P ≤ 0.001 
HIWATE 3 0 – 2000 900 1430 ± 2.0 0.99 F 8, 37 = 133; P ≤ 0.001 
HIWATE 4 0 – 1600 1000 1079 ± 3.3 0.99 F 10, 37 = 78.0; P ≤ 0.001 
HIWATE 5 0 – 3800 
 
3600 5659 ± 1.4 0.74 F 10, 38 = 3.14; P ≤ 0.005 
HIWATE 6 0 – 2200 
 
 
1600 1925 ± 2.0 0.90 F 11, 39 = 20.0; P ≤ 0.001 
HIWATE 7 0 – 2200 
 
600 1119 ± 2.9 0.95 F 9, 26 = 76.3; P ≤ 0.001 
HIWATE 8 0 – 3000 
 
2000 2206 ± 5.6 0.98 F 13, 50 = 9.29; P ≤ 0.001 
HIWATE 9 0 – 2400 
 
 
1600 1847 ±  6.9 0.89 F 10, 42 = 6.87; P ≤ 0.001 
HIWATE 10 0 – 1600 
 
400 1052 ± 6.2 0.98 F 8, 50 = 7.18; P ≤ 0.001 
HIWATE 11 0 – 2400 
 
 
1600 1901 ± 3.7 0.99 F 10, 33 = 15.9; P ≤ 0.001 
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Table 5.7. Description of each HIWATE sample, DBPs identified and gross correlation with the rank order 
of CHO cell cytotoxicity and genotoxicity. 
 
Correlation with the rank order of CHO cell cytotoxicity: r = 0.78 (P ≤ 0.005). Correlation with the rank 
order of CHO cell genotoxicity: r = 0.52 (P = 0.105). Rank order where 1 is the highest response and 11 is 
the lowest response. a The CHO cell cytotoxic potency index value is in arbitrary units and the value 
corresponds to (LC50
-1  103) for each HIWATE sample. b The CHO cell genotoxic potency index value is 
the reciprocal HIWATE sample concentration factor that was calculated to induce a 50% SCGE tail DNA 
value  104 and is presented in arbitrary units. 
  
Sample 
Number 
Number of 
Identified DBPs 
Rank order of 
Number of 
Identified DBPs 
Rank order of 
Cytotoxic 
Potency Index a 
Rank order of 
Genotoxic 
Potency Index b 
HIWATE 1 86 1 2 4 
HIWATE 2 76 5 3 5 
HIWATE 3 85 2 1 6 
HIWATE 4 41 7 3 2 
HIWATE 5 13 11 11 11 
HIWATE 6 18 10 10 9 
HIWATE 7 83 3 5 3 
HIWATE 8 77 4 8 10 
HIWATE 9 45 6 7 7 
HIWATE 10 41 7 6 1 
HIWATE 11 40 9 8 8 
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Table 5.8. Pearson Product Moment correlation analyses of the relative concentrations of each DBP 
group versus CHO cell chronic cytotoxicity or acute genotoxicity. 
 
a Relative concentration is defined as the integrated area for each chromatographic peak summed for 
each DBP chemical class. b The CHO cell cytotoxic potency index value corresponds to (LC50
-1  103) for 
each HIWATE sample. c The CHO cell genotoxic potency index value is the reciprocal HIWATE sample 
concentration factor that was calculated to induce a 50% SCGE tail DNA value 104. 
  
Relative Concentration 
of DBP Class a 
Cytotoxic Potency 
Index Value b 
(LC50
-1 103) 
Genotoxic Potency 
Index Value c 
(50% tail DNA-1 104) 
THMs 
r = 0.74 
P ≤  0.010 
r = 0.45 
P = 0.164 
Haloacids 
r = 0.75 
P ≤ 0.008 
r = 0.54 
P = 0.088 
Other monoacids 
r = 0.68 
P ≤ 0.021 
r = 0.42 
P = 0.201 
Halodiacids 
r = 0.80 
P ≤ 0.003 
r = 0.40 
P = 0.221 
Haloamides 
r = 0.68 
P ≤ 0.021 
r = 0.45 
P = 0.170 
Haloaromatics 
r = 0.64 
P ≤ 0.035 
r = 0.52 
P = 0.103 
Brominated DBPs 
r = 0.68 
P ≤ 0.022 
r = 0.46 
P = 0.154 
Chlorinated DBPs 
r = 0.78 
P ≤ 0.005 
r = 0.56 
P = 0.073 
Iodinated DBPs 
r = 0.82 
P ≤ 0.002 
r = 0.53 
P = 0.093 
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Table 5.9. General comparisons among published HIWATE epidemiological results and data presented in 
this study. 
 
 a TTHM, total THMs; bLBW, low birth weight; c SGA, small for gestational age [50, 51]. 
 
Reference DBP Metric Epidemiol. 
Metric 
HIWATE 
Sample No. 
(this study) 
Number of 
DBPs  
(this tudy) 
CHO Cell 
Cytotox. 
Index 
Value  
(this study) 
CHO Cell 
Genotox. 
Index 
Value  
(this study) 
[50] 
Low TTHM a 
(mean = 1.3 
µg/L) 
3.4% LBW b  
7.8% SGA c 
HIWATE 6 
Viciunai 
Lithuania 
18 2.7 5.19 
[50] 
High TTHM a 
(mean = 21.9 
µg/L) 
5.4% LBWb  
8.7% SGAc  
HIWATE 4 
Petruniusai 
Lithuania 
41 9.3 9.27 
[51] 
Sabadell water 11.5 %SGA c HIWATE 3 
Sabadell Spain 
85 12.6 6.99 
[51] 
Valencia water 12.2 %SGA c HIWATE 7 
Valencia Spain 
83 8.2 8.94 
[51] 
Asturias water 9.0 %SGA c HIWATE 9 
Asturias Spain 
45 7.1 5.41 
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Figure 5.1. HIWATE water sampling locations. 
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Figure 5.2. Examples of two GC/MS chromatograms. 
  
Modena, Italy (HIWATE 5) 
Barcelona, Spain (HIWATE 1) 
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Figure 5.3. Example of a GCxGC-TOF-MS chromatogram (HIWATE 1). 
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Figure 5.4. Log-linear plot of the concentration-response curves of 11 HIWATE samples illustrating CHO 
cell chronic (72-h) cytotoxicity. 
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Figure 5.5. HIWATE 1 CHO cell chronic cytotoxicity. 
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Figure 5.6. HIWATE 2 CHO cell chronic cytotoxicity. 
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Figure 5.7. HIWATE 3 CHO cell chronic cytotoxicity. 
  
177 
 
HIWATE Sample 4 Concentration Factor
0 50 100 150 200
C
H
O
 C
e
ll 
C
h
ro
n
ic
 C
y
to
to
x
ic
it
y
: 
M
e
a
n
 C
e
ll 
D
e
n
s
it
y
a
s
 t
h
e
 P
e
rc
e
n
t 
o
f 
th
e
 N
e
g
a
ti
v
e
 C
o
n
tr
o
l 
(±
S
E
)
0
20
40
60
80
100
HIWATE Sample 4
Kaunas (Petruniusai), Lithuania
 
Figure 5.8. HIWATE 4 CHO cell chronic cytotoxicity. 
  
178 
 
HIWATE Sample 5 Concentration Factor
0 200 400 600 800 1000
C
H
O
 C
e
ll 
C
h
ro
n
ic
 C
y
to
to
x
ic
it
y
: 
M
e
a
n
 C
e
ll 
D
e
n
s
it
y
a
s
 t
h
e
 P
e
rc
e
n
t 
o
f 
th
e
 N
e
g
a
ti
v
e
 C
o
n
tr
o
l 
(±
S
E
)
0
20
40
60
80
100
HIWATE Sample 5
Modena, Italy
 
Figure 5.9. HIWATE 5 CHO cell chronic cytotoxicity. 
  
179 
 
HIWATE Sample 6 Concentration Factor
0 100 200 300 400 500 600
C
H
O
 C
e
ll 
C
h
ro
n
ic
 C
y
to
to
x
ic
it
y
: 
M
e
a
n
 C
e
ll 
D
e
n
s
it
y
a
s
 t
h
e
 P
e
rc
e
n
t 
o
f 
th
e
 N
e
g
a
ti
ve
 C
o
n
tr
o
l 
(±
S
E
)
0
20
40
60
80
100
HIWATE Sample 6
 Kaunas (Viciunai), Lithuania
 
Figure 5.10. HIWATE 6 CHO cell chronic cytotoxicity. 
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Figure 5.11. HIWATE 7 CHO cell chronic cytotoxicity. 
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Figure 5.12. HIWATE 8 CHO cell chronic cytotoxicity. 
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Figure 5.13. HIWATE 9 CHO cell chronic cytotoxicity. 
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Figure 5.14. HIWATE 10 CHO cell chronic cytotoxicity. 
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Figure 5.15. HIWATE 11 CHO cell chronic cytotoxicity. 
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Figure 5.16. The distributions of the CHO cell cytotoxic index values for each HIWATE sample.  
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 Figure 5.17. Log-linear plot of the concentration-response curves of 11 HIWATE samples illustrating 
CHO cell acute (4h exposure) genotoxicity.  
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Figure 5.18. HIWATE 1 CHO cell genotoxicity. 
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Figure 5.19. HIWATE 2 CHO cell genotoxicity. 
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Figure 5.20. HIWATE 3 CHO cell genotoxicity. 
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Figure 5.21. HIWATE 4 CHO cell genotoxicity. 
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Figure 5.22. HIWATE 5 CHO cell genotoxicity. 
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Figure 5.23. HIWATE 6 CHO cell genotoxicity. 
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Figure 5.24. HIWATE 7 CHO cell genotoxicity. 
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Figure 5.25. HIWATE 8 CHO cell genotoxicity. 
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Figure 5.26. HIWATE 9 CHO cell genotoxicity. 
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Figure 5.27. HIWATE 10 CHO cell genotoxicity. 
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Figure 5.28. HIWATE 11 CHO cell genotoxicity. 
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Figure 5.29. The distributions of the CHO cell genotoxic index values for each HIWATE sample. 
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CHAPTER 6 
THE IMPACT OF X-RAY CONTRAST AGENTS ON FORMATION AND TOXICITY OF 
DISINFECTION BY-PRODUCTS IN DRINKING WATER 
 
PREFACE  
 This work is a part of an international collaborative study involving research on 
analytical chemistry and toxicology. Dr. T. Ternes (Bundesanstalt für Gewässerkunde, Koblenz 
Germany), Dr. S. Duirk (University of Akron) and Dr. S. Richardson (University of South Carolina) 
are conducting the analytical chemistry experiments on the DBP formation kinetics and DBP 
identification. 
  
6.1. INTRODUCTION  
 Drinking water disinfection by-products (DBPs) are formed through the reaction 
between disinfectants and natural organic matter (NOM). The levels and distribution of DBPs 
highly depend on the source water characteristics such as pH, temperature, and other 
contaminants present in the raw water. Emerging environmental contaminants which can react 
with disinfectants to form contaminant DBPs include consumer products, pharmaceuticals, 
pesticides, etc. [1, 2]. With all source water conditions being equal, the type of disinfectant 
generates different levels of total organic halide (TOX) as well as significant differences in the 
resulting distribution of DBP classes [3, 4]. For example, when source waters were collected and 
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treated with different disinfectants, chlorination produced a higher level of total organic 
chlorine (TOCl) and total organic bromine (TOBr) than chloramination and chlorine dioxide 
treatment in the presence of bromide. Pre-ozonation decreased the formation of TOX during 
post-chlorination [4].  
 Iodinated X-ray contrast media (ICM) are widely used at medical centers to enhance the 
visibility of fluids or structures within the body such as the blood vessels or gastrointestinal 
tract for medical imaging. Types of ICM vary by their osmolarity, viscosity, and absolute iodine 
content. ICM have a triiodobenzoic acid unit as their basic structure and their molecular 
weights vary (600 – 850 Da) by the type of side chains including carboxyl, hydroxyl, and amide 
functional groups (Figure 6.1). The worldwide consumption of ICM is around 3.5  106 kg/year, 
and a single application can be up to 200g/d. After application, 95% of unmetabolized ICM are 
eliminated through urine and feces within 24 hours [5]. While ICM are generally stable in water, 
several biological transformation products (TPs) of these ICM were identified (Figure 6.2) [6]. 
TPs are formed in wastewater treatment and enter source waters [6]. Incomplete removal of 
ICM in wastewater treatment plants could lead to an elevation of ICM concentrations in 
streams and rivers [1, 7-10]. ICM were also found in groundwater [11].  
 The ICM in source waters may act as potential DBP precursors and react with oxidizing 
disinfectants to form highly toxic DBPs such as iodinated DBPs (iodo-DBPs) and higher 
molecular weight DBPs of unknown toxicity. Iodo-DBPs, including iodinated trihalomethanes 
(iodo-THMs) and iodinated acids (iodo-acids) are commonly found in chlorinated and 
chloraminated drinking water in the U.S. and Canada [12]. Iodo-DBPs are highly cytotoxic and 
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genotoxic, and to date, iodoacetic acid is known to be the most genotoxic individual DBP 
among iodo-DBPs [13]. Naturally occurring iodide (I-) can be oxidized by disinfectants (chlorine, 
chloramine, or ozone) to hypoiodous acid (HOI), which can react with NOM or be further 
oxidized to an inactive iodate (IO3
-) [14]. In a comparison study, chloramine did not further 
oxidize hypoiodous acid to iodate, while chlorine and ozone transformed iodide to iodate 
within seconds to minutes (Figure 6.3) [14]. Therefore, the probability of the iodo-DBPs 
formation during drinking water disinfection increases in the order of chloramine > chlorine > 
ozone.  
 ICM are primary contributors to the TOX burden in clinical wastewater and play a major 
role as a source of absorbable organic iodine in wastewater [15]. Duirk et al. analyzed the 
source waters for ten of the original 23 cities involved in the iodo-DBP occurrence study [12] 
and found four ICM including Iopamidol, Iopromide, Iohexol, and Diatrizoate [6]. In this study, 
Iopamidol was detected most frequently (six of the ten plants) with a maximum concentration 
of 2.7 µg/L. The chemical mechanism involved in the formation of iodo-DBPs by ICM is known 
to be different from the mechanism involving the naturally occurring iodide. Reactions with 
Iopamidol appear to involve an initial attack of disinfectants to Iopamidol and release iodine 
which reacts with NOM to form iodo-DBPs [6]. Duirk et al. suggested that ICM can act as an 
organic iodine source to form iodo-DBPs in chlorinated or chloraminated NOM-containing 
source waters (Figure 6.4) [6]. Besides the formation of iodo-DBPs, the activated benzene ring 
and other functional groups attached can react with oxidizing disinfectants and form high 
molecular DBPs of unknown toxicity.  
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 The overall hypothesis of this study is that oxidizing disinfectants react with non-toxic 
ICM to form highly toxic iodo-DBPs and higher molecular weight DBPs of unknown toxicity. This 
is an international collaborative study (U.S. and Germany) involving analytical chemistry and 
toxicology and both real source waters and isolated NOM from the U.S. and Germany was used 
in these experiments. We conducted the controlled laboratory reactions of five ICMs 
(Iopamidol, Diatrizoate, Iopromide, Iomeprol, and Iohexol) with chlorine and chloramine under 
different conditions including changes in pH, oxidant dose, NOM level, and bromide 
concentrations to simulate drinking water treatment. Specifically, the German researchers will 
identify the initial, high molecular weight DBPs formed during the reaction of ICM and their TPs 
with oxidants. The German group will also determine the kinetic parameters of these reactions. 
The U.S. researchers will focus on low molecular weight DBPs including iodo-THMs and iodo-
acids formed during the reaction of oxidants with ICM and their TPs. The in vitro mammalian 
cell cytotoxicity and genotoxicity of the reaction product mixtures and of individual identified 
iodo-DBPs will be measured to determine which ICM and reaction conditions give rise to toxic 
by-products. This study will elucidate the overall mechanisms of the formation of iodo-DBPs 
and any other DBPs identified in this research from reactions with ICM and their TPs, and a 
kinetic model will be developed to predict the formation of iodo-DBPs.  
  This chapter focuses on the results from the analytical biological studies on the 
cytotoxicity and genotoxicity of the reaction product mixtures from two experimental designs. 
The specific objectives of this chapter were to: i) disinfect the source waters from Akron (OH) 
with chlorine or chloramine with or without Iopamidol, extract and concentrate the organic 
fraction and determine the relative in vitro chronic cytotoxicity and acute genotoxicity in 
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mammalian cells for each sample, ii) disinfect the source waters from Akron (OH) with chlorine 
with or without four ICM (Iopromide, Iohexol, Diatrizoate, Iomeprol), extract and concentrate 
the organic fraction and determine the relative in vitro chronic cytotoxicity and acute 
genotoxicity in mammalian cells for each sample, and iii) analyze for the impact of disinfectant 
types and individual ICM on overall toxicity.  
 
6.2. MATERIALS AND METHODS 
6.2.1. Chemicals and Reagents 
 General reagents were purchased from Sigma-Aldrich Co. (St. Louis, MO) and Fisher 
Scientific Co. (Itasca, IL). Media and fetal bovine serum (FBS) were purchased from Fisher 
Scientific Co. (Itasca, IL).  
6.2.2. Sample Preparation 
 Two sets of experiments were conducted for this study. Experimental group 1 consisted 
of the Akron source water (AOH, 20L) with and without Iopamidol and with and without 
chlorine or monochloramine disinfection.  The conditions of each sample are listed in Table 6.1. 
Experimental group 2 consisted of the AOH (20L) with and without 4 different ICM (Iopromide, 
Iohexol, Iomeprol and Diatrizoate) with and without chlorine disinfection (Table 6.2). Water 
samples were extracted and concentrated to 2 mL ethyl acetate for the biological experiments.  
 XAD 2 and XAD 8 resins were soxhlet-cleaned according to the procedure provided by Dr. 
Richardson group in U.S. EPA (Athens, GA) [16]. Soxhlet-cleaned resins were kept in baked 
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glassware in HPLC-grade methanol at 4°C. The water samples were prepared and extracted 
over XAD resins by Dr. Duirk’s laboratory in University of Akron (Akron, OH). The final extracts 
were prepared in ethyl acetate and were shipped to our laboratory (Urbana, IL). The ethyl 
acetate was removed over a stream of dry N2 gas and solvent exchanged into dimethylsulfoxide 
(DMSO). These samples were stored in Supelco glass vials with Teflon cap liners at −20° C.  
6.2.3. Chinese Hamster Ovary Cells 
 Chinese hamster ovary (CHO) cell line AS52, clone 11-4-8 was used for the biological 
assays [17-19]. CHO cells were maintained on glass culture plates in Ham’s F12 medium 
containing 5% fetal bovine serum (FBS), 1% antibiotics (100 U/mL sodium penicillin G, 100 
µg/mL streptomycin sulfate, 0.25 µg/mL amphotericin B in 0.85% saline), and 1% glutamine at 
37°C in a humidified atmosphere of 5% CO2.  
6.2.4. CHO Cell Chronic Cytotoxicity Assay 
 This assay measures the reduction in cell density as a function of the water sample 
concentrates (WSCs) over a period of approximately 3 cell divisions (72 h). Chronic cytotoxicity 
to CHO cells was measured using an assay we previously developed for the analysis of DBPs [20]. 
For each experiment, a series of dilutions were prepared by diluting the WSCs with F12 culture 
medium on the day of the experiment and rapidly transferred into the well with CHO cells for 
treatment. These dilution series represent a range of concentration factors for the organics in 
the original water. Flat-bottom, tissue culture 96-well microplates were employed; 4 replicate 
wells were prepared for each concentration of a specific extract for each water sample. Eight 
wells were reserved for the blank control consisting of 200 µL of F12 medium + 5% fetal bovine 
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serum (FBS). The negative control consisted of 8 wells containing 100 µL of a titered CHO cell 
suspension (3×104 cells/mL) plus 100 µL F12 + FBS. The wells for the remaining columns 
contained 3,000 CHO cells, F12 + FBS and a known concentration of a water sample organic 
extract for a total of 200 μL. To prevent cross-over contamination between wells due to 
volatilization of the organic extract, a sheet of sterile AlumnaSeal™ (RPI Corporation, Mt. 
Prospect, IL) was pressed over the wells before the microplate was covered. The microplate 
was placed on a rocking platform for 10 min to uniformly distribute the cells, and then placed in 
a tissue culture incubator for 72 h. After incubation, each well was gently aspirated, fixed in 100% 
methanol for 10 min, and stained for 10 min with a 1% crystal violet solution in 50% methanol. 
The plate was gently washed in tap water, inverted and tapped dry upon paper towels, and 50 
μL of dimethyl sulfoxide/methanol (3:1 v/v) was added to each well for 10 min. The plate was 
analyzed in a BioRad microplate reader at 595 nm. The data were automatically recorded and 
transferred to an Excel spreadsheet on a microcomputer connected to the microplate reader. 
The blank-corrected absorbance value of the negative control (cells with medium only) was set 
at 100%. The absorbance for each treatment group well was converted into a percentage of the 
negative control. For each organic extract concentration, 4-8 replicate wells were analyzed per 
experiment, and the experiments were repeated 2-3 times. A concentration-response curve 
was generated for each WSC and a regression analysis was conducted to each curve. The LC50 
values were calculated from each regression analysis, where the LC50 represents the WSC 
concentration factor that induced a 50% reduction in cell density as compared to the 
concurrent negative control.  
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6.2.5. Single Cell Gel Electrophoresis Assay  
 Single cell gel electrophoresis (SCGE) is a molecular genetic assay that quantitatively 
measures the level of genomic DNA damage induced in individual nuclei of treated cells [21-23]. 
We employed the microplate SCGE method [24]. The day before treatment, 4×104 CHO cells 
were added to each microplate well in 200 µL of F12 + 5% FBS and incubated. The next day, the 
cells were washed with Hank’s balanced salt solution (HBSS) and treated with a series of 
concentrations of an organic extract from the WSCs in F12 medium without FBS in a total 
volume of 25 μL for 4 h at 37°C, 5% CO2. The wells were covered with sterile AlumnaSeal™. 
After incubation, the cells were washed 2× with HBSS and harvested with 50 μL of 0.01% trypsin 
+ 53 μM EDTA. The trypsin was inactivated with 70 µL of F12 + FBS. Acute cytotoxicity was 
measured from a 10 μL aliquot of cell suspension mixed with 10 µL of 0.05% trypan blue vital 
dye in phosphate-buffered saline (PBS) [25]. SCGE data were not used if the acute cytotoxicity 
exceeded 30%. The remaining cell suspension from each well was embedded in a layer of low 
melting point agarose prepared with PBS upon clear microscope slides that were previously 
coated with a layer of 1% normal melting point agarose prepared with deionized water and 
dried overnight. The cellular membranes were removed by an overnight immersion in lysing 
solution (2.5 M NaCl, 100 mM Na2EDTA, 10 mM Tris, 1% sodium sarcosinate, 1% Triton X-100, 
and 10% DMSO)  at 4°C. The microgels were placed in an alkaline buffer (1 mM Na2EDTA, 300 
mM  NaOH,  pH 13.5) in an electrophoresis tank, and the DNA was denatured for 20 min. The 
microgels were electrophoresed at 25 V, 300 mA (0.72 V/cm) for 40 min at 4°C. The microgels 
were neutralized with Tris buffer (pH 7.5), rinsed in cold water, dehydrated in cold methanol, 
dried at 50°C, and stored at room temperature in a covered slide box. For analysis of the WSC 
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samples, the microgels were hydrated in cold water for 30 min and stained with 65 μL of 
ethidium bromide (20 μg/mL) for 3 min. The microgels were rinsed in cold water and analyzed 
with a Zeiss fluorescence microscope with an excitation filter of BP 546/10 nm and a barrier 
filter of 590 nm. For each experiment, 2 microgels were prepared per treatment group. 
Randomly chosen nuclei (25 per microgel) were analyzed using a charged coupled device 
camera. A computerized image analysis system (Comet IV, Perspective Instruments, Ltd, Suffolk, 
UK) was employed to determine the SCGE %Tail DNA value of the nuclei as indices of DNA 
damage. The digitalized data were automatically transferred to a computer based spreadsheet 
for subsequent statistical analysis. Within each experiment, a negative control, a positive 
control (3.8 mM ethylmethanesulfonate), and concentration series of an organic extract from 
WSCs were analyzed concurrently. The experiments were repeated 2-3 times for each WSC. 
Within each concentration factor range with >70% cell viability, a concentration-response curve 
was generated for each WSC from repeated experiments, and non-linear regression analysis 
was conducted. The concentration factor that induces 50% of the genomic DNA to migrate from 
the nucleus (50%Tail DNA value) was calculated from each regression analysis.  
6.2.6. Statistical Analysis 
 For the cytotoxicity assay, a one-way analysis of variance (ANOVA) test was conducted 
to determine if the WSC induced a statistically significant level of cell death at a specific 
concentration. If a significant F value (P ≤ 0.05) was obtained, a Holm-Sidak multiple 
comparison versus the control group analysis was performed to identify the lowest cytotoxic 
concentration. The power of the test statistic (1−β) was maintained as ≥ 0.8 at α = 0.05. For the 
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SCGE assay, the %Tail DNA values are not normally distributed which limits the use of 
parametric statistics [26]. The mean %Tail DNA value for each microgel was calculated and 
these values were averaged among all of the microgels for each WSC concentration. A one-way 
ANOVA test was conducted on these averaged %Tail DNA values [27]. If a significant F value of P 
≤ 0.05 was obtained, a Holm-Sidak multiple comparison versus the control group analysis was 
conducted with the power ≥ 0.8 at α = 0.05. A bootstrap statistical approach was used to 
generate a series of multiple LC50 values and %Tail DNA per WSC [28, 29]. 
 
6.3. RESULTS AND DISCUSSION 
6.3.1. Experimental Group 1: CHO Cell Chronic Cytotoxicity Analyses  
 The CHO cell cytotoxicity concentration-response curves for the experimental group 1 
samples are presented in Figures 6.5-6.10. Table 6.3 presents the LC50 concentration factor for 
each WSC and the lowest concentration factor that induced a significant increase from the 
negative control. A statistical analysis within each WSC for each cytotoxicity concentration-
response curve and an ANOVA test against the negative control is also presented in Table 6.3. 
Using a bootstrap statistical approach a series of multiple LC50 values were generated per WSC; 
for each LC50 value a cytotoxicity index (CTI) value was calculated as (LC50)
-1(103). These 
dimensionless values were then analyzed using an ANOVA test to determine significant 
differences among the WSC groups. The mean bootstrap CTI (±SE) are presented in Figure 6.11. 
From an ANOVA test of the bootstrap mean CTI values, significant differences were resolved 
among the WSC these differences are presented in Table 6.4. 
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 A small, but significant increase in cytotoxicity was induced by Iopamidol alone as 
compared to the source water, while no significant difference was observed between Iopamidol 
and the source water after NH2Cl disinfection (Table 6.4). The chlorinated source water was 
significantly more cytotoxic than the source water alone or the source water disinfected with 
monochloramine. Chlorinated source water plus Iopamidol showed the highest CTI value (CTI = 
21.0) followed by the chlorinated source water without Iopamidol (CTI = 18.9). A clear 
significant increase in cytotoxicity was induced by Iopamidol in chloraminated water (CTI 
without Iopamidol = 7.73, CTI with Iopamidol = 16.6). Of importance is that the relative 
Iopamidol-mediated increase in CHO cell cytotoxicity was much greater when NH2Cl was used 
as the disinfectant versus chlorine. The relative Iopamidol-mediated percent increase in 
cytotoxicity over the chlorinated Akron source water was 7.5%. While the relative Iopamidol-
mediated cytotoxicity associated with chloramines disinfection was 114%. An explanation of 
these results may be that, compared to chlorine, chloramines disinfection enhances the 
generation of HOI and the formation of highly toxic iodinated DBPs [14, 30]. These data 
demonstrate that Iopamidol enhances the cytotoxicity of disinfected source water. The 
Iopamidol-mediated increase in CHO cell toxicity was also observed in a previous study using 
source waters from Athens Clark County, GA, which indicates that the increased cytotoxicity is 
independent of source water (Athens Clark County, GA versus Akron, OH).  
6.3.2. Experimental Group 1: CHO Cell Acute Genotoxicity Analyses  
 The CHO cell SCGE genotoxicity concentration-response curves for the experimental 
group 1 samples are presented in Figures 6.12-6.17. Table 6.5 presents a statistical analysis 
210 
 
within each WSC for each genotoxicity concentration-response curve and a test against the 
negative control. Table 6.5 presents the 50%Tail DNA concentration factor for each WSC and 
the lowest concentration factor that induced a significant increase over the negative control. 
Using a bootstrap statistical approach a series of multiple 50%Tail DNA values were generated 
per WSC; for each 50%Tail DNA value a genotoxicity index (GTI) value was calculated as 
(50%Tail DNA)-1(104). These dimensionless values were then analyzed using an ANOVA test to 
determine significant differences among the WSC groups. The mean bootstrap GTI (±SE) are 
presented in Figure 6.18. From an ANOVA test of the bootstrap mean genotoxicity index values, 
significant differences were resolved among the WSC; these differences are presented in Table 
6.6.  
 The presence of Iopamidol enhanced the genotoxicity of the source water. No 
significant difference was observed between the source water and the source water after 
chloramination (Table 6.6). The chlorinated source water was significantly more genotoxic than 
the source water alone or the chloraminated source water (Figure 6.18). A small, but significant 
increase in genotoxicity was induced by Iopamidol alone as compared to the source water. 
Chlorinated water with Iopamidol was significantly more genotoxic than the chlorinated source 
water alone. A significant increase in genotoxicity was induced by Iopamidol in chloraminated 
water but the GTI value for chloraminated water with Iopamidol (GTI = 37.1) was smaller than 
the GTI value for chlorinated water only (GTI = 44.8). The relative Iopamidol-mediated percent 
increase in genotoxicity over the chlorinated Akron source water was 66%, while the relative 
Iopamidol-mediated percent increase in genotoxicity over the chloraminated water was 97%. 
As with the CHO cytotoxicity data, an explanation of these results may be that chloramines 
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disinfection enhances the generation of HOI and the formation of highly toxic iodinated DBPs 
[14, 30]. These data demonstrate that besides affecting cytotoxicity, Iopamidol enhances the 
genotoxicity of disinfected source water.  These results were in agreement with our previously 
published work and indicate that the Iopamidol-mediated increased genotoxicity was 
independent of source water [6]. 
6.3.3. Experimental Group 2: CHO Cell Chronic Cytotoxicity Analyses  
 The CHO cell cytotoxicity concentration-response curves for the experimental group 2 
samples are presented in Figures 6.19-6.26. Table 6.7 presents a statistical analysis within each 
experimental group 2 water sample concentrate for each cytotoxicity concentration-response 
curve and an ANOVA test against the negative control. Table 6.7 also presents the LC50 
concentration factor for each WSC and also the lowest concentration factor that induced a 
significant increase from the negative control. CTI values for each sample were obtained 
through the approach described in section 6.3.1. The mean bootstrap CTI (±SE) are presented in 
Figure 6.27. The significant differences in CTI values among the WSCs are presented in Table 6.8.  
 Cytotoxicity significantly increased for all chlorinated groups compared to their non-
chlorinated groups. Based on the CTI values, Iopromide showed the lowest increase (41% 
higher compared to the non-chlorinated water with Iopromide) while Iohexol showed the 
highest increase (224% higher compared to the non-chlorinated water with Iohexol) among the 
four ICM pairs.  
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6.3.4. Experimental Group 2: CHO Cell Acute Genotoxicity Analyses  
 The CHO cell SCGE genotoxicity concentration-response curves for the experimental 
group 2 samples are presented in Figures 6.28-6.35. Table 6.9 presents a statistical analysis 
within each WSC for each genotoxicity concentration-response curve and a test against the 
negative control. The 50%Tail DNA concentration factor for each experimental group 2 WSC 
and the lowest concentration factor that induced a significant increase over the negative 
control are presented in Table 6.9. GTI values for each sample were obtained through the 
approach described in section 6.3.2. The mean bootstrap GTI (±SE) are presented in Figure 6.33. 
Significant differences of GTI values among WSCs are presented in Table 6.10.  
 The genotoxicity of Iopromide, Iohexol, Diatrizoate or Iomeprol in source water were 
not significantly different from the source water. Chlorination of ICM containing waters 
significantly increased the genotoxicity of waters compared to their ICM alone pairs. Only 
Iohexol enhanced the genotoxicity compared to the chlorinated source water. Interestingly, 
Iopromide expressed reduced genotoxicity as compared to the chlorinated source water (Figure 
6.36).  
 
6.4. CONCLUSION 
 Iopamidol generated an enhanced level of CHO cell cytotoxicity and genotoxicity in 
conjunction with either chlorine or chloramines disinfection. These data with the Akron source 
water are in general agreement with the experiments conducted with Athens, Clark County 
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source water [6]. These data suggest that Iodo-DBPs, which are more toxic than chlorinated or 
brominated DBPs, were generated from iodide released from Iopamidol under disinfection 
conditions leading to enhanced cytotoxicity and genotoxicity [31]. For the other ICMs 
(Experimental Group 2) Akron source water was compared with and without chlorine 
disinfection. These data demonstrated that Iopromide, Iohexol, Diatrizoate or Iomeprol alone 
expressed some cytotoxicity over the control.  Also these agents expressed higher cytotoxicity 
when treated with Cl2. Using the SCGE assay, only Iohexol expressed the most enhanced 
genotoxicity compared to the chlorinated source water, while Iopromide reduced the 
genotoxicity. Of the five X-ray contrast agents evaluated for their mammalian cell cytotoxicity 
and genotoxicity, Iopamidol in water disinfected with chlorine or chloramines was clearly the 
most responsive in generating adverse biological responses in the CHO cell assays. For further 
interpretation, high molecular weight DBPs and low molecular weight DBPs have to be 
identified and the toxicity of those individual DBPs needs to be determined.  
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TABLES AND FIGURES 
Table 6.1. Experimental group 1: Akron source water with and without Iopamidol (IDOL) and disinfected 
with either chlorine (Cl) or monochloramine (NH2Cl). 
Samplea Source water Iopamidol Disinfection 
AOHTOX-DI DI NAb NA 
AOHTOX-SW Akron NA NA 
AOHTOX-IDOL Akron 5 µM NA 
AOHTOX-CL Akron NA [Cl2]T = 100 µM 
AOHTOX-CL-IDOL Akron 5 µM [Cl2]T = 100 µM 
AOHTOX-NH2CL Akron NA [NH2Cl]T = 100 µM 
AOHTOX-NH2CL-IDOL Akron 5 µM [NH2Cl]T = 100 µM 
 
a Experiments were performed on 20 L of water sources. Each sample was extracted and concentrated 
into ethyl acetate with a final volume of 2 mL. b NA; not applied.  
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Table 6.2. Experimental group 2: Akron source water with 4 Iodinated X-ray contrast media (ICM) and 
with and without chlorine (Cl2) disinfection.  
Samplea ICM ICM concentration Disinfection 
AOHTOX-Iopromide Iopromide 5 µM NAb 
AOHTOX-CL-Iopromide Ioprimide 5 µM [Cl2]T = 100 µM 
AOHTOX-Iohexol Iohexol 5 µM NA 
AOHTOX-CL-Iohexol Iohexol 5 µM [Cl2]T = 100 µM 
AOHTOX-Diatrizoate Diatrizoate 5 µM NA 
AOHTOX-CL-Diatrizoate Diatrizoate 5 µM [Cl2]T = 100 µM 
AOHTOX-Iomeprol Iomeprol 5 µM NA 
AOHTOX-CL-Iomeprol Iomeprol 5 µM [Cl2]T = 100 µM 
 
a Experiments were performed on 20 L of water sources. Each sample was extracted and concentrated 
into ethyl acetate with a final volume of 2 mL. b NA; not applied.  
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Table 6.3. Experimental group 1: Comparative CHO cell chronic cytotoxicity of X-ray contrast agent 
Iopamidol in Akron source water with and without Iopamidol (IDOL) and disinfected with either chlorine 
(Cl) or monochloramine (NH2Cl). 
Sample LC50 (CF) 
a r2 b Lowest Cytotoxic      
Conc. Factor c 
ANOVA Test Statistic d 
AOHTOX-SW 161.3 0.94 75 F 10, 50 = 53.5; P ≤ 0.001 
AOHTOX-CL 53.0 0.94 25 F 10, 45 = 141.3; P ≤ 0.001 
AOHTOX-IDOL 123.7 0.96 75 F 9, 48 = 167.8; P ≤ 0.001 
AOHTOX-CL-IDOL 47.6 0.97 25 F 11, 122 = 140.6; P ≤ 0.001 
AOHTOX-NH2CL 129.3 0.94 100 F 10, 50 = 72.3; P ≤ 0.001 
AOHTOX-NH2CL-IDOL 60.3 0.99 25 F 10, 125 = 154.3; P ≤ 0.001 
 
a The LC50 value is the fold concentration factor of the WSC sample, determined from a regression 
analysis of the data, that induced a cell density of 50% as compared to the concurrent negative controls. 
b r2 is the coefficient of determination for the regression analysis upon which the LC50 value was 
calculated. c Lowest cytotoxic concentration was the lowest concentration factor of the WSC in the 
concentration-response curve that induced a statistically significant reduction in cell density as 
compared to the concurrent negative controls.  d The degrees of freedom for the between-groups and 
residual associated with the calculated F-test result and the resulting probability value. 
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Table 6.4. Experimental group 1: Test for significance among CTI values.  
 SW IDOL CL CL-IDOL NH2CL NH2CL-IDOL 
SW       
IDOL       
CL       
CL-IDOL       
NH2CL       
NH2CL-IDOL       
 
Abbreviations; SW=Akron source water, IDOL = iopamidol, CL=source water plus chlorine disinfection, 
CL-IDOL=source water plus Iopamidol plus chlorine disinfection, NH2CL=source water plus chloramine 
disinfection, NH2CL-IDOL=source water plus Iopamidol plus chloramine disinfection. In the pairwise 
comparison red indicates a significant difference between the paired groups, green indicates no 
significant difference between the paired groups.   
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Table 6.5. Experimental group 1: Comparative CHO cell acute genotoxicity of X-ray contrast agent 
Iopamidol in Akron source water with and without Iopamidol (IDOL) and disinfected with either chlorine 
(Cl) or monochloramine (NH2Cl). 
Sample 50%Tail 
DNA (CF) a 
r2 b Lowest  
Genotoxic 
Conc. Factor c 
ANOVA Test Statistic d 
AOHTOX-SW 680.0 0.99 650 F 14, 39 = 12.0; P ≤ 0.001 
AOHTOX-CL 223.3 0.96 175 F 9, 40 = 20.4; P ≤ 0.001 
AOHTOX-IDOL 527.4 0.58 250 F 10, 43 = 3.35; P ≤ 0.003 
AOHTOX-CL-IDOL 135.6 0.99 100 F 6, 21 = 32.8; P ≤ 0.001 
AOHTOX-NH2CL 545.4 0.99 350 F 14, 27 = 65.6; P ≤ 0.001 
AOHTOX-NH2CL-IDOL 279.4 0.98 250 F 12, 29 = 60.6; P ≤ 0.001 
 
a The SCGE 50% Tail DNA value is the WSC sample concentration factor determined from a regression 
analysis of the data that was calculated to induce a 50% SCGE Tail DNA value.  b r2 is the coefficient of 
determination for the regression analysis upon which the SCGE %Tail DNA value was calculated. c The 
lowest genotoxic concentration was the lowest concentration factor of the WSC sample in the 
concentration-response curve that induced a statistically significant amount of genomic DNA damage as 
compared to the negative control. d The degrees of freedom for the between-groups and residual 
associated with the calculated F-test result and the resulting probability value. 
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Table 6.6. Experimental group 1: Test for significance among GTI values.  
 SW IDOL CL CL-IDOL NH2CL NH2CL-IDOL 
SW       
IDOL       
CL       
CL-IDOL       
NH2CL       
NH2CL-IDOL       
 
Abbreviations; SW=Akron source water, IDOL = iopamidol, CL=source water plus chlorine disinfection, 
CL-IDOL=source water plus Iopamidol plus chlorine disinfection, NH2CL=source water plus chloramine 
disinfection, NH2CL-IDOL=source water plus Iopamidol plus chloramine disinfection. In the pairwise 
comparison red indicates a significant difference between the paired groups, green indicates no 
significant difference between the paired groups.  
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Table 6.7. Experimental group 2: Comparative CHO cell chronic cytotoxicity of X-ray contrast agents 
Iopromide, Iohexol, Diatrizoate and Iomeprol in Akron source water samples with and without Cl2 
disinfection.  
Sample LC50 
(CF) a 
r2 b Lowest  
Cytotoxic 
Conc. Factor c 
ANOVA Test Statistic d 
AOHTOX Iopromide 53.4 0.92 25.0 F 10, 117 = 39.7; P ≤ 0.001 
AOHTOX Iopromide + Cl2 38.0 0.93 15.0 F 11, 172 = 22.9; P ≤ 0.001 
AOHTOX Iohexol 46.6 0.96 20.0 F 16, 167 = 16.4; P ≤ 0.001 
AOHTOX Iohexol + Cl2 14.4 0.93 7.5 F 11, 124 = 26.1; P ≤ 0.001 
AOHTOX Diatrizoate 74.0 0.87 20.0 F 15, 168 = 24.9; P ≤ 0.001 
AOHTOX Diatrizoate + Cl2 26.9 0.96 15.0 F 11, 124 = 37.7; P ≤ 0.001 
AOHTOX Iomeprol 44.0 0.96 10.0 F 10, 85 = 26.7; P ≤ 0.001 
AOHTOX Iomeprol + Cl2 22.9 0.99 7.5 F 15, 164 = 31.9; P ≤ 0.001 
 
a The LC50 value is the fold concentration factor of the WCS sample, determined from a regression 
analysis of the data, that induced a cell density of 50% as compared to the concurrent negative controls. 
b r2 is the coefficient of determination for the regression analysis upon which the LC50 value was 
calculated.  c Lowest cytotoxic concentration was the lowest concentration factor of the WSC in the 
concentration-response curve that induced a statistically significant reduction in cell density as 
compared to the concurrent negative controls.  d The degrees of freedom for the between-groups and 
residual associated with the calculated F-test result and the resulting probability value. 
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Table 6.8. Experimental group 2: Test for significance among CTI values. 
 SW CL IPRO IPRO 
CL 
IHX IHX 
CL 
DTZ DTZ 
CL 
IOME IOME 
CL 
SW           
CL           
IPRO           
IPROCL           
IHX           
IHXCL           
DTZ           
DTZCL           
IOME           
IOMECL           
 
Abbreviations; SW=Akron source water, CL=Akron source water plus Cl2, IPRO=Iopromide, 
IPROCL=Iopromide plus Cl2, IHX=Iohexol, IHXCL=Iohexol plus Cl2, DTZ=Diatrizoate, DTZCL=Diatrizoate + 
Cl2, IOME=Iomeprol, IOMECL=Iomeprol + Cl2. In the pairwise comparison red indicates a significant 
difference between the paired groups, green indicates no significant difference between the paired 
groups.  
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Table 6.9. Experimental group 2: Comparative CHO cell acute genotoxicity of X-ray contrast agents 
Iopromide, Iohexol, Diatrizoate and Iomeprol in Akron source water samples with and without Cl2 
disinfection.  
Sample 50%Tail 
DNA (CF) a 
r2 b Lowest Genotoxic 
Conc. Factor c 
ANOVA Test Statistic d 
Iopromide 508.6 0.99 460.0 F 9, 34 = 19.7; P ≤ 0.001 
Iopromide + Cl2 267.0 0.96 250.0 F 11, 38 = 44.6; P ≤ 0.001 
Iohexol 562.3 0.95 480.0 F 14, 39 = 7.79; P ≤ 0.001 
Iohexol + Cl2 169.0 0.98 140.0 F 8, 40 = 28.9; P ≤ 0.001 
Diatrizoate 789.5 0.99 700.0 F 13, 58 = 30.9; P ≤ 0.001 
Diatrizoate + Cl2 206.7 0.99 140.0 F 12, 49 = 193.8; P ≤ 0.001 
Iomeprol 706.3 0.95 700.0 F 12, 31 = 7.39; P ≤ 0.001 
Iomeprol + Cl2 211.2 0.89 150.0 F 9, 32 = 18.8; P ≤ 0.001 
 
a The SCGE 50% Tail DNA value is the WSC sample concentration factor determined from a regression 
analysis of the data that was calculated to induce a 50% SCGE Tail DNA value.  b r2 is the coefficient of 
determination for the regression analysis upon which the SCGE %Tail DNA value was calculated. c The 
lowest genotoxic concentration was the lowest concentration factor of the WSC sample in the 
concentration−response curve that induced a statistically significant amount of genomic DNA damage as 
compared to the negative control. d The degrees of freedom for the between-groups and residual 
associated with the calculated F-test result and the resulting probability value. 
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Table 6.10. Experimental group 2: Test for significance among GTI values. 
 SW CL IPRO IPRO 
CL 
IHX IHX 
CL 
DTZ DTZ 
CL 
IOME IOME 
CL 
SW           
CL           
IPRO           
IPROCL           
IHX           
IHXCL           
DTZ           
DTZCL           
IOME           
IOMECL           
 
Abbreviations; SW=Akron source water, CL=Akron source water plus Cl2, IPRO=Iopromide, 
IPROCL=Iopromide plus Cl2, IHX=Iohexol, IHXCL=Iohexol plus Cl2, DTZ=Diatrizoate, DTZCL=Diatrizoate + 
Cl2, IOME=Iomeprol, IOMECL=Iomeprol + Cl2. In the pairwise comparison red indicates a significant 
difference between the paired groups, green indicates no significant difference between the paired 
groups.  
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Figure 6.1. Chemical structures of iodinated X-ray contrast agents (ICM) analyzed in this study. 
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Figure 6.2. Chemical structures of some transformation products of X-ray contrast media. 
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Figure 6.3. Chemical mechanisms involved in the formation of iodo-DBPs by chlorine and chloramine. 
Figure based on data by Bichsel and von Guten [14].   
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Figure 6.4. Chemical mechanism involved in the formation of iodo-DBPs by Iopamidol [6].  
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Figure 6.5. CHO cell chronic cytotoxicity concentration-response curve of AOHTOX-SW.   
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Water Sample AOHTOX plus Iopamidol
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Figure 6.6. CHO cell chronic cytotoxicity concentration-response curve of AOHTOX-IDOL.   
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Water Sample AOHTOX-CL
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Figure 6.7. CHO cell chronic cytotoxicity concentration-response curve of AOHTOX-CL.   
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Figure 6.8. CHO cell chronic cytotoxicity concentration-response curve of AOHTOX-CL-IDOL.   
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Water Sample AOHTOX-NH
2
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Figure 6.9. CHO cell chronic cytotoxicity concentration-response curve of AOHTOX-NH2CL.   
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Figure 6.10. CHO cell chronic cytotoxicity concentration-response curve of AOHTOX-NH2CL-IDOL.   
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Figure 6.11. Experimental group 1: CHO cell chronic cytotoxicity index (CTI) values.  
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Figure 6.12. CHO cell acute genotoxicity concentration-response curve of AOHTOX-SW.   
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Figure 6.13. CHO cell acute genotoxicity concentration-response curve of AOHTOX-IODOL. 
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Figure 6.14. CHO cell acute genotoxicity concentration-response curve of AOHTOX-CL. 
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Figure 6.15. CHO cell acute genotoxicity concentration-response curve of AOHTOX-CL-IODOL. 
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Figure 6.16. CHO cell acute genotoxicity concentration-response curve of AOHTOX-NH2CL. 
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Figure 6.17. CHO cell acute genotoxicity concentration-response curve of AOHTOX-NH2CL-IODOL. 
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Figure 6.18. Experimental group 1: CHO cell acute genotoxicity index (GTI) values.  
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Figure 6.19. CHO cell chronic cytotoxicity concentration-response curve of AOHTOX-Iopromide.   
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2
(Concentration Factor)
0 10 20 30 40 50
C
H
O
 C
e
ll 
C
y
to
to
x
ic
it
y
: 
M
e
a
n
 C
e
ll 
D
e
n
s
it
y
a
s
 t
h
e
 P
e
rc
e
n
t 
o
f 
th
e
 N
e
g
a
ti
ve
 C
o
n
tr
o
l 
(±
S
E
)
0
20
40
60
80
100
 
 
Figure 6.20. CHO cell chronic cytotoxicity concentration-response curve of AOHTOX-CL-Iopromide.   
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Figure 6.21. CHO cell chronic cytotoxicity concentration-response curve of AOHTOX-Iohexol.   
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Figure 6.22. CHO cell chronic cytotoxicity concentration-response curve of AOHTOX-CL-Iohexol.   
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Figure 6.23. CHO cell chronic cytotoxicity concentration-response curve of AOHTOX-Diatrizoate.   
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Figure 6.24. CHO cell chronic cytotoxicity concentration-response curve of AOHTOX-CL-Diatrizoate.   
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Figure 6.25. CHO cell chronic cytotoxicity concentration-response curve of AOHTOX-Iomeprol.   
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Figure 6.26. CHO cell chronic cytotoxicity concentration-response curve of AOHTOX-CL-Iomeprol.   
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Figure 6.27. Experimental group 2: CHO cell chronic cytotoxicity index (CTI) values.  
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Figure 6.28. CHO cell acute genotoxicity concentration-response curve of AOHTOX-Iopromide. 
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Figure 6.29. CHO cell acute genotoxicity concentration-response curve of AOHTOX-CL-Iopromide. 
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Figure 6.30. CHO cell acute genotoxicity concentration-response curve of AOHTOX-Iohexol. 
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Figure 6.31. CHO cell acute genotoxicity concentration-response curve of AOHTOX-CL-Iohexol. 
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Figure 6.32. CHO cell acute genotoxicity concentration-response curve of AOHTOX-Diatrizoate. 
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Figure 6.33. CHO cell acute genotoxicity concentration-response curve of AOHTOX-CL-Diatrizoate. 
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Akron OH Source Water: Iomeprol
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Figure 6.34. CHO cell acute genotoxicity concentration-response curve of AOHTOX-Iomeprol. 
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Figure 6.35. CHO cell acute genotoxicity concentration-response curve of AOHTOX-CL-Iomeprol. 
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Figure 6.36. Experimental group 2: CHO cell acute genotoxicity index (GTI) values.  
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CHAPTER 7 
CONCLUSIONS 
 
 The objectives of this dissertation were to analyze the comparative toxicity of emerging 
haloacetaldehyde (HAL) drinking water disinfection by-products (DBPs) and to investigate the 
molecular mechanism of DBP induced toxicity with haloacetic acids (HAAs). Development of a 
single well microplate-based ATP-protein measurement assay with HAAs, as a novel toxicity 
metric for DBPs was included as a part of the research. In addition, two complex DBP mixture 
studies were conducted. The first study investigated the occurrence and in vitro mammalian 
cell toxicity of DBPs in European drinking water samples collected from the site where 
epidemiological studies on reproductive outcomes were being conducted in relation with the 
HIWATE project. The correlations of analytical chemistry, analytical biology, and epidemiology 
were investigated. The second study focused on the impact of iodinated X-ray contrast media in 
the source water and the type of disinfectant on the overall toxicity of DBP mixtures.  
 Following conclusions were derived from these studies: 
1. Occurrence and comparative toxicity of the haloacetaldehyde disinfection by-products in 
drinking water   
 Iodoacetaldehyde was identified as a new HAL DBP by applying a new analytical 
chemical method.  
264 
 
 Ten HALs were analyzed for their in vitro cytotoxicity and genotoxicity in Chinese 
hamster ovary (CHO) cells. The most cytotoxic HALs were tribromoacetaldehyde (TCAL) 
and chloroacetaldehyde (CAL), followed by dibromoacetaldehyde (DBAL) and 
bromochloroacetaldehyde (BCAL). The most genotoxic HAL was bromoacetaldehyde 
(BAL), followed by CAL and dibromochloroacetaldehyde (DBCAL).  
 HALs were the second most cytotoxic DBP class among six DBP chemical classes (THMs, 
HAAs, HALs, halonitromethanes, haloacetonitriles, and haloacetamides). Therefore, 
HALs may adversely affect the public health and the environment.  
2. Investigate the biological mechanism induced by haloacetic acid disinfection by-products and 
the development of a single well microplate-based ATP-protein measurement assay  
 All three mono-halogenated HAAs (monoHAAs) including chloroacetic acid (CAA), 
bromoacetic acid (BAA), and iodoacetic acid (IAA) induced ATP depletion in CHO cells, 
and  simultaneous treatment with 10 mM pyruvate caused a significant recovery of 
cellular ATP levels.  
 The monoHAA-mediated ATP depletion followed a rank order of IAA > BAA >> CAA. This 
pattern and magnitude of ATP depletion directly correlated with the α-carbon-halide 
(αC-X) bond length and relative alkylation potential of each monoHAA and was inversely 
correlated with the αC-X bond dissociation energy.  
 ATP depletion was highly correlated with the inhibition kinetics of GAPDH and with 
diverse measurements of toxicity including cytotoxicity, genotoxicity, mutagenicity and 
teratogenicity published in the literature over the past decades.     
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 When the single well microplate-based ATP-protein measurement assay was applied, 
the cellular ATP levels for monoHAA-treated cells were significantly reduced, but were 
not concentration-dependent unlike the results from the parallel plate method used for 
the pyruvate supplementation study.  
 With the single well assay, monoHAAs showed the greatest reduction in ATP levels, 
whereas diHAAs showed a moderate reduction with higher concentration ranges. 
TriHAAs increases ATP levels. The average ATP levels as the % of negative control were 
40.9% for monoHAAs, 72.9% for diHAAs, and 120% for triHAAs.  
3. The occurrence and toxicity of disinfection by-products in European drinking waters in 
relation with the HIWATE epidemiology study 
 Eleven drinking water samples were collected from seven cities within five European 
countries (France, Lithuania, Spain, Italy, and the United Kingdom), where an 
epidemiologic study of reproductive outcomes was being conducted. Over 90 DBPs 
were identified in the samples, including several haloacids, halophenols, haloamides, 
halonitromethanes, haloketones (HKs), haloaldehydes, and haloalkenes. 
  Twenty-one target DBPs, including 4 U.S-regulated trihalomethanes (THMs), 9 HAAs, 4 
haloacetonitriles (HANs), 2 HKs, trichloroacetaldehyde (chloral hydrate), and 
trichloronitromethane (chloropicrin) were quantified, and substantial differences were 
observed in the DBP occurrence from the different locations.  
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 CHO cell chronic cytotoxicity was analyzed for each HIWATE sample. Based on LC50 
values, samples from Barcelona, Spain were ranked as the three most cytotoxic (sample 
1, 2, and 3).  
 CHO cell acute genotoxicity was analyzed for each HIWATE sample. Based on 50% Tail 
DNA values, the sample from Bradford, U.K. (sample 10) was most genotoxic followed 
by samples from Kaunas, Lithuania (sample 4) and Valencia, Spain (sample 7). 
 The cytotoxic potency index values significantly correlated with the number of identified 
DBPs (r = 0.78; P ≤ 0.005) and the level of 21 target DBPs (r = 0.77; P ≤ 0.006). The 
genotoxic potency index values were not significantly correlated with either of these 
metrics or with any DBP chemical class. 
 Cytotoxicity was significantly correlated with the relative concentrations of THMs (r = 
0.74; P ≤ 0.01), haloacids (r = 0.75; P ≤ 0.008), other monoacids (r = 0.68; P ≤ 0.021), 
halodiacids (r = 0.80; P ≤ 0.003), haloamides (r = 0.68; P ≤ 0.021), haloaromatics (r = 0.64; 
P ≤ 0.035), brominated (r = 0.68; P ≤ 0.022), chlorinated (r = 0.78; P ≤ 0.005) , and 
iodinated (r = 0.82; P ≤ 0.002) DBPs. There were no statistically significant correlations 
with genotoxicity and the above DBP classes.  
4. The impact of X-ray contrast agents on formation and toxicity of disinfection by-products in 
drinking water  
 Iopamidol generated an enhanced level of CHO cell cytotoxicity and genotoxicity in 
conjunction with either chlorine or chloramines disinfection. The relative Iopamidol-
267 
 
mediated increase in CHO cell cytotoxicity and genotoxicity was much greater when 
chloramine was used as the disinfectant as compared to chlorine. 
 Four other ICMs (Iopromide, Iohexol, Diatrizoate and Iomeprol) expressed some 
cytotoxicity over the control, and expressed higher cytotoxicity when chlorinated. Only 
Iohexol expressed an enhanced genotoxicity compared to the chlorinated source water 
control, while Iopromide reduced the genotoxicity.  
 Of the five X-ray contrast agents evaluated for their mammalian cell cytotoxicity and 
genotoxicity, Iopamidol in water disinfected with chlorine or chloramines was clearly the 
most responsive in generating adverse biological responses.  
 
 This study focused on the occurrence and toxicity of emerging HAL DBPs and identified a 
new HAL DBP, iodoacetaldehyde. This study provided the first systematic, quantitative 
comparison of HAL toxicity. HALs may adversely affect the public health and the environment 
and further research are needed to investigate the mode of action of their toxicity. This study 
extended our research on the molecular mechanism(s) of toxicity of DBPs by investigating the 
impact of monoHAAs on cellular ATP levels and the attenuation by pyruvate supplementation. 
This study also provided a platform for the development of a novel bioassay, which 
quantitatively measures the toxicity of DBPs at molecular cellular levels. An alteration in cellular 
ATP homeostasis at non-cytotoxic concentrations may be an important metric of toxic action. 
This assay allows measurements of adverse biological responses at DBP concentrations found in 
finished drinking water. Additional studies are needed to validate the utility of the assay, and 
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we will further determine if pyruvate dehydrogenase complex is stimulated by the di- and 
triHAAs. The HIWATE study was unique in that it integrated quantitative in vitro toxicological 
data with analytical chemistry and human epidemiologic data for drinking water DBPs. Future 
studies will investigate the possible association between chronic cytotoxicity, acute 
genotoxicity, multivariate comparisons of identified DBPs and epidemiology across the entire 
HIWATE program. We plan to compare other in vitro and molecular toxicity metrics and rates of 
adverse pregnancy measurements. The impacts of ICM on complex DBP mixture toxicity were 
investigated in this study. For precise interpretation, high molecular weight DBPs and low 
molecular weight DBPs and the ICM transformation products will need to be identified and the 
toxicity of those individual agents need to be determined.    
 
 
